| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR MYH7 MYO9A MARK3 SPTAN1 SPTBN1 GAS2 RABGAP1 PICALM CEP350 DST BRCA1 ABRAXAS1 JAKMIP1 DIAPH3 FKBP4 AKAP5 MYH7B ANXA2 ANXA2P2 SYNE1 SHROOM2 KIF20B AFAP1 SMC3 LMO7 TTLL6 MYH14 P4HB CEP70 KIRREL1 MYH15 LIMCH1 FHDC1 CEP57 UNC13A | 3.22e-07 | 1099 | 260 | 36 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH7 MYO9A CHD4 DNAH14 ACSL4 MYH7B ANXA1 DDX60 ABCC9 YTHDC2 UPF1 DDX55 KIF20B MFSD2A ATP6V0D1 SMC3 MYH14 ERCC6L2 SMARCA2 MYH15 ATP2A2 ATP2B2 ATP5F1A | 6.04e-06 | 614 | 260 | 23 | GO:0140657 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 8.63e-06 | 11 | 260 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 2.14e-05 | 5 | 260 | 3 | GO:0019834 | |
| GeneOntologyMolecularFunction | GTPase binding | ERC1 SPTBN1 RABGAP1 PICALM RABGAP1L MFN2 DIAPH3 WDR44 UNC13B ANKFY1 ANXA2 ANXA2P2 ALS2 ODF2 DEPDC5 | 8.13e-05 | 360 | 260 | 15 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | ERC1 RABGAP1 PICALM RABGAP1L MFN2 DIAPH3 WDR44 UNC13B ANKFY1 ANXA2 ANXA2P2 ALS2 ODF2 DEPDC5 | 8.68e-05 | 321 | 260 | 14 | GO:0031267 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.27e-04 | 38 | 260 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.58e-04 | 118 | 260 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 1.69e-04 | 2 | 260 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 1.69e-04 | 2 | 260 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 1.69e-04 | 2 | 260 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | actin binding | MYH7 MYO9A SPTAN1 SPTBN1 GAS2 DST DIAPH3 AKAP5 MYH7B SYNE1 SHROOM2 AFAP1 MYH14 P4HB MYH15 LIMCH1 FHDC1 | 1.93e-04 | 479 | 260 | 17 | GO:0003779 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.07e-04 | 42 | 260 | 5 | GO:0098918 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH7 SPTAN1 SPTBN1 UNC13B AKAP5 MYH14 MYH15 UNC13C ATP2B2 UNC13A KCNH5 | 2.25e-04 | 230 | 260 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.07e-04 | 130 | 260 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 3.35e-04 | 26 | 260 | 4 | GO:0052742 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-phosphate 4-kinase activity | 5.02e-04 | 3 | 260 | 2 | GO:0016309 | |
| GeneOntologyMolecularFunction | tubulin binding | TPR GAS2 RABGAP1 CEP350 DST BRCA1 ABRAXAS1 JAKMIP1 DIAPH3 KIF20B SMC3 TTLL6 CEP70 FHDC1 CEP57 | 5.22e-04 | 428 | 260 | 15 | GO:0015631 |
| GeneOntologyMolecularFunction | phospholipase inhibitor activity | 5.67e-04 | 13 | 260 | 3 | GO:0004859 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 7.58e-04 | 32 | 260 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH7 MYO9A SPTAN1 SPTBN1 GAS2 MYH7B SYNE1 SHROOM2 MYH14 MYH15 | 8.18e-04 | 227 | 260 | 10 | GO:0051015 |
| GeneOntologyMolecularFunction | calcium ion binding | SPTAN1 SNTN DST UNC13B ANXA1 ANXA2 ANXA2P2 NUCB1 MMRN1 TLL2 ASPH PITPNM3 ADGRE5 UNC13C PLCH1 MICU2 ATP2A2 ATP2B2 PCDH8 UNC13A RCN3 | 8.44e-04 | 749 | 260 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | S100 protein binding | 8.84e-04 | 15 | 260 | 3 | GO:0044548 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ERC1 SPTAN1 SPTBN1 PICALM NRXN3 DST SYK DIAPH3 BAIAP2 SFN AKAP5 ANXA1 ANXA2 ARVCF P4HB NUMB KIRREL1 TNR | 9.11e-04 | 599 | 260 | 18 | GO:0050839 |
| GeneOntologyMolecularFunction | double-stranded DNA helicase activity | 9.96e-04 | 4 | 260 | 2 | GO:0036121 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 1.08e-03 | 16 | 260 | 3 | GO:0019992 | |
| GeneOntologyMolecularFunction | helicase activity | 1.11e-03 | 158 | 260 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 1.52e-03 | 95 | 260 | 6 | GO:0005546 | |
| GeneOntologyMolecularFunction | lipase inhibitor activity | 1.54e-03 | 18 | 260 | 3 | GO:0055102 | |
| GeneOntologyMolecularFunction | cadherin binding | ERC1 SPTAN1 SPTBN1 PICALM DIAPH3 BAIAP2 SFN AKAP5 ANXA1 ANXA2 ARVCF NUMB | 1.71e-03 | 339 | 260 | 12 | GO:0045296 |
| GeneOntologyMolecularFunction | cadherin binding involved in cell-cell adhesion | 1.81e-03 | 19 | 260 | 3 | GO:0098641 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.95e-03 | 41 | 260 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | phospholipid binding | SPTBN1 ADGRB1 WASHC2A PICALM AMER2 PIK3C2G SNX32 UNC13B ANKFY1 WASHC2C APOA5 ANXA1 ANXA2 ANXA2P2 UNC13C UNC13A | 2.32e-03 | 548 | 260 | 16 | GO:0005543 |
| GeneOntologyBiologicalProcess | cell morphogenesis | HECW1 NUMBL MYO9A GAS2 ADGRB1 SPART PICALM POTEE NRXN3 KIDINS220 DST UCHL1 MFN2 FLRT3 BAIAP2 DNMBP SLC23A2 AKAP5 ARHGEF28 ANXA1 POTEF SYNE1 LAMA3 ALS2 SHROOM2 KIF20B LIFR MFSD2A IFRD1 LATS2 MYH14 PALM3 NUMB POTEJ POTEI TNR ATP2B2 UNC13A ZMYM4 CUX1 | 1.48e-08 | 1194 | 260 | 40 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | HECW1 NUMBL MYO9A ADGRB1 SPART PICALM POTEE NRXN3 KIDINS220 DST UCHL1 MFN2 FLRT3 BAIAP2 SLC23A2 AKAP5 ARHGEF28 POTEF SYNE1 LAMA3 ALS2 KIF20B LIFR MFSD2A IFRD1 NUMB POTEJ POTEI TNR UNC13A CUX1 | 3.18e-08 | 802 | 260 | 31 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | HECW1 NUMBL MYO9A ADGRB1 SPART PICALM POTEE NRXN3 KIDINS220 DST UCHL1 MFN2 FLRT3 BAIAP2 SLC23A2 AKAP5 ARHGEF28 POTEF SYNE1 LAMA3 ALS2 KIF20B LIFR MFSD2A IFRD1 NUMB POTEJ POTEI TNR UNC13A CUX1 | 5.11e-08 | 819 | 260 | 31 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | HECW1 NUMBL MYO9A ADGRB1 SPART PICALM POTEE NRXN3 KIDINS220 DST UCHL1 MFN2 FLRT3 BAIAP2 SLC23A2 AKAP5 ARHGEF28 POTEF SYNE1 LAMA3 ALS2 KIF20B LIFR MFSD2A IFRD1 NUMB POTEJ POTEI TNR UNC13A CUX1 | 6.18e-08 | 826 | 260 | 31 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell junction organization | NUMBL ASIC1 MYO9A ERC1 ADGRB1 TSC1 CHD4 BCR PICALM POTEE NRXN3 DST MFN2 FLRT3 BAIAP2 UNC13B AKAP5 POTEF LAMA3 RAPGEF1 ALS2 CNKSR2 SHROOM2 NUMB KIRREL1 ADGRE5 LIMCH1 POTEJ POTEI TNR ATP2B2 PCDH8 UNC13A | 2.42e-07 | 974 | 260 | 33 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | NUMBL MYO9A GAS2 PICALM MFN2 BAIAP2 DNMBP SLC23A2 AKAP5 ANXA1 MFSD2A MYH14 PALM3 NUMB UNC13A ZMYM4 CUX1 | 3.18e-07 | 302 | 260 | 17 | GO:0022604 |
| GeneOntologyBiologicalProcess | synapse organization | NUMBL ASIC1 MYO9A ERC1 ADGRB1 TSC1 CHD4 PICALM POTEE NRXN3 MFN2 FLRT3 BAIAP2 UNC13B AKAP5 POTEF ALS2 CNKSR2 NUMB ADGRE5 POTEJ POTEI TNR ATP2B2 PCDH8 UNC13A | 6.25e-07 | 685 | 260 | 26 | GO:0050808 |
| GeneOntologyBiologicalProcess | neuron projection development | HECW1 NUMBL MYO9A ADGRB1 SPART TSC1 GPRIN1 PICALM ACSL4 POTEE NRXN3 KIDINS220 DST UCHL1 MFN2 FLRT3 BAIAP2 SLC23A2 FKBP4 AKAP5 ARHGEF28 POTEF SYNE1 LAMA3 RAPGEF1 GPRIN3 ALS2 KIF20B LIFR MFSD2A IFRD1 NUMB POTEJ POTEI TNR ATP2B2 UNC13A CUX1 | 8.32e-07 | 1285 | 260 | 38 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HECW1 NUMBL ADGRB1 SPART PICALM POTEE NRXN3 KIDINS220 DST UCHL1 MFN2 FLRT3 BAIAP2 AKAP5 ARHGEF28 POTEF SYNE1 LAMA3 ALS2 MFSD2A IFRD1 NUMB POTEJ POTEI TNR ATP2B2 CUX1 | 9.91e-07 | 748 | 260 | 27 | GO:0048667 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH7 SPTAN1 SPTBN1 GAS2 ADGRB1 TSC1 BCR WASHC2A POTEE MFN2 MYH16 DIAPH3 BAIAP2 AMOTL2 RAP1GDS1 WASHC2C MYH7B ANXA1 POTEF ABCC9 SHROOM2 RNH1 MYH14 KIRREL1 LIMCH1 FHDC1 POTEJ POTEI ATP2A2 | 4.78e-06 | 912 | 260 | 29 | GO:0030029 |
| GeneOntologyBiologicalProcess | intracellular transport | TPR CLUAP1 ERC1 VPS13C TSC1 BCR WASHC2A PICALM DST BRCA1 SNX32 UCHL1 PIP4K2A SYK AP1M1 DIAPH3 HEATR5B SFN CCHCR1 ANKFY1 AKAP5 WASHC2C ANXA2 ANXA2P2 SYNE1 AP1M2 ALS2 UPF1 KIF20B HPS3 IWS1 PPP1R10 VIPAS39 ATP6V0D1 LMNA P4HB ASPH ELAVL1 ATP2A2 GRAMD1C | 5.01e-06 | 1496 | 260 | 40 | GO:0046907 |
| GeneOntologyBiologicalProcess | dense core granule priming | 7.85e-06 | 4 | 260 | 3 | GO:0061789 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH7 SPTAN1 SPTBN1 GAS2 ADGRB1 TSC1 BCR WASHC2A POTEE MFN2 MYH16 DIAPH3 BAIAP2 AMOTL2 RAP1GDS1 WASHC2C ANXA1 POTEF SHROOM2 RNH1 MYH14 KIRREL1 LIMCH1 FHDC1 POTEJ POTEI | 1.12e-05 | 803 | 260 | 26 | GO:0030036 |
| GeneOntologyBiologicalProcess | neuron development | HECW1 NUMBL MYO9A ADGRB1 SPART TSC1 GPRIN1 PICALM ACSL4 POTEE NRXN3 KIDINS220 DST UCHL1 MFN2 FLRT3 BAIAP2 SLC23A2 FKBP4 AKAP5 ARHGEF28 POTEF SYNE1 LAMA3 RAPGEF1 GPRIN3 ALS2 KIF20B LIFR MFSD2A IFRD1 NUMB POTEJ POTEI TNR ATP2B2 UNC13A CUX1 | 1.71e-05 | 1463 | 260 | 38 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis | PICALM PIK3CB SYK AKAP5 BMP2K APOA5 ANXA2 ANXA2P2 SYNE1 NUMB | 2.98e-05 | 156 | 260 | 10 | GO:0048259 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 3.98e-05 | 31 | 260 | 5 | GO:0098974 | |
| GeneOntologyBiologicalProcess | regulation of dendrite morphogenesis | 4.85e-05 | 103 | 260 | 8 | GO:0048814 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 7.30e-05 | 35 | 260 | 5 | GO:0099188 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TPR ERC1 VPS13C SPTAN1 SPTBN1 TSC1 RABGAP1 WASHC2A MAP3K4 NCAPG BRCA1 PIP4K2A MFN2 PIP4K2B DIAPH3 BAIAP2 FKBP4 WDR44 RAP1GDS1 WASHC2C ANXA1 ANXA2 SYNE1 UPF1 ODF2 SHROOM2 KIF20B PPP1R10 LMNA RNH1 CEP70 SMARCA2 KIRREL1 LIMCH1 | 8.12e-05 | 1342 | 260 | 34 | GO:0033043 |
| GeneOntologyBiologicalProcess | organelle assembly | TPR MYH7 CLUAP1 RABGAP1 CEP350 NRXN3 BRCA1 ABRAXAS1 PIP4K2A MFN2 AP1M1 PIP4K2B DIAPH3 CEP126 DNMBP WDR44 DCAF13 B3GLCT POC1A SYNE1 CNTRL ODF2 HPS3 VIPAS39 ATP6V0D1 SMC3 CEP70 CEP152 FHDC1 ATP2A2 | 1.10e-04 | 1138 | 260 | 30 | GO:0070925 |
| GeneOntologyBiologicalProcess | axonogenesis | NUMBL ADGRB1 SPART PICALM POTEE NRXN3 DST UCHL1 FLRT3 BAIAP2 ARHGEF28 POTEF LAMA3 ALS2 IFRD1 NUMB POTEJ POTEI TNR | 1.11e-04 | 566 | 260 | 19 | GO:0007409 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | HECW1 NUMBL MYO9A GAS2 ADGRB1 SPART BCR PICALM BRCA1 PIK3CB MFN2 BAIAP2 DNMBP SLC23A2 AKAP5 WARS1 ANXA1 SYNE1 MFSD2A IFRD1 RNH1 MYH14 PALM3 NUMB TNR MTDH UNC13A ZMYM4 CUX1 | 1.23e-04 | 1090 | 260 | 29 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 1.24e-04 | 150 | 260 | 9 | GO:0050773 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 1.58e-04 | 2 | 260 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 1.58e-04 | 2 | 260 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | postsynapse organization | NUMBL ASIC1 MYO9A ADGRB1 POTEE NRXN3 MFN2 BAIAP2 POTEF CNKSR2 NUMB POTEJ POTEI | 1.83e-04 | 313 | 260 | 13 | GO:0099173 |
| GeneOntologyBiologicalProcess | positive regulation of dendrite morphogenesis | 1.99e-04 | 67 | 260 | 6 | GO:0050775 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | HECW1 NUMBL PICALM KIDINS220 MFN2 BAIAP2 AKAP5 SYNE1 NUMB CUX1 | 2.17e-04 | 198 | 260 | 10 | GO:0048813 |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 2.23e-04 | 10 | 260 | 3 | GO:0099525 | |
| GeneOntologyBiologicalProcess | positive regulation of cell morphogenesis | 2.34e-04 | 69 | 260 | 6 | GO:0010770 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | TPR NUMBL ASIC1 SPTAN1 SPTBN1 ADGRB1 TSC1 CHD4 RABGAP1 BRCA1 SACS PIP4K2A SYK MFN2 PIP4K2B FLRT3 BAIAP2 FKBP4 WDR44 UNC13B WARS1 WASHC2C SYNE1 RAPGEF1 ODF2 NUMB KIRREL1 ADGRE5 LIMCH1 UNC13A | 2.35e-04 | 1189 | 260 | 30 | GO:0044087 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | TPR NUMBL ERC1 ADGRB1 TSC1 BCR PICALM MAP3K4 NCAPG KIDINS220 PIP4K2A SYK MFN2 PIP4K2B FLRT3 BAIAP2 UNC13B ANKFY1 AKAP5 WARS1 WASHC2C APOA5 ANXA1 ANXA2 ANXA2P2 SYNE1 RAPGEF1 PPP1R10 NUMB KIRREL1 ADGRE5 LIMCH1 CUX1 | 2.51e-04 | 1366 | 260 | 33 | GO:0051130 |
| GeneOntologyBiologicalProcess | white fat cell differentiation | 2.53e-04 | 25 | 260 | 4 | GO:0050872 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 2.53e-04 | 25 | 260 | 4 | GO:0048791 | |
| GeneOntologyBiologicalProcess | vesicle organization | ERC1 PICALM PIP4K2A AP1M1 PIP4K2B DIAPH3 ANKFY1 ANXA1 ANXA2 ALS2 SHROOM2 HPS3 VIPAS39 ATP6V0D1 UNC13A | 2.70e-04 | 415 | 260 | 15 | GO:0016050 |
| GeneOntologyBiologicalProcess | phosphatidylinositol metabolic process | INPP5B INPP5D CHRM5 PIK3C2G PIK3CB PIP4K2A PIP4K2B PITPNM3 PLCH1 | 3.16e-04 | 170 | 260 | 9 | GO:0046488 |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 4.00e-04 | 12 | 260 | 3 | GO:0099011 | |
| GeneOntologyBiologicalProcess | autophagosome-lysosome fusion | 4.00e-04 | 12 | 260 | 3 | GO:0061909 | |
| GeneOntologyBiologicalProcess | vesicle fusion | 4.49e-04 | 142 | 260 | 8 | GO:0006906 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 4.71e-04 | 3 | 260 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 4.71e-04 | 3 | 260 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | neuroblast division in subventricular zone | 4.71e-04 | 3 | 260 | 2 | GO:0021849 | |
| GeneOntologyBiologicalProcess | 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process | 4.71e-04 | 3 | 260 | 2 | GO:1902635 | |
| GeneOntologyBiologicalProcess | organelle membrane fusion | 4.93e-04 | 144 | 260 | 8 | GO:0090174 | |
| GeneOntologyBiologicalProcess | axon development | NUMBL ADGRB1 SPART PICALM POTEE NRXN3 DST UCHL1 FLRT3 BAIAP2 ARHGEF28 POTEF LAMA3 ALS2 IFRD1 NUMB POTEJ POTEI TNR | 5.38e-04 | 642 | 260 | 19 | GO:0061564 |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 5.94e-04 | 31 | 260 | 4 | GO:0016082 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH7 MYO9A INPP5D SPTAN1 SPTBN1 GAS2 TSC1 POTEE PTPN12 DST MYH16 DIAPH3 BAIAP2 MYH7B ANXA1 ANXA2 ANXA2P2 POTEF SHROOM2 AFAP1 MYH14 MYH15 LIMCH1 FHDC1 POTEJ POTEI | 1.77e-08 | 576 | 261 | 26 | GO:0015629 |
| GeneOntologyCellularComponent | actin filament | MYO9A INPP5D GAS2 TSC1 POTEE DIAPH3 ANXA1 POTEF AFAP1 FHDC1 POTEJ POTEI | 3.12e-07 | 146 | 261 | 12 | GO:0005884 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH7 MYO9A INPP5D SPTAN1 SPTBN1 GAS2 TSC1 CMYA5 DNAH14 POTEE ADRA1A DST JAKMIP1 DIAPH3 BAIAP2 FKBP4 WDR44 MYH7B ANXA1 COL28A1 POTEF SYNE1 ABCC9 ODF2 SHROOM2 KIF20B AFAP1 LMNA TTLL6 MYH14 MYH15 FHDC1 POTEJ POTEI CEP57 AHNAK2 | 6.41e-07 | 1179 | 261 | 36 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH7 MYO9A INPP5D SPTAN1 SPTBN1 GAS2 TSC1 CMYA5 DNAH14 POTEE ADRA1A DST JAKMIP1 DIAPH3 BAIAP2 FKBP4 WDR44 MYH7B ANXA1 COL28A1 POTEF SYNE1 ABCC9 ODF2 SHROOM2 KIF20B AFAP1 LMNA TTLL6 MYH14 MYH15 FHDC1 POTEJ POTEI CEP57 AHNAK2 | 7.51e-07 | 1187 | 261 | 36 | GO:0099081 |
| GeneOntologyCellularComponent | myosin complex | 8.56e-06 | 59 | 261 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | early endosome | INPP5B WASHC2A PICALM RABGAP1L AP1M1 ANKFY1 WASHC2C APOA5 ANXA1 ANXA2 ANXA2P2 NUCB1 RAPGEF1 ALS2 HPS3 GPR107 VIPAS39 ATP6V0D1 NUMB | 1.09e-05 | 481 | 261 | 19 | GO:0005769 |
| GeneOntologyCellularComponent | glutamatergic synapse | NUMBL ASIC1 MYO9A ERC1 SPTAN1 SPTBN1 ADGRB1 CHD4 BCR ADRA1A NRXN3 FLRT3 BAIAP2 CPSF2 UNC13B ANO2 AKAP5 ALS2 CNKSR2 NUMB ELAVL1 OLFM2 TNR ATP2B2 PCDH8 UNC13A | 1.28e-05 | 817 | 261 | 26 | GO:0098978 |
| GeneOntologyCellularComponent | synaptic membrane | ASIC1 ERC1 ADGRB1 PICALM CHRM5 ADRA1A NRXN3 FLRT3 BAIAP2 UNC13B ANO2 AKAP5 ANXA1 SYNE1 SHC4 CNKSR2 UNC13C OLFM2 ATP2B2 PCDH8 UNC13A | 1.50e-05 | 583 | 261 | 21 | GO:0097060 |
| GeneOntologyCellularComponent | actin filament bundle | 1.76e-05 | 118 | 261 | 9 | GO:0032432 | |
| GeneOntologyCellularComponent | myosin II complex | 2.27e-05 | 28 | 261 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ASIC1 ERC1 SPTBN1 ADGRB1 TSC1 CHD4 BCR PICALM DST FLRT3 BAIAP2 UNC13B AKAP5 ALS2 CNKSR2 NUMB OLFM2 TNR ATP2B2 | 3.44e-05 | 523 | 261 | 19 | GO:0098984 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 5.96e-05 | 107 | 261 | 8 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 5.96e-05 | 107 | 261 | 8 | GO:0001725 | |
| GeneOntologyCellularComponent | microtubule organizing center | CLUAP1 ERC1 CHD4 RABGAP1 BIRC6 CEP350 AUNIP BRCA1 CROCC2 DIAPH3 CEP126 CCHCR1 DCAF13 POC1A CNTRL ALS2 ODF2 CCDC141 KIF20B ATP6V0D1 LATS2 TTLL6 CEP70 ERCC6L2 CEP152 CEP57 | 9.18e-05 | 919 | 261 | 26 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CLUAP1 ERC1 CHD4 RABGAP1 BIRC6 CEP350 AUNIP BRCA1 CROCC2 CEP126 DCAF13 POC1A CNTRL ALS2 ODF2 CCDC141 KIF20B ATP6V0D1 LATS2 CEP70 ERCC6L2 CEP152 CEP57 | 1.07e-04 | 770 | 261 | 23 | GO:0005813 |
| GeneOntologyCellularComponent | actomyosin | 1.12e-04 | 117 | 261 | 8 | GO:0042641 | |
| GeneOntologyCellularComponent | asymmetric synapse | ASIC1 ERC1 SPTBN1 ADGRB1 TSC1 CHD4 BCR PICALM DST FLRT3 BAIAP2 AKAP5 ALS2 CNKSR2 NUMB OLFM2 ATP2B2 | 1.12e-04 | 477 | 261 | 17 | GO:0032279 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.74e-04 | 23 | 261 | 4 | GO:0098831 | |
| GeneOntologyCellularComponent | postsynaptic density | ASIC1 ERC1 SPTBN1 ADGRB1 TSC1 BCR PICALM DST FLRT3 BAIAP2 AKAP5 ALS2 CNKSR2 NUMB OLFM2 ATP2B2 | 1.88e-04 | 451 | 261 | 16 | GO:0014069 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 2.37e-04 | 45 | 261 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | myosin filament | 2.44e-04 | 25 | 261 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | cell cortex | ERC1 INPP5D SPTAN1 SPTBN1 TSC1 DST UNC13B ANXA2 ANXA2P2 POTEF SHROOM2 ASPH UNC13C UNC13A | 2.54e-04 | 371 | 261 | 14 | GO:0005938 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PDE8A ADGRB1 TSC1 CMYA5 PICALM MAP3K4 DST OSBP2 HEATR5B FKBP4 WDR44 AKAP5 ANXA2 ANXA2P2 SYNE1 CNTRL RAPGEF1 YTHDC2 UPF1 KIF20B LMNA KIRREL1 DEPDC5 ATP2A2 MTDH | 2.93e-04 | 934 | 261 | 25 | GO:0048471 |
| GeneOntologyCellularComponent | pinosome | 2.95e-04 | 11 | 261 | 3 | GO:0044352 | |
| GeneOntologyCellularComponent | macropinosome | 2.95e-04 | 11 | 261 | 3 | GO:0044354 | |
| GeneOntologyCellularComponent | excitatory synapse | 3.94e-04 | 107 | 261 | 7 | GO:0060076 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYO9A INPP5D GAS2 TSC1 DNAH14 POTEE DST JAKMIP1 DIAPH3 BAIAP2 FKBP4 WDR44 ANXA1 POTEF ODF2 SHROOM2 KIF20B AFAP1 LMNA TTLL6 FHDC1 POTEJ POTEI CEP57 | 4.02e-04 | 899 | 261 | 24 | GO:0099513 |
| GeneOntologyCellularComponent | postsynapse | ASIC1 MYO9A ERC1 SPTAN1 SPTBN1 ADGRB1 TSC1 BCR PICALM CHRM5 ADRA1A DST FLRT3 BAIAP2 CPSF2 AKAP5 SYNE1 SHC4 ALS2 CNKSR2 NUMB ELAVL1 OLFM2 ATP2B2 PCDH8 RPL13 | 4.52e-04 | 1018 | 261 | 26 | GO:0098794 |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 4.62e-04 | 3 | 261 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 4.62e-04 | 3 | 261 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | cell-cell junction | SPTAN1 ADGRB1 DST NHS FLRT3 BAIAP2 AMOTL2 DNMBP ANXA1 ANXA2 LAMA3 SHROOM2 ARVCF LMO7 KIRREL1 PALS2 ATP2A2 MTDH | 4.83e-04 | 591 | 261 | 18 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic specialization | ASIC1 ERC1 SPTBN1 ADGRB1 TSC1 BCR PICALM DST FLRT3 BAIAP2 AKAP5 ALS2 CNKSR2 NUMB OLFM2 ATP2B2 | 6.24e-04 | 503 | 261 | 16 | GO:0099572 |
| GeneOntologyCellularComponent | lipid droplet | 6.40e-04 | 116 | 261 | 7 | GO:0005811 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 6.49e-04 | 32 | 261 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | ribbon synapse | 6.49e-04 | 32 | 261 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 6.49e-04 | 32 | 261 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | myofibril | MYH7 SPTAN1 SPTBN1 CMYA5 ADRA1A DST MYH7B SYNE1 ABCC9 MYH15 AHNAK2 | 6.75e-04 | 273 | 261 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | endosome | VPS13C INPP5B WASHC2A BIRC6 PICALM FFAR4 KIDINS220 SNX32 RABGAP1L AP1M1 DIAPH3 AMOTL2 WDR44 ANKFY1 AKAP5 WASHC2C APOA5 ANXA1 ANXA2 ANXA2P2 NUCB1 RAPGEF1 ALS2 HPS3 GPR107 VIPAS39 ATP6V0D1 NUMB | 7.26e-04 | 1167 | 261 | 28 | GO:0005768 |
| GeneOntologyCellularComponent | basement membrane | 8.64e-04 | 122 | 261 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH7 SPTAN1 SPTBN1 CMYA5 ADRA1A DST MYH7B SYNE1 ABCC9 MYH15 AHNAK2 | 1.10e-03 | 290 | 261 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | spindle pole | 1.14e-03 | 205 | 261 | 9 | GO:0000922 | |
| GeneOntologyCellularComponent | axon | MYO9A SPTAN1 SPTBN1 TSC1 GPRIN1 BCR POTEE DST SACS UCHL1 FLRT3 FKBP4 UNC13B POTEF ALS2 KIF20B ATP6V0D1 MYH14 UNC13C POTEJ POTEI UNC13A | 1.90e-03 | 891 | 261 | 22 | GO:0030424 |
| GeneOntologyCellularComponent | midbody | 1.97e-03 | 222 | 261 | 9 | GO:0030496 | |
| GeneOntologyCellularComponent | cell cortex region | 2.37e-03 | 45 | 261 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | presynaptic membrane | ERC1 PICALM ADRA1A NRXN3 UNC13B ANO2 UNC13C ATP2B2 PCDH8 UNC13A | 2.63e-03 | 277 | 261 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | anchoring junction | SPTAN1 ADGRB1 PTPN12 DST NHS FLRT3 BAIAP2 AMOTL2 DNMBP ANXA1 ANXA2 LAMA3 SHROOM2 AFAP1 ARVCF LMO7 P4HB NUMB KIRREL1 ADGRE5 PALS2 ATP2A2 MTDH | 2.72e-03 | 976 | 261 | 23 | GO:0070161 |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 3.13e-03 | 7 | 261 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | dendritic spine | 3.50e-03 | 242 | 261 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 4.00e-03 | 247 | 261 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | BRCA1-A complex | 4.14e-03 | 8 | 261 | 2 | GO:0070531 | |
| GeneOntologyCellularComponent | sarcomere | 4.21e-03 | 249 | 261 | 9 | GO:0030017 | |
| HumanPheno | Pes cavus | MYH7 MYO9A SPTAN1 SPART SACS UCHL1 MFN2 FLRT3 B3GLCT WARS1 SYNE1 ALS2 CCDC141 IFRD1 LMNA SORD | 3.71e-05 | 304 | 86 | 16 | HP:0001761 |
| HumanPheno | Absent patellar reflexes | 4.82e-05 | 13 | 86 | 4 | HP:0006844 | |
| HumanPheno | Absent deep tendon reflexes | 4.82e-05 | 13 | 86 | 4 | HP:0001314 | |
| HumanPheno | Upper limb amyotrophy | 6.69e-05 | 83 | 86 | 8 | HP:0009129 | |
| HumanPheno | Abnormality of the voice | MYH7 MYO9A SPTBN1 ARHGEF38 SPART DST MFN2 FLRT3 VARS1 POC1A SYNE1 LAMA3 ALS2 CCDC141 LIFR LMNA ARVCF SMC3 MYH14 P4HB UNC13A ATP5F1A | 6.74e-05 | 545 | 86 | 22 | HP:0001608 |
| HumanPheno | Amyotrophy involving the extremities | 9.71e-05 | 112 | 86 | 9 | HP:0003671 | |
| HumanPheno | Distal amyotrophy | MYH7 MYO9A SPTAN1 SPART SACS MFN2 CEP126 WARS1 ALS2 LMNA MYH14 TNR UNC13A | 1.06e-04 | 230 | 86 | 13 | HP:0003693 |
| HumanPheno | Limb undergrowth | MYH7 SPTAN1 HMGCR FANCD2 BRCA1 MFN2 NHS DPYD B3GLCT WARS1 POC1A ALS2 ESCO2 LIFR LMNA SMC3 SMARCA2 CEP57 RPL13 | 1.10e-04 | 444 | 86 | 19 | HP:0009826 |
| MousePheno | abnormal soleus morphology | 2.81e-05 | 24 | 216 | 5 | MP:0003081 | |
| MousePheno | edema | CLUAP1 MYO9A INPP5D SPTAN1 SPTBN1 TSC1 BCR BIRC6 MAP3K4 PTPN12 SYK BAIAP2 PRRC2B RAP1GDS1 RAPGEF1 ATE1 NCOR2 LMNA KCTD3 NUMB ELAVL1 ATP2A2 RCN3 | 3.39e-05 | 581 | 216 | 23 | MP:0001785 |
| MousePheno | increased spinal cord apoptosis | 3.56e-05 | 5 | 216 | 3 | MP:0013182 | |
| Domain | Unc-13 | 2.67e-06 | 3 | 260 | 3 | IPR027080 | |
| Domain | Spectrin | 1.38e-05 | 23 | 260 | 5 | PF00435 | |
| Domain | tRNA-bd_arm | 1.72e-05 | 24 | 260 | 5 | IPR010978 | |
| Domain | Munc13_dom-2 | 2.61e-05 | 5 | 260 | 3 | IPR014772 | |
| Domain | Munc13_subgr_dom-2 | 2.61e-05 | 5 | 260 | 3 | IPR019558 | |
| Domain | Membr_traf_MHD | 2.61e-05 | 5 | 260 | 3 | PF10540 | |
| Domain | MHD2 | 2.61e-05 | 5 | 260 | 3 | PS51259 | |
| Domain | DUF1041 | 2.61e-05 | 5 | 260 | 3 | SM01145 | |
| Domain | PID | 3.80e-05 | 28 | 260 | 5 | PF00640 | |
| Domain | Myosin_N | 4.44e-05 | 15 | 260 | 4 | IPR004009 | |
| Domain | Myosin_N | 4.44e-05 | 15 | 260 | 4 | PF02736 | |
| Domain | Spectrin_repeat | 4.54e-05 | 29 | 260 | 5 | IPR002017 | |
| Domain | Actin_CS | 5.85e-05 | 16 | 260 | 4 | IPR004001 | |
| Domain | PID | 7.45e-05 | 32 | 260 | 5 | PS01179 | |
| Domain | ACTINS_2 | 7.57e-05 | 17 | 260 | 4 | PS00432 | |
| Domain | Munc13_1 | 8.96e-05 | 7 | 260 | 3 | IPR014770 | |
| Domain | MHD1 | 8.96e-05 | 7 | 260 | 3 | PS51258 | |
| Domain | DUF1041 | 8.96e-05 | 7 | 260 | 3 | PF06292 | |
| Domain | CAPS_dom | 8.96e-05 | 7 | 260 | 3 | IPR010439 | |
| Domain | Myosin_tail_1 | 9.63e-05 | 18 | 260 | 4 | PF01576 | |
| Domain | Actin/actin-like_CS | 9.63e-05 | 18 | 260 | 4 | IPR020902 | |
| Domain | Myosin_tail | 9.63e-05 | 18 | 260 | 4 | IPR002928 | |
| Domain | ACTINS_ACT_LIKE | 1.21e-04 | 19 | 260 | 4 | PS01132 | |
| Domain | Myosin-like_IQ_dom | 1.21e-04 | 19 | 260 | 4 | IPR027401 | |
| Domain | - | 1.21e-04 | 19 | 260 | 4 | 4.10.270.10 | |
| Domain | MYOSIN_MOTOR | 1.73e-04 | 38 | 260 | 5 | PS51456 | |
| Domain | Myosin_head_motor_dom | 1.73e-04 | 38 | 260 | 5 | IPR001609 | |
| Domain | Myosin_head | 1.73e-04 | 38 | 260 | 5 | PF00063 | |
| Domain | MYSc | 1.73e-04 | 38 | 260 | 5 | SM00242 | |
| Domain | NumbF | 1.93e-04 | 2 | 260 | 2 | PF06311 | |
| Domain | DUF4757 | 1.93e-04 | 2 | 260 | 2 | PF15949 | |
| Domain | Numb_domain | 1.93e-04 | 2 | 260 | 2 | IPR010449 | |
| Domain | DUF4757 | 1.93e-04 | 2 | 260 | 2 | IPR031865 | |
| Domain | Numb/numb-like | 1.93e-04 | 2 | 260 | 2 | IPR016698 | |
| Domain | FAM21 | 1.93e-04 | 2 | 260 | 2 | IPR027308 | |
| Domain | PTB | 2.22e-04 | 40 | 260 | 5 | SM00462 | |
| Domain | PTB/PI_dom | 2.50e-04 | 41 | 260 | 5 | IPR006020 | |
| Domain | CH | 2.85e-04 | 65 | 260 | 6 | SM00033 | |
| Domain | CH | 4.28e-04 | 70 | 260 | 6 | PF00307 | |
| Domain | - | 4.62e-04 | 71 | 260 | 6 | 1.10.418.10 | |
| Domain | CH | 5.36e-04 | 73 | 260 | 6 | PS50021 | |
| Domain | CAP-ZIP_m | 5.74e-04 | 3 | 260 | 2 | PF15255 | |
| Domain | GRIN_C | 5.74e-04 | 3 | 260 | 2 | PF15235 | |
| Domain | FAM21/CAPZIP | 5.74e-04 | 3 | 260 | 2 | IPR029341 | |
| Domain | BAT2_N | 5.74e-04 | 3 | 260 | 2 | IPR009738 | |
| Domain | BAT2_N | 5.74e-04 | 3 | 260 | 2 | PF07001 | |
| Domain | GRIN_C | 5.74e-04 | 3 | 260 | 2 | IPR032745 | |
| Domain | PRRC2 | 5.74e-04 | 3 | 260 | 2 | IPR033184 | |
| Domain | CH-domain | 6.20e-04 | 75 | 260 | 6 | IPR001715 | |
| Domain | - | POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF YTHDC2 ANKRD36B ANKRD36 POTEJ POTEI | 7.41e-04 | 248 | 260 | 11 | 1.25.40.20 |
| Domain | ANK | POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF YTHDC2 ANKRD36B ANKRD36 POTEJ POTEI | 8.18e-04 | 251 | 260 | 11 | SM00248 |
| Domain | Actin | 8.59e-04 | 31 | 260 | 4 | IPR004000 | |
| Domain | Actin | 8.59e-04 | 31 | 260 | 4 | PF00022 | |
| Domain | ACTIN | 8.59e-04 | 31 | 260 | 4 | SM00268 | |
| Domain | ANK_REPEAT | POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF YTHDC2 ANKRD36B ANKRD36 POTEJ POTEI | 8.73e-04 | 253 | 260 | 11 | PS50088 |
| Domain | Ank_2 | POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF ANKRD36B ANKRD36 POTEJ POTEI | 8.93e-04 | 215 | 260 | 10 | PF12796 |
| Domain | Ankyrin_rpt-contain_dom | POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF YTHDC2 ANKRD36B ANKRD36 POTEJ POTEI | 9.01e-04 | 254 | 260 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF YTHDC2 ANKRD36B ANKRD36 POTEJ POTEI | 9.01e-04 | 254 | 260 | 11 | PS50297 |
| Domain | SPEC | 9.71e-04 | 32 | 260 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.71e-04 | 32 | 260 | 4 | IPR018159 | |
| Domain | - | 1.12e-03 | 148 | 260 | 8 | 2.60.40.150 | |
| Domain | Ankyrin_rpt | POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF YTHDC2 ANKRD36B ANKRD36 POTEJ POTEI | 1.16e-03 | 262 | 260 | 11 | IPR002110 |
| Domain | Ank | POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF ANKRD36B ANKRD36 POTEJ POTEI | 1.39e-03 | 228 | 260 | 10 | PF00023 |
| Domain | Thioredoxin_CS | 1.57e-03 | 17 | 260 | 3 | IPR017937 | |
| Domain | DH_1 | 1.83e-03 | 63 | 260 | 5 | PS00741 | |
| Domain | ZF_DAG_PE_2 | 1.96e-03 | 64 | 260 | 5 | PS50081 | |
| Domain | ZF_DAG_PE_1 | 1.96e-03 | 64 | 260 | 5 | PS00479 | |
| Domain | C1 | 2.10e-03 | 65 | 260 | 5 | SM00109 | |
| Domain | C2_dom | 2.14e-03 | 164 | 260 | 8 | IPR000008 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | MYO9A SPTAN1 SPTBN1 BCR PICALM POTEE KIDINS220 DST NHS DIAPH3 BAIAP2 DNMBP ANKFY1 ARHGEF28 ACBD5 RAPGEF1 ALS2 KCTD3 | 4.38e-05 | 450 | 192 | 18 | M27078 |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 5.07e-05 | 49 | 192 | 6 | M40046 | |
| Pubmed | MYH7 PPRC1 ERC1 SPTAN1 SPTBN1 TSC1 CHD4 C4orf17 ACSL4 POTEE NRXN3 DST BRCA1 SACS FAM186A PIP4K2A PIP4K2B JAKMIP1 DIAPH3 VARS1 PRRC2B SFN DCAF13 AKAP5 MYH7B ANXA2 POTEF SYNE1 MED8 CNTRL NUCB1 DNAJC18 ODF2 DDX55 PDIA6 LATS2 LMNA SBNO1 LMO7 MYH14 P4HB MYH15 LIMCH1 POTEJ POTEI PLCH1 CEP57 ATP2A2 ATP2B2 MTDH ATP5F1A CUX1 RPL13 | 2.14e-21 | 1442 | 269 | 53 | 35575683 | |
| Pubmed | NUMBL ERC1 SPTAN1 SPTBN1 TSC1 NOL10 GPRIN1 BIRC6 CEP350 FANCD2 ACSL4 PTPN12 NCAPG CASKIN2 GLYR1 ZNF638 CPSF1 NHS BAIAP2 CPSF2 PRRC2A FKBP4 PRRC2B AKAP5 ACBD5 GPRIN3 ODF2 TXNDC12 PPM1G IWS1 PPP1R10 NCOR2 PDIA6 VIPAS39 ARVCF P4HB KCTD3 INTS4 NUMB KIRREL1 ATP2A2 ATP5F1A RPL13 | 3.84e-19 | 1049 | 269 | 43 | 27880917 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR MYO9A SPTAN1 SPTBN1 TSC1 NOL10 CHD4 BIRC6 ACSL4 PTPN12 NCAPG DST PELO GLYR1 PIP4K2A EIF2B4 ZNF638 CPSF1 AP1M1 MGA VARS1 GPI ANKFY1 DCAF13 WARS1 ANXA1 UPF1 KIF20B LIG3 NCOR2 PDIA6 LMNA RNH1 ARVCF SMC3 MYH14 P4HB ASPH SMARCA2 PDCD11 ELAVL1 POLD3 ATP2A2 ATP5F1A RPL13 AHNAK2 SORD | 5.02e-18 | 1353 | 269 | 47 | 29467282 |
| Pubmed | TPR HECW1 ERC1 SPTAN1 SPTBN1 ADGRB1 RABGAP1 GPRIN1 BCR WASHC2A BIRC6 AMER2 SCD UCHL1 GLYR1 RABGAP1L AP1M1 PIP4K2B BAIAP2 VARS1 CNOT3 WARS1 WASHC2C ANXA1 ANXA2 ANXA2P2 ACBD5 CNKSR2 ATE1 SHROOM2 TXNDC12 PPM1G VIPAS39 ATP6V0D1 LMNA P4HB PITPNM3 POLD3 ATP2A2 PCDH8 MTDH UNC13A RPL13 | 7.87e-18 | 1139 | 269 | 43 | 36417873 | |
| Pubmed | NUMBL MYO9A MARK3 ERC1 SPTAN1 SPTBN1 TSC1 BCR KIDINS220 DST SACS UCHL1 PIP4K2A ALB BAIAP2 PRRC2A VARS1 PRRC2B GPI RAP1GDS1 WARS1 ANXA1 ANXA2 ANXA2P2 SYNE1 YTHDC2 CNKSR2 UPF1 SHROOM2 CERS5 PDIA6 AFAP1 ATP6V0D1 LMNA ARVCF LMO7 MYH14 P4HB ELAVL1 LIMCH1 PLCH1 TNR ATP2A2 ATP2B2 MTDH UNC13A ATP5F1A RPL13 | 8.47e-18 | 1431 | 269 | 48 | 37142655 | |
| Pubmed | CMPK1 VPS13C INPP5B KDM3B CHD4 GPRIN1 BIRC6 CEP350 KIDINS220 DST BRCA1 EIF2B4 ZNF638 ALB BAIAP2 MGA PRRC2B NOL8 GPI TCF12 BMP2K CNTRL ACBD5 NELFB GPRIN3 CNKSR2 PPM1G CASP12 VIPAS39 KIRREL1 CLSPN MTDH ATP5F1A CUX1 RPL13 | 5.97e-17 | 777 | 269 | 35 | 35844135 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR SPTAN1 SPTBN1 MED14 KDM3B NASP CHD4 GPRIN1 FANCD2 ZNF638 CPSF1 CPSF2 DNMBP PRRC2A CNOT3 WDR44 WASHC2C SPATA19 NELFB YTHDC2 ODF2 IWS1 NCOR2 ZNF106 PDIA6 LMNA LMO7 ASPH SMARCA2 LIMCH1 ATP2A2 ZHX1 ZMYM4 | 2.40e-15 | 774 | 269 | 33 | 15302935 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR MARK3 ERC1 SPTAN1 SPTBN1 NOL10 DST GLYR1 EIF2B4 ZNF638 CPSF1 AP1M1 ALB BAIAP2 FKBP4 SFN NOL8 DCAF13 ANXA1 ANXA2 DDX60 LAMA3 YTHDC2 UPF1 DDX55 KIF20B PPM1G PPP1R10 AFAP1 LMNA RNH1 SMC3 LMO7 P4HB ASPH PDCD11 ELAVL1 MICU2 MTDH ATP5F1A RPL13 | 7.20e-15 | 1257 | 269 | 41 | 36526897 |
| Pubmed | MYH7 PPRC1 ERC1 VPS13C SPTAN1 SPTBN1 MED14 NASP CHD4 BCR SCD GLYR1 ZNF638 CPSF1 ALB MGA CASP8AP2 WARS1 SYNE1 CNTRL UPF1 PPM1G CASP12 LIG3 NCOR2 TTLL6 P4HB ELAVL1 LIMCH1 MTDH ZMYM4 RPL13 | 7.43e-15 | 754 | 269 | 32 | 35906200 | |
| Pubmed | NUMBL MARK3 MED14 NOL10 POTEE KIDINS220 DST BRCA1 SCD BAIAP2 CPSF2 HEATR5B DNMBP PRRC2A VARS1 CNOT3 NOL8 BMP2K SYNE1 MED8 ACBD5 YTHDC2 ODF2 DDX55 KIF20B IWS1 PPP1R10 PDIA6 IFRD1 AFAP1 ATP6V0D1 P4HB ASPH KCTD3 SMARCA2 PALM3 PDCD11 NUMB LIMCH1 MICU2 ATP2A2 ZHX1 ATP5F1A ZMYM4 | 2.58e-14 | 1497 | 269 | 44 | 31527615 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ERC1 SPTAN1 SPART BCR WASHC2A CEP350 BRCA1 PIP4K2A DIAPH3 BAIAP2 DNMBP MGA PRRC2A VARS1 PRRC2B NOL8 DCAF13 WARS1 BMP2K ANXA1 DDX60 YTHDC2 UPF1 DDX55 PPP1R10 LMO7 MYH14 ATP2A2 MTDH AHNAK2 | 1.01e-13 | 724 | 269 | 30 | 36232890 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NUMBL KDM3B SPART PICALM HMCES MGA TCF12 WASHC2C ANXA1 ANXA2 MED8 UPF1 LZIC PPP1R10 LIG3 NCOR2 ZNF106 LMNA SBNO1 MYH14 POLD3 MTDH ZMYM4 AHNAK2 | 1.24e-13 | 444 | 269 | 24 | 34795231 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR VPS13C SPTAN1 SPTBN1 NASP NOL10 CHD4 CMYA5 FANCD2 NCAPG KIDINS220 UCHL1 GLYR1 CPSF1 AP1M1 VARS1 FKBP4 GPI ANKFY1 DCAF13 WARS1 ANXA2 SYNE1 YTHDC2 UPF1 DDX55 LIG3 PDIA6 ATP6V0D1 RPRD1A LMNA SBNO1 SMC3 MYH14 P4HB PDCD11 ELAVL1 ATP2A2 MTDH ATP5F1A RPL13 | 4.38e-13 | 1425 | 269 | 41 | 30948266 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR NUMBL ERC1 KDM3B NASP SPART TSC1 CHD4 GPRIN1 PICALM PTPN12 DST UCHL1 ZNF638 PRRC2A FKBP4 PRRC2B WDR44 NOL8 GPI WARS1 WASHC2C YTHDC2 UPF1 LZIC PPP1R10 LIG3 PDIA6 NUMB MTDH ATP5F1A RPL13 AHNAK2 | 4.54e-13 | 934 | 269 | 33 | 33916271 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CMPK1 ERC1 SPTAN1 SPTBN1 CHD4 PICALM DST SCD FKBP4 SFN GPI WARS1 ANXA1 ANXA2 SYNE1 CNTRL AP1M2 GPRIN3 UPF1 PDIA6 LMNA MYH14 P4HB ELAVL1 PCNX1 PALS2 ATP2A2 ATP5F1A AHNAK2 SORD | 1.60e-12 | 807 | 269 | 30 | 30575818 |
| Pubmed | TPR SPTAN1 SPTBN1 NOL10 CHD4 BIRC6 DST GLYR1 ZNF638 CPSF1 PRRC2A FKBP4 PRRC2B DCAF13 WARS1 ANXA1 YTHDC2 UPF1 PPM1G LMNA RNH1 MYH14 P4HB SMARCA2 PDCD11 ELAVL1 ATP2A2 | 1.96e-12 | 653 | 269 | 27 | 22586326 | |
| Pubmed | TPR MARK3 SPTAN1 SPTBN1 MED14 CHD4 PELO CPSF1 NHS AMOTL2 MGA PRRC2A VARS1 FKBP4 CNOT3 SFN GPI ANXA2 MED8 UPF1 LIG3 NCOR2 LMNA RNH1 ARVCF SMC3 LMO7 MYH14 P4HB SMARCA2 ELAVL1 LIMCH1 POLD3 ATP2A2 ATP5F1A CUX1 RPL13 | 2.83e-12 | 1247 | 269 | 37 | 27684187 | |
| Pubmed | TPR HECW1 NUMBL ASIC1 ERC1 SPTAN1 SPTBN1 TSC1 CHD4 BCR PICALM DST MFN2 JAKMIP1 BAIAP2 CPSF2 MGA PRRC2A PRRC2B ANKFY1 SYNE1 CNKSR2 UPF1 NCOR2 ARVCF ELAVL1 LIMCH1 CABIN1 TNR PCDH8 UNC13A CUX1 | 5.28e-12 | 963 | 269 | 32 | 28671696 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR CHD4 CEP350 DST SACS UCHL1 ZNF638 CPSF1 ALB CPSF2 HEATR5B MGA VARS1 FKBP4 GPI ANXA1 ANXA2 SYNE1 YTHDC2 PPP1R10 LIG3 PDIA6 LMNA SMC3 LMO7 MYH14 P4HB PDCD11 ELAVL1 ATP2A2 MTDH ATP5F1A RPL13 | 5.42e-12 | 1024 | 269 | 33 | 24711643 |
| Pubmed | PPRC1 ERC1 SPTAN1 SPTBN1 NASP CHD4 CMYA5 CEP350 DST SACS JAKMIP1 BAIAP2 AMOTL2 PRRC2A VARS1 CNOT3 GPRASP2 UNC13B RAP1GDS1 WARS1 SYNE1 NUCB1 ODF2 SHROOM2 RPRD1A SBNO1 LMO7 MYH14 CEP70 ANKRD36 PALS2 CABIN1 ATP2A2 ATP5F1A ZMYM4 CUX1 RPL13 | 6.76e-12 | 1285 | 269 | 37 | 35914814 | |
| Pubmed | NUMBL MARK3 SPTAN1 SPTBN1 SPART GPRIN1 WASHC2A NCAPG KIDINS220 SACS CASKIN2 SCD GLYR1 EIF2B4 DIAPH3 BAIAP2 FKBP4 NOL8 CASP8AP2 DCAF13 AKAP5 SYNE1 NUCB1 ACBD5 DNAJC18 UPF1 PPM1G LIFR PDIA6 LMNA P4HB ASPH PDCD11 NUMB KIRREL1 PLCH1 ATP2A2 MTDH CUX1 RPL13 | 7.03e-12 | 1487 | 269 | 40 | 33957083 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MYO9A ERC1 SPART TSC1 RABGAP1 BCR WASHC2A POTEE PELO UCHL1 PIP4K2A DIAPH3 DNMBP CNOT3 PRRC2B CASP8AP2 WASHC2C KIF20B PPM1G NCOR2 LMO7 POTEJ POTEI CLSPN ZMYM4 | 7.41e-12 | 588 | 269 | 25 | 38580884 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NUMBL MYO9A MARK3 ERC1 SPTAN1 SPTBN1 KDM3B BCR CEP350 DST MAST4 CASKIN2 RABGAP1L NHS AP1M1 BAIAP2 DNMBP SFN ARHGEF28 POTEF NELFB ALS2 ZNF106 IFRD1 LMO7 NUMB CEP152 LIMCH1 PLCH1 AHNAK2 | 8.00e-12 | 861 | 269 | 30 | 36931259 |
| Pubmed | ERC1 SPTAN1 MED14 NASP SPART CEP350 NCAPG DST BRCA1 GLYR1 PIP4K2A ZNF638 PIP4K2B ALB MED8 ODF2 DDX55 PPM1G IWS1 ESCO2 PPP1R10 LIG3 PDIA6 MYH14 CEP152 CABIN1 | 9.04e-12 | 645 | 269 | 26 | 25281560 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOL4 NUMBL SPTAN1 SPTBN1 MED14 CHD4 KIDINS220 DST SACS GLYR1 ZNF638 CPSF1 ALB CPSF2 VARS1 ANXA2 SYNE1 UPF1 DDX55 IWS1 PPP1R10 LIG3 PDIA6 AFAP1 LMNA P4HB KCTD3 INTS4 ELAVL1 ATP2A2 MTDH UNC13A RPL13 | 2.32e-11 | 1082 | 269 | 33 | 38697112 |
| Pubmed | VPS13C KDM3B SPART BCR NRXN3 DST MAST4 CASKIN2 FLRT3 CEP126 AMOTL2 CPSF2 DNMBP CASP8AP2 DDX55 GPR107 AFAP1 LMO7 PDCD11 PCNX1 DEPDC5 CEP57 ZMYM4 | 3.40e-11 | 529 | 269 | 23 | 14621295 | |
| Pubmed | MARK3 SPTAN1 SPTBN1 NOL10 CHD4 CEP350 ACSL4 UCHL1 GLYR1 EIF2B4 CPSF1 FLRT3 BAIAP2 CPSF2 PRRC2A VARS1 PRRC2B UNC13B GPI ANXA1 ANXA2 UPF1 DDX55 ESCO2 ANKRD36B PPP1R10 LMO7 MYH14 P4HB ASPH PDCD11 NUMB ELAVL1 LIMCH1 POTEJ MTDH ATP5F1A | 4.31e-11 | 1371 | 269 | 37 | 36244648 | |
| Pubmed | MARK3 SPTAN1 SPTBN1 CHD4 HMGCR PICALM FANCD2 NCAPG DST PELO EIF2B4 PRRC2A CNOT3 PRRC2B BMP2K DDX60 YTHDC2 UPF1 PPM1G IWS1 LIFR LIG3 PDIA6 AFAP1 ATP6V0D1 LMNA RNH1 LMO7 ASPH PDCD11 ELAVL1 LIMCH1 CABIN1 ATP2A2 MTDH ATP5F1A CUX1 AHNAK2 | 4.37e-11 | 1440 | 269 | 38 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | SPTAN1 SPTBN1 KDM3B NASP RABGAP1 CMYA5 WASHC2A BIRC6 FANCD2 PTPN12 NCAPG AP1M1 DNMBP VARS1 FKBP4 WDR44 SFN RAP1GDS1 ANKFY1 WARS1 ANXA2 NUCB1 NELFB ATE1 PPM1G IWS1 PDIA6 RPRD1A LMNA RNH1 SBNO1 MYH14 P4HB LIMCH1 POLD3 RPL13 AHNAK2 SORD | 5.89e-11 | 1455 | 269 | 38 | 22863883 |
| Pubmed | TPR MARK3 INPP5B NASP TSC1 HMGCR BIRC6 FANCD2 PELO PIK3CB SCD CPSF1 MFN2 NHS DIAPH3 MGA GPI ARHGEF28 UPF1 DDX55 GPR107 IWS1 ZBTB49 ZNF106 MFSD2A RPRD1A RNH1 SBNO1 SMC3 P4HB ELAVL1 DEPDC5 CLSPN ATP5F1A ZMYM4 RPL13 | 7.03e-11 | 1327 | 269 | 36 | 32694731 | |
| Pubmed | TPR ERC1 SPTAN1 MED14 KDM3B NASP GPRIN1 NCAPG DIAPH3 AMOTL2 MGA PRRC2A PRRC2B WDR44 ANXA2 MED8 UPF1 PPP1R10 LMO7 PDCD11 NUMB ZMYM4 CUX1 | 7.09e-11 | 549 | 269 | 23 | 38280479 | |
| Pubmed | TPR SPTAN1 SPTBN1 GLYR1 CPSF1 ALB JAKMIP1 MGA PRRC2A PRRC2B ANKFY1 ANXA2 YTHDC2 UPF1 PDIA6 LMNA RNH1 SMC3 P4HB ELAVL1 MTDH ATP5F1A RPL13 | 7.62e-11 | 551 | 269 | 23 | 34728620 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR MARK3 SPTAN1 SPTBN1 NOL10 CHD4 DST GLYR1 CPSF1 VARS1 DCAF13 BMP2K ANXA1 ANXA2 ANXA2P2 SYNE1 SHC4 UPF1 DDX55 LMNA SMC3 LMO7 MYH14 PDCD11 NUMB ELAVL1 LIMCH1 ATP2A2 ATP5F1A RPL13 | 8.56e-11 | 949 | 269 | 30 | 36574265 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPR ERC1 SPTAN1 SPTBN1 TSC1 CHD4 BIRC6 NCAPG PELO EIF2B4 ZNF638 AP1M1 DIAPH3 PRRC2A VARS1 SFN GPI ANXA1 ANXA2 NELFB UPF1 DDX55 TXNDC12 PPM1G IWS1 PDIA6 LMNA SBNO1 SMC3 P4HB ASPH ELAVL1 ATP2A2 MTDH ATP5F1A RPL13 AHNAK2 | 1.05e-10 | 1415 | 269 | 37 | 28515276 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR MYH7 ERC1 SPTAN1 SPTBN1 NASP SPART CHD4 DST PELO UCHL1 EIF2B4 PRRC2A VARS1 FKBP4 GPI WARS1 ANXA1 ANXA2 UPF1 TXNDC12 PPM1G LIG3 PDIA6 SMC3 LMO7 P4HB ELAVL1 LIMCH1 POLD3 ATP2A2 ATP5F1A RPL13 | 1.10e-10 | 1149 | 269 | 33 | 35446349 |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | NASP CHD4 ZNF638 FKBP4 SFN GPI ANXA1 ANXA2 ANXA2P2 ALS2 KIF20B LIG3 PDIA6 ATP6V0D1 CABIN1 ATP5F1A CUX1 RPL13 | 1.49e-10 | 332 | 269 | 18 | 30595499 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | NOL10 CHD4 PELO UCHL1 GLYR1 MGA VARS1 FKBP4 NOL8 DCAF13 YTHDC2 UPF1 PPM1G LIG3 RNH1 PDCD11 CABIN1 ZMYM4 | 3.34e-10 | 349 | 269 | 18 | 25665578 |
| Pubmed | NUMBL MARK3 VPS13C INPP5B SPART GPRIN1 PICALM HMCES KIDINS220 PELO BAIAP2 PRRC2B WDR44 B3GLCT WARS1 BMP2K MED8 NUCB1 UPF1 TXNDC12 PPP1R10 PDIA6 VIPAS39 LMNA P4HB ASPH NUMB KIRREL1 MTDH ZMYM4 | 3.51e-10 | 1007 | 269 | 30 | 34597346 | |
| Pubmed | NOL4 SPTAN1 SPTBN1 WASHC2A DST BRCA1 GLYR1 ZNF638 CPSF1 CPSF2 MGA PRRC2A FKBP4 CNOT3 PRRC2B SFN TCF12 MED8 UPF1 PPM1G CASP12 LIG3 NCOR2 SMC3 MYH14 P4HB SMARCA2 PDCD11 ELAVL1 CEP152 CABIN1 ATP2A2 ZHX1 ZMYM4 CUX1 SORD | 5.26e-10 | 1429 | 269 | 36 | 35140242 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SPTBN1 KDM3B NASP SPART CHD4 RABGAP1 GPRIN1 ACSL4 PTPN12 NCAPG PELO AP1M1 BAIAP2 VARS1 FKBP4 PRRC2B SFN GPI RAP1GDS1 DCAF13 ANXA1 ANXA2 UPF1 PPM1G IWS1 NCOR2 ATP6V0D1 P4HB SMARCA2 PDCD11 NUMB ATP2A2 ATP5F1A RPL13 AHNAK2 | 6.14e-10 | 1367 | 269 | 35 | 32687490 |
| Pubmed | VPS13C KDM3B TSC1 HMGCR BCR WASHC2A BIRC6 HMCES CEP350 AUNIP SCD ZNF638 PIP4K2B BAIAP2 CPSF2 MGA VARS1 SHC4 ZNF106 VIPAS39 RNH1 KIRREL1 POLD3 PLCH1 CLSPN | 7.54e-10 | 733 | 269 | 25 | 34672954 | |
| Pubmed | ERC1 SPTAN1 SPART HMGCR WASHC2A CEP350 EIF2B4 MFN2 PRRC2A PRRC2B YTHDC2 PPM1G ZNF106 SBNO1 CLSPN | 8.44e-10 | 242 | 269 | 15 | 34011540 | |
| Pubmed | CMPK1 VPS13C TSC1 CHD4 UCHL1 ALB AMOTL2 VARS1 FKBP4 GPI WARS1 ANXA1 ANXA2 SYNE1 NUCB1 UPF1 PDIA6 LMNA RNH1 SMC3 MYH14 P4HB ELAVL1 ATP2A2 ATP5F1A RPL13 | 1.01e-09 | 803 | 269 | 26 | 36517590 | |
| Pubmed | MYO9A ERC1 BCR WASHC2A PICALM CEP350 PTPN12 KIDINS220 DST MAST4 NHS YTHDC2 AFAP1 CEP152 | 1.14e-09 | 209 | 269 | 14 | 36779422 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MARK3 ERC1 SPART NOL10 CEP350 FANCD2 JAKMIP1 GPRASP2 PRRC2B NOL8 CCHCR1 RAP1GDS1 TCF12 CNTRL YTHDC2 UPF1 ATE1 RNH1 SBNO1 LMO7 MYH14 P4HB INTS4 LIMCH1 CUX1 | 1.34e-09 | 754 | 269 | 25 | 33060197 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MARK3 ADGRB1 KDM3B CHD4 BCR FABP4 BRCA1 ABRAXAS1 UCHL1 ALB PRRC2A VARS1 GPRASP2 PRRC2B UNC13B ANKFY1 ANXA1 ANXA2P2 YTHDC2 CNKSR2 ATE1 PPM1G IWS1 RNH1 SMC3 KCTD3 SMARCA2 MTDH ZMYM4 | 1.45e-09 | 1005 | 269 | 29 | 19615732 |
| Pubmed | TPR MYO9A SPTAN1 SPTBN1 MAP3K4 CEP350 DST BAIAP2 MGA WDR44 CASP8AP2 RAP1GDS1 SYNE1 CNTRL LAMA3 RAPGEF1 ZNF106 SMC3 ZHX1 CUX1 | 1.75e-09 | 486 | 269 | 20 | 20936779 | |
| Pubmed | TPR CMPK1 MED14 KDM3B CHD4 RABGAP1 FANCD2 NCAPG CPSF1 CPSF2 FKBP4 GPI CASP8AP2 ANXA1 ANXA2 MED8 NELFB UPF1 PPM1G IWS1 PPP1R10 LIG3 NCOR2 RNH1 SBNO1 SMC3 SMARCA2 POLD3 SORD | 1.78e-09 | 1014 | 269 | 29 | 32416067 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | BCR POTEE PTPN12 PIK3CB BAIAP2 SFN ANXA1 ANXA2 POTEF NUCB1 AP1M2 PDIA6 NUMB ATP2A2 ATP5F1A | 1.83e-09 | 256 | 269 | 15 | 24189400 |
| Pubmed | TPR NUMBL MYO9A MARK3 ERC1 SPTBN1 SPART GPRIN1 KIDINS220 DST DIAPH3 PRRC2A ANXA2 YTHDC2 UPF1 ATE1 PPM1G PDIA6 SMC3 NUMB PLCH1 ATP2A2 ATP5F1A RPL13 | 1.89e-09 | 708 | 269 | 24 | 39231216 | |
| Pubmed | TPR SERPINA3 SPTAN1 SPTBN1 CHD4 FANCD2 POTEE BRCA1 ZNF638 CPSF1 SFN ANXA1 ANXA2 PDIA6 LMNA SMC3 LMO7 MYH14 P4HB ELAVL1 ATP2A2 ATP5F1A RPL13 | 1.97e-09 | 652 | 269 | 23 | 31180492 | |
| Pubmed | TPR SPTAN1 SPTBN1 CHD4 ACSL4 POTEE PIP4K2A EIF2B4 CPSF2 PRRC2A VARS1 GPI UPF1 PDIA6 LMO7 MYH14 P4HB ASPH PDCD11 NUMB ATP2A2 MTDH ATP5F1A RPL13 | 2.05e-09 | 711 | 269 | 24 | 33022573 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PHF20 NOL10 CHD4 DST BRCA1 ABRAXAS1 SCD GLYR1 ZNF638 CPSF1 CPSF2 MGA NOL8 CASP8AP2 ANXA2 IWS1 PPP1R10 LIG3 NCOR2 ZNF106 LMNA LMO7 ASPH PDCD11 INTS4 ELAVL1 CABIN1 ATP2A2 MTDH ATP5F1A ZMYM4 CUX1 RPL13 | 2.19e-09 | 1294 | 269 | 33 | 30804502 |
| Pubmed | CMPK1 SPTAN1 KDM3B SPART BIRC6 PTPN12 KIDINS220 DST MFN2 DIAPH3 FKBP4 CNOT3 PRRC2B DCAF13 WARS1 ANXA2 NUCB1 DDX55 TXNDC12 ZNF106 PDIA6 AFAP1 ATP6V0D1 SMC3 P4HB ASPH PDCD11 NUMB ELAVL1 ATP2A2 ATP5F1A RCN3 SORD | 2.32e-09 | 1297 | 269 | 33 | 33545068 | |
| Pubmed | PICALM KIDINS220 CASKIN2 ZNF638 NHS DNMBP PRRC2B YTHDC2 PDIA6 LATS2 P4HB NUMB KIRREL1 MTDH AHNAK2 | 2.64e-09 | 263 | 269 | 15 | 34702444 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | VPS13C SPTAN1 PICALM GPI WARS1 BMP2K MYH7B ANXA1 LMNA LMO7 LIMCH1 ATP2A2 MTDH ATP5F1A AHNAK2 | 3.41e-09 | 268 | 269 | 15 | 33024031 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | KDM3B SPART CHD4 CEP350 BRCA1 MGA VARS1 PRRC2B TCF12 ANXA2 LMNA SBNO1 CLSPN ATP2A2 ATP5F1A ZMYM4 RPL13 | 3.48e-09 | 357 | 269 | 17 | 37059091 |
| Pubmed | 3.50e-09 | 4 | 269 | 4 | 11919279 | ||
| Pubmed | CMPK1 SPTBN1 ACSL4 PELO UCHL1 ALB VARS1 SFN ANXA2 UPF1 LMNA RNH1 P4HB ASPH ATP5F1A AHNAK2 | 3.56e-09 | 312 | 269 | 16 | 37120454 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | CMPK1 MYO9A MARK3 TGM5 KIDINS220 CROCC2 EIF2B4 ZNF638 FKBP4 PRRC2B SFN GPI ANXA1 LAMA3 YTHDC2 LIG3 RNH1 MYH14 P4HB ASPH PDCD11 NUMB PLCH1 CUX1 | 3.61e-09 | 732 | 269 | 24 | 34732716 |
| Pubmed | PPRC1 MARK3 ERC1 TSC1 WASHC2A MAP3K4 KIDINS220 RABGAP1L MFN2 SLC23A2 PRRC2B UNC13B ANKFY1 WASHC2C SYNE1 ALS2 CNKSR2 LIMCH1 | 3.81e-09 | 407 | 269 | 18 | 12693553 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | VPS13C SPTAN1 SPTBN1 MED14 NOL10 CHD4 UCHL1 ALB SFN CCHCR1 ANXA1 ANXA2 ANXA2P2 CNTRL NUCB1 TXNDC12 LMNA RNH1 ASPH ATP2A2 ATP5F1A | 3.98e-09 | 564 | 269 | 21 | 21565611 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | NUMBL MARK3 ERC1 SPTAN1 SPTBN1 GPRIN1 PICALM KIDINS220 DST CASKIN2 NHS DIAPH3 BAIAP2 SFN ANXA1 ANXA2 ARVCF LMO7 PALM3 NUMB LIMCH1 | 4.11e-09 | 565 | 269 | 21 | 25468996 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NASP NOL10 CHD4 GLYR1 ZNF638 VARS1 FKBP4 SFN NOL8 DCAF13 ANXA1 ANXA2 KIF20B TXNDC12 PPM1G PPP1R10 NCOR2 ZNF106 PDIA6 LMNA SMC3 P4HB PDCD11 ELAVL1 CLSPN ATP2A2 ATP5F1A RPL13 | 4.30e-09 | 989 | 269 | 28 | 36424410 |
| Pubmed | TPR ERC1 VPS13C INPP5B SPTAN1 SPTBN1 NASP SPART TSC1 RABGAP1 DST SCD WDR44 WARS1 ACBD5 YTHDC2 LMNA LIMCH1 MTDH CUX1 AHNAK2 | 4.50e-09 | 568 | 269 | 21 | 37774976 | |
| Pubmed | TPR NOL4 ERC1 CHD4 RABGAP1 BCR BIRC6 DST UCHL1 DIAPH3 MGA GPRASP2 CASP8AP2 ANKFY1 KIF20B NCOR2 ZMYM4 CUX1 | 5.77e-09 | 418 | 269 | 18 | 34709266 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | SPTAN1 SPTBN1 PICALM ACSL4 POTEE ALB BAIAP2 GPI ANXA1 ANXA2 POTEF UPF1 LIG3 PDIA6 LMNA LMO7 MYH14 P4HB LIMCH1 ATP5F1A RPL13 | 6.48e-09 | 580 | 269 | 21 | 35676659 |
| Pubmed | SPTAN1 SPTBN1 BCR BAIAP2 VARS1 AKAP5 ANXA2 ANXA2P2 UPF1 ATP2A2 ATP2B2 | 6.76e-09 | 131 | 269 | 11 | 28634551 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR SPTAN1 SPTBN1 CHD4 PICALM FANCD2 NCAPG PELO ZNF638 CPSF1 DIAPH3 CPSF2 MAGEE2 YTHDC2 UPF1 NCOR2 LMNA SMC3 LMO7 SMARCA2 ELAVL1 | 6.88e-09 | 582 | 269 | 21 | 20467437 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | TPR CHD4 CPSF1 CPSF2 PRRC2B WARS1 ANXA2 ANXA2P2 UPF1 PPP1R10 NCOR2 SMARCA2 ELAVL1 | 7.76e-09 | 203 | 269 | 13 | 22083510 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPR MYH7 SPTAN1 SPTBN1 ACSL4 NCAPG IL1R2 EIF2B4 SFN GPI MYH7B ANXA1 UPF1 PDIA6 LMNA RNH1 LMO7 MYH14 P4HB LIMCH1 ATP2A2 ATP5F1A | 8.68e-09 | 647 | 269 | 22 | 26618866 |
| Pubmed | TPR SPTAN1 SPTBN1 PICALM ZNF638 VARS1 ANXA2 LMO7 MYH14 ASPH PDCD11 ATP2A2 ATP5F1A RPL13 AHNAK2 | 1.24e-08 | 295 | 269 | 15 | 26209609 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | TPR SPTBN1 NOL10 CHD4 GLYR1 ZNF638 ALB CPSF2 ANXA2 DDX55 IWS1 LIG3 LMNA SMC3 SMARCA2 PDCD11 ELAVL1 MTDH ATP5F1A CUX1 RPL13 | 1.34e-08 | 605 | 269 | 21 | 28977666 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | TPR SPTAN1 SPTBN1 CPSF1 AP1M1 VARS1 FKBP4 ANKFY1 WARS1 ANXA1 NUCB1 UPF1 PDIA6 LMNA MYH14 P4HB ASPH ELAVL1 ATP2A2 MTDH SORD | 1.42e-08 | 607 | 269 | 21 | 39147351 |
| Pubmed | NUMBL MARK3 ERC1 SPTBN1 TSC1 ALB JAKMIP1 BAIAP2 SFN ALS2 SHROOM2 LMO7 P4HB ATP5F1A | 1.46e-08 | 255 | 269 | 14 | 15324660 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NOL4 KDM3B NASP CHD4 BRCA1 ABRAXAS1 GLYR1 MGA NELFB DDX55 KIF20B PPM1G IWS1 PPP1R10 LIG3 SBNO1 SMC3 CABIN1 ZHX1 ZMYM4 CUX1 | 1.46e-08 | 608 | 269 | 21 | 36089195 |
| Pubmed | SPTAN1 SPTBN1 MED14 ALB JAKMIP1 RAP1GDS1 TCF12 MED8 ATE1 LIG3 PDIA6 LMNA LMO7 MYH14 P4HB ASPH ATP2A2 RPL13 SORD | 1.78e-08 | 503 | 269 | 19 | 36217030 | |
| Pubmed | MYH7 SPTAN1 SPTBN1 ALB ANXA1 ANXA2 LMNA RNH1 MYH14 P4HB POTEJ POTEI ATP2A2 ATP5F1A RPL13 | 1.93e-08 | 305 | 269 | 15 | 33194618 | |
| Pubmed | MYH7 KDM3B SPART CPSF1 MYH16 DIAPH3 BAIAP2 CPSF2 PRRC2A ANXA1 ANXA2 RPRD1A ELAVL1 | 2.03e-08 | 220 | 269 | 13 | 24550385 | |
| Pubmed | TPR ERC1 SPTAN1 SPTBN1 DST ZNF638 PRRC2A SFN MMRN1 LIG3 LMNA RNH1 LMO7 P4HB ELAVL1 AHNAK2 | 2.66e-08 | 360 | 269 | 16 | 33111431 | |
| Pubmed | TPR PICALM ACSL4 DST BRCA1 ABRAXAS1 AP1M1 AMOTL2 FKBP4 DCAF13 BMP2K ANXA1 DDX60 PPM1G PPP1R10 ZNF106 ATP6V0D1 SMARCA2 PDCD11 ELAVL1 MTDH | 2.99e-08 | 634 | 269 | 21 | 34591612 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | TPR SPTBN1 CHD4 POTEE GLYR1 ZNF638 VARS1 NOL8 POTEF DDX55 LMNA ELAVL1 POTEJ POTEI | 3.14e-08 | 271 | 269 | 14 | 32433965 |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | GAS2 CHD4 PELO AP1M1 PRRC2A CASP8AP2 TCF12 SYNE1 UPF1 TXNDC12 LIG3 NCOR2 MYH14 MTDH CUX1 | 3.79e-08 | 321 | 269 | 15 | 32098917 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SPTAN1 SPTBN1 WASHC2A ALB PRRC2A PRRC2B SFN WASHC2C ANXA1 GPRIN3 YTHDC2 UPF1 PPM1G IWS1 NCOR2 ELAVL1 LIMCH1 MTDH | 4.07e-08 | 475 | 269 | 18 | 31040226 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | SPTAN1 SPTBN1 CHD4 DST ALB VARS1 FKBP4 GPI ANXA2P2 LMNA SMC3 LMO7 KCTD3 LIMCH1 ATP2A2 ATP5F1A CUX1 RPL13 | 4.33e-08 | 477 | 269 | 18 | 31300519 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | NUMBL MARK3 SPTBN1 ADGRB1 GPRIN1 PICALM KIDINS220 DST CASKIN2 FLRT3 SLC23A2 WDR44 GPRIN3 LATS2 NUMB KIRREL1 | 5.03e-08 | 377 | 269 | 16 | 38117590 |
| Pubmed | MYH7 SPTAN1 SPTBN1 NOL10 DST SFN WASHC2C ANXA1 ANXA2 POTEF PPM1G PPP1R10 NCOR2 RPRD1A SMC3 ATP2B2 MTDH RPL13 AHNAK2 | 5.15e-08 | 538 | 269 | 19 | 28524877 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR SPTAN1 SPTBN1 CHD4 NCAPG ZNF638 CPSF2 VARS1 WASHC2C UPF1 LMNA SMC3 LMO7 P4HB AHNAK2 | 5.89e-08 | 332 | 269 | 15 | 32786267 |
| Pubmed | TPR MYO9A INPP5B NASP BCR POTEE CPSF1 CPSF2 DNMBP MGA PRRC2A FKBP4 ANKFY1 ARHGEF28 ANXA1 ANXA2 ALS2 CNKSR2 TXNDC12 PPM1G PPP1R10 RPRD1A LMNA SMC3 P4HB | 6.14e-08 | 916 | 269 | 25 | 32203420 | |
| Pubmed | TPR CHD4 KIDINS220 ZNF638 CPSF1 PRRC2A POTEF MYH14 PDCD11 POTEJ ATP2A2 ATP2B2 | 6.75e-08 | 202 | 269 | 12 | 24639526 | |
| Pubmed | SERPINA3 MYH7 SPTBN1 SPART CHD4 CMYA5 BIRC6 DST MGA ANKFY1 TCF12 SYNE1 CCDC141 LMNA MYH14 P4HB INTS4 ZMYM4 | 8.02e-08 | 497 | 269 | 18 | 23414517 | |
| Pubmed | SPTAN1 SPTBN1 CHD4 ZNF638 CPSF1 PRRC2A ANXA2 ANXA2P2 PPP1R10 LIG3 ATP6V0D1 SMC3 LMO7 ELAVL1 LIMCH1 | 8.04e-08 | 340 | 269 | 15 | 24332808 | |
| Pubmed | TPR ERC1 NASP PTPN12 ZNF638 NHS PRRC2A FKBP4 WDR44 SFN WASHC2C NELFB IWS1 PPP1R10 PDIA6 LMNA LMO7 NUMB | 9.58e-08 | 503 | 269 | 18 | 16964243 | |
| Pubmed | SPTAN1 SPTBN1 NASP UCHL1 VARS1 FKBP4 GPI ANXA1 ANXA2 UPF1 PDIA6 LMNA SMC3 P4HB ATP5F1A RPL13 | 1.02e-07 | 397 | 269 | 16 | 21319273 | |
| Pubmed | TPR SPTAN1 SPTBN1 KDM3B NASP CHD4 WASHC2A DST UCHL1 CPSF1 BAIAP2 POTEF KIF20B PDIA6 LMO7 POTEJ POTEI ATP5F1A | 1.05e-07 | 506 | 269 | 18 | 30890647 | |
| Pubmed | MED14 FANCD2 BRCA1 ABRAXAS1 MGA RAD52 TCF12 MED8 NELFB KIF20B PPM1G PPP1R10 LIG3 ZNF106 CABIN1 ATP2A2 ZHX1 | 1.12e-07 | 453 | 269 | 17 | 29656893 | |
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 1.20e-07 | 7 | 269 | 4 | 36398873 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | TPR MYO9A CEP350 FANCD2 UCHL1 HEATR5B FKBP4 GPI SYNE1 PPM1G PPP1R10 LIG3 PDIA6 P4HB KCTD3 INTS4 POTEI ATP2A2 CUX1 | 1.37e-07 | 573 | 269 | 19 | 28330616 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MARK3 MED14 NOL10 CHD4 BIRC6 GLYR1 EIF2B4 PRRC2A NOL8 DCAF13 ANXA1 ANXA2 YTHDC2 UPF1 DDX55 KIF20B LIG3 SMC3 ASPH PDCD11 MTDH RPL13 | 1.42e-07 | 759 | 269 | 22 | 35915203 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SERPINA3 CLUAP1 PHF20 MYO9A SPTBN1 ADGRB1 ARHGEF38 RFTN2 WASHC2A TMC3 ACSL4 IL1R2 PIK3CB PRRC2B WASHC2C MYH7B ACBD5 DDX55 GPR107 ESCO2 CASP12 ZNF106 ARVCF SMC3 MYH14 CGRRF1 POLD3 ATP2B2 ATP5F1A | 1.45e-07 | 1242 | 269 | 29 | 30973865 |
| Interaction | PFN1 interactions | TPR NUMBL MYO9A ERC1 VPS13C SPTAN1 SPTBN1 TSC1 RABGAP1 BCR BIRC6 CEP350 FANCD2 KIDINS220 BRCA1 RABGAP1L DIAPH3 BAIAP2 DNMBP WDR44 RAD52 ANKFY1 DCAF13 ANXA2 UPF1 ELAVL1 CEP152 LIMCH1 ZMYM4 AHNAK2 | 7.81e-12 | 509 | 266 | 30 | int:PFN1 |
| Interaction | CIT interactions | TPR CMPK1 ERC1 SPTAN1 SPTBN1 NOL10 CHD4 CMYA5 BIRC6 PICALM MAP3K4 ACSL4 PELO BRCA1 PIK3CB GLYR1 ZNF638 CPSF1 ALB CPSF2 PRRC2A GPI DCAF13 ANXA1 ANXA2 ANXA2P2 SYNE1 DDX60 YTHDC2 IWS1 LIG3 PDIA6 LATS2 LMNA SMC3 LMO7 MYH14 P4HB ASPH SMARCA2 PDCD11 INTS4 ELAVL1 POTEJ ATP2A2 GRAMD1C MTDH ATP5F1A CUX1 RCN3 RPL13 AHNAK2 | 3.01e-11 | 1450 | 266 | 52 | int:CIT |
| Interaction | KDM1A interactions | TPR NOL4 ERC1 MYT1 TSC1 CHD4 RABGAP1 BCR BIRC6 CEP350 FANCD2 C4orf17 NCAPG DST BRCA1 UCHL1 GLYR1 RABGAP1L DIAPH3 BAIAP2 CPSF2 MGA VARS1 FKBP4 CNOT3 GPRASP2 CASP8AP2 ANKFY1 KIF20B ESCO2 NCOR2 RPRD1A CEP70 SMARCA2 CEP152 CEP57 ZMYM4 CUX1 | 8.02e-10 | 941 | 266 | 38 | int:KDM1A |
| Interaction | KCTD13 interactions | NUMBL MYO9A MARK3 ERC1 SPTAN1 SPTBN1 TSC1 BCR KIDINS220 DST SACS UCHL1 PIP4K2A ALB BAIAP2 PRRC2A VARS1 PRRC2B GPI RAP1GDS1 WARS1 ANXA1 ANXA2 SYNE1 YTHDC2 CNKSR2 UPF1 SHROOM2 CERS5 PDIA6 AFAP1 ATP6V0D1 LMNA ARVCF LMO7 MYH14 P4HB ELAVL1 LIMCH1 PLCH1 TNR ATP2A2 ATP2B2 MTDH UNC13A ATP5F1A RPL13 | 2.39e-09 | 1394 | 266 | 47 | int:KCTD13 |
| Interaction | YWHAG interactions | NUMBL MYO9A MARK3 ERC1 SPTAN1 SPTBN1 KDM3B TSC1 BCR CEP350 FANCD2 DST MAST4 CASKIN2 RABGAP1L ZNF638 NHS AP1M1 ALB JAKMIP1 BAIAP2 AMOTL2 DNMBP GPRASP2 SFN ARHGEF28 PAGE4 POTEF NELFB ALS2 SHROOM2 ZNF106 IFRD1 LATS2 LMNA RNH1 LMO7 P4HB NUMB ELAVL1 PLCH1 ATP5F1A AHNAK2 | 6.79e-09 | 1248 | 266 | 43 | int:YWHAG |
| Interaction | KIF23 interactions | ERC1 SPTAN1 SPTBN1 NOL10 CHD4 BIRC6 MAP3K4 ACSL4 POTEE BRCA1 CPSF1 ALB HEATR5B SFN NOL8 ANXA1 ANXA2 ANXA2P2 DNAJC18 YTHDC2 UPF1 KIF20B TXNDC12 LIG3 PDIA6 LATS2 LMNA RNH1 TTLL6 MYH14 P4HB ASPH PDCD11 ELAVL1 ATP2A2 ATP5F1A RPL13 AHNAK2 | 9.78e-09 | 1031 | 266 | 38 | int:KIF23 |
| Interaction | RAB11A interactions | TPR SERPINA3 NUMBL ASIC1 MARK3 VPS13C SPTAN1 SPTBN1 TSC1 RABGAP1 GPRIN1 WASHC2A BIRC6 PICALM FANCD2 KIDINS220 DST RABGAP1L DIAPH3 HEATR5B WDR44 AKAP5 ANXA1 ANXA2 VIPAS39 SMC3 PDCD11 NUMB ELAVL1 KIRREL1 MTDH ATP5F1A AHNAK2 | 1.70e-08 | 830 | 266 | 33 | int:RAB11A |
| Interaction | IFI16 interactions | TPR SPTAN1 NOL10 CHD4 PELO BRCA1 UCHL1 GLYR1 RABGAP1L PIP4K2A ZNF638 HEATR5B PRRC2A VARS1 FKBP4 ANKFY1 DCAF13 SYNE1 YTHDC2 UPF1 DDX55 PPM1G LIG3 PDIA6 RNH1 MYH14 PDCD11 MTDH ATP5F1A RPL13 | 2.38e-08 | 714 | 266 | 30 | int:IFI16 |
| Interaction | YWHAQ interactions | TPR MYH7 NUMBL MYO9A MARK3 ERC1 TSC1 BCR CEP350 FANCD2 ACSL4 DST MAST4 BRCA1 PIK3CB ZNF638 NHS ALB BAIAP2 AMOTL2 DNMBP VARS1 SFN ARHGEF28 ANXA1 ANXA2 POTEF NELFB ALS2 UPF1 ZNF106 LMNA RNH1 LMO7 P4HB NUMB PLCH1 CABIN1 ATP5F1A | 2.71e-08 | 1118 | 266 | 39 | int:YWHAQ |
| Interaction | RCOR1 interactions | TPR NOL4 ERC1 SPTAN1 MYT1 CHD4 RABGAP1 BCR BIRC6 NCAPG DST RABGAP1L MGA VARS1 GPRASP2 CCHCR1 CASP8AP2 ANKFY1 KIF20B ESCO2 NCOR2 RPRD1A ZMYM4 CUX1 | 4.58e-08 | 494 | 266 | 24 | int:RCOR1 |
| Interaction | PML interactions | NUMBL KDM3B SPART CHD4 PICALM HMCES FANCD2 ACSL4 NCAPG BRCA1 EIF2B4 CASP8AP2 ANKFY1 TCF12 WASHC2C ANXA1 ANXA2 MED8 UPF1 LZIC PPP1R10 LIG3 NCOR2 ZNF106 LMNA SBNO1 LMO7 MYH14 P4HB POLD3 MTDH ZMYM4 RPL13 AHNAK2 | 8.37e-08 | 933 | 266 | 34 | int:PML |
| Interaction | RICTOR interactions | CMPK1 CLUAP1 SPTBN1 NASP TSC1 HMGCR WASHC2A FANCD2 ACSL4 PELO BRCA1 UCHL1 ALB MGA VARS1 SFN WASHC2C ANXA2 UPF1 PPM1G LMNA RNH1 P4HB ASPH ELAVL1 DEPDC5 ATP5F1A CUX1 RPL13 AHNAK2 | 9.13e-08 | 759 | 266 | 30 | int:RICTOR |
| Interaction | YWHAZ interactions | NUMBL MYO9A MARK3 ERC1 SPTAN1 SPTBN1 TSC1 BCR MAP3K4 FANCD2 DST MAST4 BRCA1 UCHL1 ZNF638 NHS JAKMIP1 CEP126 BAIAP2 DNMBP PRRC2A FKBP4 SFN RAD52 ARHGEF28 ANXA1 ANXA2 POTEF NELFB ALS2 CNKSR2 NKX1-2 LATS2 RPRD1A LMNA LMO7 NUMB DEPDC5 PLCH1 ATP2A2 ATP2B2 ATP5F1A | 9.59e-08 | 1319 | 266 | 42 | int:YWHAZ |
| Interaction | STX6 interactions | NUMBL MARK3 SPTAN1 SPTBN1 TSC1 RABGAP1 GPRIN1 WASHC2A PICALM KIDINS220 DST DIAPH3 BAIAP2 ANKFY1 WASHC2C BMP2K VIPAS39 LMNA ASPH NUMB CUX1 AHNAK2 | 1.42e-07 | 448 | 266 | 22 | int:STX6 |
| Interaction | ACE2 interactions | TPR CMPK1 NUMBL SPTAN1 SPTBN1 RABGAP1 PICALM NCAPG UCHL1 AP1M1 ALB DIAPH3 BAIAP2 VARS1 PRRC2B WDR44 DCAF13 ANXA2 ANXA2P2 GPRIN3 UPF1 SHROOM2 LIG3 PDIA6 LMNA RNH1 KCTD3 PDCD11 NUMB ELAVL1 POTEJ ATP2A2 MTDH ATP5F1A RPL13 AHNAK2 SORD | 1.84e-07 | 1106 | 266 | 37 | int:ACE2 |
| Interaction | C11orf52 interactions | NUMBL MARK3 SPTAN1 SPTBN1 GPRIN1 PICALM KIDINS220 DST CASKIN2 FLRT3 BAIAP2 AKAP5 GPRIN3 ARVCF NUMB KIRREL1 PALS2 PLCH1 | 1.85e-07 | 311 | 266 | 18 | int:C11orf52 |
| Interaction | NAA40 interactions | TPR NUMBL ERC1 KDM3B NASP SPART TSC1 CHD4 GPRIN1 PICALM PTPN12 DST UCHL1 ZNF638 PRRC2A FKBP4 PRRC2B WDR44 NOL8 GPI WARS1 WASHC2C YTHDC2 UPF1 LZIC PPP1R10 LIG3 PDIA6 NUMB LIMCH1 MTDH ATP5F1A RPL13 AHNAK2 | 2.53e-07 | 978 | 266 | 34 | int:NAA40 |
| Interaction | SUMO2 interactions | TPR SPTAN1 SPTBN1 CHD4 FANCD2 NCAPG DST BRCA1 ABRAXAS1 ZNF638 CPSF2 VARS1 CASP8AP2 WASHC2C ANXA1 UPF1 LMNA SMC3 LMO7 P4HB ELAVL1 ZHX1 ZMYM4 CUX1 AHNAK2 | 3.32e-07 | 591 | 266 | 25 | int:SUMO2 |
| Interaction | YWHAH interactions | NUMBL MYO9A MARK3 ERC1 SPTAN1 SPTBN1 KDM3B TSC1 BCR CEP350 FANCD2 DST MAST4 CASKIN2 RABGAP1L ZNF638 NHS JAKMIP1 BAIAP2 AMOTL2 DNMBP SFN ARHGEF28 POTEF CNTRL NELFB ALS2 ZNF106 LATS2 LMO7 NUMB ELAVL1 CEP152 LIMCH1 PLCH1 AHNAK2 | 4.86e-07 | 1102 | 266 | 36 | int:YWHAH |
| Interaction | HDAC1 interactions | TPR MYH7 ERC1 SPTAN1 MYT1 CHD4 RABGAP1 BCR BIRC6 FANCD2 NCAPG DST BRCA1 SYK ZNF638 DIAPH3 CPSF2 MGA VARS1 GPRASP2 CASP8AP2 ANKFY1 MED8 KIF20B ESCO2 NCOR2 IFRD1 LATS2 SMC3 LMO7 MYH14 SMARCA2 POLD3 CABIN1 ZHX1 CUX1 | 5.53e-07 | 1108 | 266 | 36 | int:HDAC1 |
| Interaction | YWHAB interactions | NUMBL MYO9A MARK3 ERC1 SPTAN1 SPTBN1 TSC1 BCR CEP350 FANCD2 DST MAST4 ZNF638 NHS JAKMIP1 BAIAP2 AMOTL2 DNMBP GPRASP2 SFN ARHGEF28 POTEF NELFB ALS2 ZNF106 VIPAS39 RNH1 LMO7 P4HB NUMB ELAVL1 PLCH1 ATP5F1A AHNAK2 | 5.80e-07 | 1014 | 266 | 34 | int:YWHAB |
| Interaction | CCDC8 interactions | TPR CHD4 CEP350 FANCD2 DST SACS GLYR1 ALB HEATR5B VARS1 GPRASP2 ANXA2 YTHDC2 LIG3 PDIA6 LMNA SMC3 LMO7 MYH14 P4HB PDCD11 ELAVL1 CEP57 ATP2A2 MTDH ATP5F1A | 6.61e-07 | 656 | 266 | 26 | int:CCDC8 |
| Interaction | SLX4 interactions | KDM3B SPART CHD4 CEP350 FANCD2 BRCA1 AP1M1 MGA VARS1 PRRC2B NOL8 TCF12 ANXA2 ODF2 ZNF106 LMNA SBNO1 SMC3 PDCD11 CLSPN ATP2A2 ATP5F1A ZMYM4 RPL13 | 6.68e-07 | 572 | 266 | 24 | int:SLX4 |
| Interaction | TRRAP interactions | MYH7 PPRC1 VPS13C SPTAN1 SPTBN1 MED14 NASP BCR FANCD2 SCD GLYR1 ZNF638 ALB MGA CNOT3 CASP8AP2 WARS1 SYNE1 CNTRL UPF1 PPM1G CASP12 LIG3 NCOR2 SMC3 TTLL6 P4HB MTDH ZMYM4 | 6.99e-07 | 790 | 266 | 29 | int:TRRAP |
| Interaction | PHF21A interactions | TPR NOL4 ERC1 RABGAP1 BCR BIRC6 DST RABGAP1L DIAPH3 MGA GPRASP2 CCHCR1 CASP8AP2 ANKFY1 KIF20B ESCO2 RPRD1A ELAVL1 | 7.77e-07 | 343 | 266 | 18 | int:PHF21A |
| Interaction | TFE3 interactions | NASP CHD4 ZNF638 VARS1 FKBP4 SFN GPI ANXA1 ANXA2 ALS2 KIF20B LIG3 PDIA6 ATP6V0D1 CABIN1 ATP5F1A CUX1 RPL13 | 8.10e-07 | 344 | 266 | 18 | int:TFE3 |
| Interaction | MECP2 interactions | NOL4 NUMBL SPTAN1 SPTBN1 MED14 CHD4 KIDINS220 DST SACS GLYR1 PIP4K2A ZNF638 CPSF1 ALB CPSF2 VARS1 NOL8 DCAF13 ANXA2 SYNE1 UPF1 DDX55 IWS1 PPP1R10 LIG3 PDIA6 AFAP1 LMNA SMC3 P4HB KCTD3 SMARCA2 PDCD11 INTS4 ELAVL1 ATP2A2 MTDH UNC13A RPL13 | 1.02e-06 | 1287 | 266 | 39 | int:MECP2 |
| Interaction | RHOF interactions | CMPK1 PDE8A NUMBL ASIC1 MARK3 SPTAN1 SPTBN1 GPRIN1 PICALM POTEE NCAPG KIDINS220 CASKIN2 DIAPH3 BAIAP2 RAP1GDS1 ANKFY1 PPM1G LIG3 AFAP1 ARVCF NUMB ELAVL1 KIRREL1 ADGRE5 ATP2A2 | 1.07e-06 | 673 | 266 | 26 | int:RHOF |
| Interaction | KIF20A interactions | INPP5B SPTAN1 SPTBN1 CHD4 HMGCR PICALM ACSL4 POTEE KIDINS220 BRCA1 UCHL1 RABGAP1L ZNF638 CPSF1 ALB CPSF2 PRRC2A PRRC2B ANXA2 ANXA2P2 SYNE1 ESCO2 ZNF106 AFAP1 LMNA LMO7 MYH14 P4HB SMARCA2 ELAVL1 POTEJ ATP5F1A RPL13 AHNAK2 | 1.33e-06 | 1052 | 266 | 34 | int:KIF20A |
| Interaction | HDAC6 interactions | SPTAN1 SPTBN1 NASP PICALM ACSL4 POTEE PELO SYK CPSF1 MFN2 ALB DIAPH3 BAIAP2 GPI ANXA1 ANXA2 POTEF UPF1 CCDC141 LIG3 PDIA6 LMNA LMO7 MYH14 P4HB CEP70 ELAVL1 LIMCH1 CEP57 ATP5F1A RPL13 | 2.11e-06 | 929 | 266 | 31 | int:HDAC6 |
| Interaction | SIRT7 interactions | TPR SPTAN1 SPTBN1 NOL10 CHD4 BIRC6 DST GLYR1 ZNF638 CPSF1 PRRC2A FKBP4 PRRC2B DCAF13 WARS1 ANXA1 YTHDC2 UPF1 PPM1G LMNA RNH1 MYH14 P4HB SMARCA2 PDCD11 ELAVL1 ATP2A2 | 2.15e-06 | 744 | 266 | 27 | int:SIRT7 |
| Interaction | DIRAS3 interactions | NUMBL MARK3 SPTAN1 SPTBN1 PICALM KIDINS220 DST FKBP4 RAP1GDS1 GPRIN3 PPM1G P4HB NUMB KIRREL1 PLCH1 | 2.27e-06 | 262 | 266 | 15 | int:DIRAS3 |
| Interaction | ZFPL1 interactions | NUMBL MARK3 SPTAN1 SPTBN1 GPRIN1 PICALM FANCD2 KIDINS220 DST CASKIN2 BAIAP2 AKAP5 ACBD5 CGRRF1 PITPNM3 NUMB KIRREL1 PLCH1 CUX1 AHNAK2 | 2.32e-06 | 448 | 266 | 20 | int:ZFPL1 |
| Interaction | AGR2 interactions | CMPK1 ERC1 SPTAN1 SPTBN1 CHD4 PICALM DST SCD FKBP4 SFN GPI WARS1 ANXA1 ANXA2 SYNE1 CNTRL AP1M2 GPRIN3 UPF1 PDIA6 LMNA MYH14 P4HB ASPH ELAVL1 PCNX1 PALS2 ATP2A2 ATP5F1A AHNAK2 SORD | 2.36e-06 | 934 | 266 | 31 | int:AGR2 |
| Interaction | STX7 interactions | NUMBL MARK3 SPTAN1 SPTBN1 TSC1 RABGAP1 GPRIN1 WASHC2A PICALM KIDINS220 DST CASKIN2 RABGAP1L BAIAP2 WDR44 ANKFY1 AKAP5 BMP2K VIPAS39 LMNA ASPH NUMB ELAVL1 KIRREL1 MTDH | 2.40e-06 | 659 | 266 | 25 | int:STX7 |
| Interaction | MED4 interactions | ERC1 SPTAN1 MED14 CEP350 NCAPG DST GLYR1 PIP4K2A ZNF638 PIP4K2B ALB CCHCR1 MED8 CNTRL ODF2 PPM1G PDIA6 RPRD1A ELAVL1 CEP152 | 2.49e-06 | 450 | 266 | 20 | int:MED4 |
| Interaction | CEBPB interactions | TPR MARK3 ERC1 KDM3B NASP SPART CHD4 FABP4 ACSL4 BRCA1 ZNF638 AP1M1 ALB PRRC2A VARS1 FKBP4 SFN GPI WARS1 ANXA1 ANXA2 UPF1 KIF20B TXNDC12 PPM1G IWS1 LIG3 NCOR2 PDIA6 ATP6V0D1 LMNA SMC3 P4HB SMARCA2 ELAVL1 POLD3 MTDH ATP5F1A CUX1 RCN3 RPL13 | 2.65e-06 | 1443 | 266 | 41 | int:CEBPB |
| Interaction | EED interactions | TPR VPS13C SPTAN1 SPTBN1 MED14 NOL10 CHD4 BIRC6 PICALM FANCD2 ACSL4 BRCA1 GLYR1 ZNF638 CPSF1 AP1M1 ALB CPSF2 MGA VARS1 GPI ANKFY1 DCAF13 WARS1 BMP2K UPF1 KIF20B LIG3 PDIA6 ATP6V0D1 LMNA SMC3 SMARCA2 PALM3 PDCD11 NUMB ELAVL1 LIMCH1 ATP2A2 ATP5F1A RPL13 | 2.74e-06 | 1445 | 266 | 41 | int:EED |
| Interaction | MYH9 interactions | SPTAN1 SPTBN1 KDM3B NASP CHD4 PICALM FANCD2 NCAPG DST BRCA1 UCHL1 ALB ARHGEF28 PAGE4 BMP2K ANXA1 ANXA2 AFAP1 LMNA RNH1 LMO7 TTLL6 MYH14 LIMCH1 MTDH ATP5F1A SORD | 2.76e-06 | 754 | 266 | 27 | int:MYH9 |
| Interaction | YAP1 interactions | TPR HECW1 ERC1 SPTAN1 SPTBN1 MED14 KDM3B NASP CHD4 POTEE ALB AMOTL2 MGA PRRC2A SFN GPI POTEF MED8 CNKSR2 UPF1 PPP1R10 LATS2 LMNA MYH14 P4HB SMARCA2 NUMB ELAVL1 POTEJ POTEI ATP5F1A ZMYM4 CUX1 RPL13 | 3.21e-06 | 1095 | 266 | 34 | int:YAP1 |
| Interaction | NINL interactions | ERC1 NASP TSC1 BCR CEP350 MAST4 BRCA1 DIAPH3 DNMBP CNOT3 PRRC2B SFN CCHCR1 BMP2K ANXA1 ODF2 LATS2 LMNA LMO7 CEP152 | 3.24e-06 | 458 | 266 | 20 | int:NINL |
| Interaction | TRIM37 interactions | MYH7 SPTAN1 SPTBN1 CEP350 ALB DIAPH3 MGA TCF12 ANXA1 ANXA2 PPP1R10 NCOR2 LATS2 LMNA RNH1 MYH14 P4HB ELAVL1 CEP152 POTEJ POTEI ATP2A2 ATP5F1A RPL13 | 3.59e-06 | 630 | 266 | 24 | int:TRIM37 |
| Interaction | CDH1 interactions | NUMBL MARK3 ERC1 SPTAN1 SPTBN1 CHD4 GPRIN1 PICALM FANCD2 KIDINS220 DST BRCA1 CASKIN2 NHS AP1M1 DIAPH3 BAIAP2 SFN ANXA1 ANXA2 UPF1 LMNA ARVCF LMO7 PALM3 NUMB LIMCH1 | 3.88e-06 | 768 | 266 | 27 | int:CDH1 |
| Interaction | CAV1 interactions | CMPK1 NUMBL MARK3 SPTAN1 SPTBN1 GPRIN1 CHRM5 FANCD2 KIDINS220 DST CASKIN2 PIK3CB FLRT3 DIAPH3 ANKFY1 AKAP5 GPRIN3 TXNDC12 PPM1G LMNA ARVCF NUMB KIRREL1 CUX1 AHNAK2 SORD | 4.05e-06 | 724 | 266 | 26 | int:CAV1 |
| Interaction | CDC73 interactions | MED14 CHD4 POTEE KIDINS220 BRCA1 CPSF1 ALB CPSF2 FKBP4 GPRASP2 SFN ANXA1 ANXA2 PDIA6 RNH1 MYH14 CEP70 ATP5F1A | 4.13e-06 | 386 | 266 | 18 | int:CDC73 |
| Interaction | ATG16L1 interactions | ERC1 VPS13C INPP5D TSC1 RABGAP1 PICALM CEP350 EIF2B4 SYK ZNF638 PIP4K2B ALB DIAPH3 CPSF2 DNMBP PRRC2A CNOT3 PRRC2B CCHCR1 ARHGEF28 WARS1 MED8 CNTRL NELFB YTHDC2 DDX55 SHROOM2 TXNDC12 PDIA6 SMC3 TTLL6 ELAVL1 KIRREL1 CEP152 ATP5F1A | 4.36e-06 | 1161 | 266 | 35 | int:ATG16L1 |
| Interaction | GSK3B interactions | MYO9A ERC1 TSC1 BCR WASHC2A PICALM HMCES MAP3K4 CEP350 PTPN12 KIDINS220 DST MAST4 NHS ALB FKBP4 GPI ANXA1 ANXA2 YTHDC2 AFAP1 LMNA P4HB PDCD11 ELAVL1 CEP152 CLSPN ZHX1 RPL13 | 4.50e-06 | 868 | 266 | 29 | int:GSK3B |
| Interaction | SOX2 interactions | CMPK1 MYO9A MARK3 SPTAN1 SPTBN1 CHD4 WASHC2A PICALM TGM5 KIDINS220 CROCC2 GLYR1 EIF2B4 ZNF638 AMOTL2 FKBP4 CNOT3 PRRC2B SFN GPI TCF12 ANXA1 ANXA2 LAMA3 YTHDC2 UPF1 LIG3 NCOR2 RNH1 SMC3 MYH14 P4HB ASPH SMARCA2 PDCD11 NUMB ELAVL1 PLCH1 ATP5F1A CUX1 | 4.55e-06 | 1422 | 266 | 40 | int:SOX2 |
| Interaction | EZR interactions | NUMBL MARK3 SPTAN1 TSC1 GPRIN1 BCR WASHC2A HMCES FANCD2 PTPN12 KIDINS220 DST BRCA1 SYK DIAPH3 WDR44 RAP1GDS1 LMO7 P4HB NUMB ELAVL1 LIMCH1 | 4.68e-06 | 553 | 266 | 22 | int:EZR |
| Interaction | FLOT1 interactions | PDE8A NUMBL MARK3 SPTAN1 SPTBN1 GPRIN1 PICALM FANCD2 KIDINS220 DST CASKIN2 AKAP5 ANXA1 RAPGEF1 GPRIN3 NUMB KIRREL1 MYH15 PLCH1 ATP5F1A | 5.59e-06 | 475 | 266 | 20 | int:FLOT1 |
| Interaction | PRMT1 interactions | TPR NOL4 SPTAN1 SPTBN1 NASP FANCD2 C4orf17 NCAPG BRCA1 GLYR1 CPSF1 ALB JAKMIP1 CPSF2 MGA PRRC2A PRRC2B ANKFY1 ANXA2 YTHDC2 UPF1 PDIA6 LMNA RNH1 SMC3 P4HB ELAVL1 MTDH ATP5F1A RPL13 | 5.97e-06 | 929 | 266 | 30 | int:PRMT1 |
| Interaction | H2BC12 interactions | CHD4 CEP350 FANCD2 DST ZNF638 CPSF1 PRRC2A CNOT3 PRRC2B NOL8 PPM1G IWS1 LMNA SMC3 ANKRD36 MTDH | 6.46e-06 | 322 | 266 | 16 | int:H2BC12 |
| Interaction | ECT2 interactions | MARK3 VPS13C SPTAN1 SPTBN1 CMYA5 PICALM POTEE DST PELO PIK3CB CPSF2 UNC13B ANXA2 ANXA2P2 UPF1 PPM1G AFAP1 ATP6V0D1 LMNA LMO7 MYH14 P4HB ELAVL1 POTEJ ATP2A2 ATP5F1A CUX1 RPL13 AHNAK2 | 6.82e-06 | 887 | 266 | 29 | int:ECT2 |
| Interaction | BMI1 interactions | SPTBN1 CHD4 POTEE DST CASKIN2 IL1R2 ZNF638 CEP126 BAIAP2 MGA PRRC2A PRRC2B SFN CCHCR1 DCAF13 SYNE1 UPF1 LMNA LMO7 P4HB KCTD3 SMARCA2 PDCD11 ELAVL1 | 7.66e-06 | 659 | 266 | 24 | int:BMI1 |
| Interaction | RAB5A interactions | TPR MARK3 INPP5B SPTAN1 TSC1 WASHC2A FANCD2 ACSL4 PTPN12 DST PIK3CB DIAPH3 VARS1 WDR44 ANKFY1 WASHC2C ACBD5 ATE1 LMNA ASPH NUMB ELAVL1 KIRREL1 MTDH RPL13 | 7.97e-06 | 706 | 266 | 25 | int:RAB5A |
| Interaction | RAB35 interactions | NUMBL MARK3 VPS13C SPTAN1 SPTBN1 RABGAP1 GPRIN1 PICALM FANCD2 KIDINS220 DST CASKIN2 RABGAP1L DIAPH3 BAIAP2 AKAP5 CNTRL GPRIN3 LMNA NUMB KIRREL1 PLCH1 | 8.21e-06 | 573 | 266 | 22 | int:RAB35 |
| Interaction | FBXO42 interactions | MYO9A ERC1 SPART TSC1 RABGAP1 POTEE UCHL1 PIP4K2A DIAPH3 PRRC2B KIF20B NCOR2 ATP2A2 ATP5F1A | 9.57e-06 | 259 | 266 | 14 | int:FBXO42 |
| Interaction | YWHAE interactions | NUMBL MYO9A MARK3 ERC1 SPTAN1 TSC1 BCR FANCD2 DST MAST4 BRCA1 ZNF638 NHS JAKMIP1 BAIAP2 AMOTL2 DNMBP MGA PRRC2A SFN RAD52 RAP1GDS1 ARHGEF28 PAGE4 POTEF NELFB ALS2 SHROOM2 NCOR2 ZNF106 LMO7 NUMB DEPDC5 PLCH1 CEP57 ATP5F1A | 9.62e-06 | 1256 | 266 | 36 | int:YWHAE |
| Interaction | ACTA1 interactions | SPTAN1 GAS2 TSC1 RABGAP1 FANCD2 POTEE DST DNMBP SFN PAGE4 ANXA1 ANXA2 POTEF AFAP1 POTEJ POTEI CEP57 | 9.65e-06 | 371 | 266 | 17 | int:ACTA1 |
| Interaction | RPA4 interactions | SERPINA3 SPTAN1 SPTBN1 NASP SPART WASHC2A HMCES DST BRCA1 ZNF638 PRRC2A NOL8 GPI ANXA2 LIG3 ELAVL1 POLD3 CUX1 RPL13 | 9.86e-06 | 452 | 266 | 19 | int:RPA4 |
| Interaction | PARP1 interactions | MARK3 MED14 NOL10 CHD4 PICALM FANCD2 NCAPG KIDINS220 PELO BRCA1 SACS ABRAXAS1 GLYR1 CPSF2 MGA NOL8 RAP1GDS1 WARS1 PAGE4 ANXA1 YTHDC2 DDX55 PPM1G LIG3 ZNF106 IFRD1 LMNA RNH1 LMO7 SMARCA2 PDCD11 ELAVL1 CLSPN ATP2A2 ATP5F1A ZMYM4 CUX1 | 1.10e-05 | 1316 | 266 | 37 | int:PARP1 |
| Interaction | NCKAP5L interactions | 1.14e-05 | 106 | 266 | 9 | int:NCKAP5L | |
| Interaction | MYCN interactions | TPR MARK3 VPS13C NOL10 CHD4 HMCES BRCA1 GLYR1 ZNF638 CPSF1 ALB BAIAP2 AMOTL2 CPSF2 PRRC2A PRRC2B TCF12 ANXA2P2 SYNE1 YTHDC2 UPF1 DDX55 CASP12 LIG3 ZNF106 RPRD1A LMNA MYH14 P4HB SMARCA2 PDCD11 NUMB ELAVL1 POTEI ATP2A2 MTDH ATP5F1A RPL13 | 1.17e-05 | 1373 | 266 | 38 | int:MYCN |
| Interaction | OCLN interactions | PDE8A NUMBL MARK3 SPTAN1 SPTBN1 GPRIN1 PICALM KIDINS220 DST CASKIN2 NHS UNC13B ANKFY1 AKAP5 GPRIN3 NUMB KIRREL1 PCNX1 ADGRE5 PLCH1 | 1.19e-05 | 500 | 266 | 20 | int:OCLN |
| Interaction | TNIP1 interactions | TPR MARK3 SPTAN1 SPTBN1 NOL10 CHD4 DST GLYR1 CPSF1 AP1M1 VARS1 DCAF13 BMP2K ANXA1 ANXA2 ANXA2P2 POTEF SYNE1 SHC4 UPF1 ODF2 DDX55 LIG3 LMNA SMC3 LMO7 MYH14 PDCD11 NUMB ELAVL1 CEP152 LIMCH1 ATP2A2 ATP5F1A RPL13 | 1.21e-05 | 1217 | 266 | 35 | int:TNIP1 |
| Interaction | RALBP1 interactions | BIRC6 PICALM ALB AMOTL2 CPSF2 DNMBP CCHCR1 BMP2K AP1M2 LMNA NUMB CEP57 | 1.34e-05 | 198 | 266 | 12 | int:RALBP1 |
| Interaction | TNIK interactions | TPR SPTAN1 SPTBN1 TSC1 BCR DST BAIAP2 MGA PRRC2B SFN SYNE1 CNKSR2 NCOR2 CABIN1 TNR PCDH8 UNC13A | 1.36e-05 | 381 | 266 | 17 | int:TNIK |
| Interaction | ARL16 interactions | 1.39e-05 | 83 | 266 | 8 | int:ARL16 | |
| Interaction | CDK9 interactions | TPR SPTAN1 SPTBN1 PICALM PELO BRCA1 ZNF638 CPSF1 VARS1 DCAF13 ANXA2 PPP1R10 SMC3 LMO7 MYH14 P4HB ASPH PDCD11 ELAVL1 CLSPN ATP2A2 ATP5F1A RPL13 AHNAK2 | 1.45e-05 | 685 | 266 | 24 | int:CDK9 |
| Interaction | ATG5 interactions | VPS13C INPP5B GAS2 SPART RABGAP1 PICALM PTPN12 SACS AP1M1 DNMBP CCHCR1 TYW3 WARS1 ATP6V0D1 LMNA ELAVL1 | 1.47e-05 | 344 | 266 | 16 | int:ATG5 |
| Interaction | DYRK1A interactions | TPR ERC1 SPTAN1 SPTBN1 TSC1 PICALM BRCA1 LIPH ABRAXAS1 CNOT3 SFN NUCB1 PPM1G NCOR2 LATS2 ASPH CEP70 ELAVL1 LIMCH1 RPL13 AHNAK2 | 1.52e-05 | 552 | 266 | 21 | int:DYRK1A |
| Interaction | LAMP1 interactions | MARK3 SPTAN1 SPTBN1 HMGCR GPRIN1 KIDINS220 DST PIK3CB PIP4K2A AP1M1 BAIAP2 AKAP5 GPRIN3 VIPAS39 ATP6V0D1 MYH14 NUMB ELAVL1 KIRREL1 DEPDC5 MTDH CUX1 AHNAK2 | 1.63e-05 | 644 | 266 | 23 | int:LAMP1 |
| Interaction | MEN1 interactions | PHF20 MED14 KDM3B NOL10 CHD4 FANCD2 GLYR1 ZNF638 CPSF1 CPSF2 PRRC2A NOL8 DCAF13 WASHC2C ANXA1 UPF1 DDX55 PPP1R10 LIG3 SBNO1 SMC3 LMO7 MYH14 ASPH PDCD11 ELAVL1 ATP2A2 MTDH ZMYM4 CUX1 RPL13 | 1.63e-05 | 1029 | 266 | 31 | int:MEN1 |
| Interaction | DISC1 interactions | MYH7 SPTAN1 SPTBN1 RABGAP1 CEP350 DST GLYR1 AP1M1 CEP126 GPRASP2 CCHCR1 ANXA2 SYNE1 CCDC141 LMNA SMC3 CEP57 MTDH | 1.74e-05 | 429 | 266 | 18 | int:DISC1 |
| Interaction | C19orf38 interactions | 1.81e-05 | 86 | 266 | 8 | int:C19orf38 | |
| Interaction | CLTA interactions | NUMBL BCR PICALM KIDINS220 MAST4 RABGAP1L AP1M1 HEATR5B DNMBP CNOT3 WASHC2C BMP2K YTHDC2 UPF1 NUMB AHNAK2 | 1.89e-05 | 351 | 266 | 16 | int:CLTA |
| Interaction | HDAC4 interactions | TPR MARK3 SPTAN1 SPTBN1 SYK ZNF638 PRRC2A PRRC2B SFN WASHC2C GPRIN3 YTHDC2 UPF1 PPM1G IWS1 ESCO2 NCOR2 IFRD1 LMO7 KCTD3 CEP70 ELAVL1 LIMCH1 MTDH ATP5F1A | 1.93e-05 | 744 | 266 | 25 | int:HDAC4 |
| Interaction | RHOV interactions | MYO9A MARK3 SPTAN1 SPTBN1 PICALM KIDINS220 DST BAIAP2 MYH14 NUMB ELAVL1 KIRREL1 ADGRE5 | 2.22e-05 | 243 | 266 | 13 | int:RHOV |
| Interaction | H3C1 interactions | TPR PHF20 SPTAN1 MED14 NASP CHD4 GPRIN1 FANCD2 GLYR1 ZNF638 MGA AKAP5 SYNE1 NELFB KIF20B PPM1G ESCO2 LIG3 LMNA SMC3 MYH14 SMARCA2 MYH15 POLD3 CABIN1 ZMYM4 CUX1 RPL13 | 2.49e-05 | 901 | 266 | 28 | int:H3C1 |
| Interaction | OBSL1 interactions | TPR NOL10 CHD4 POTEE DST CROCC2 GLYR1 ZNF638 CPSF1 ALB CPSF2 MGA GPRASP2 GPI ANXA1 ANXA2 SYNE1 DDX55 PPP1R10 PDIA6 LMNA SMC3 LRRC53 ASPH PDCD11 ELAVL1 ATP5F1A RPL13 | 2.54e-05 | 902 | 266 | 28 | int:OBSL1 |
| Interaction | CHD3 interactions | TPR SPTBN1 NOL10 CHD4 FABP4 FANCD2 C4orf17 GLYR1 CPSF1 ALB CPSF2 ANXA2 DDX55 LIG3 LMNA SBNO1 SMC3 SMARCA2 PDCD11 ELAVL1 ZHX1 MTDH ATP5F1A CUX1 RPL13 | 2.58e-05 | 757 | 266 | 25 | int:CHD3 |
| Interaction | STIP1 interactions | TPR SPTAN1 SPTBN1 NASP CHD4 PICALM FANCD2 NCAPG BRCA1 UCHL1 MFN2 AP1M1 VARS1 FKBP4 ANKFY1 WARS1 DDX60 ACBD5 NELFB UPF1 LIG3 PDIA6 RPRD1A LMNA RNH1 SMC3 P4HB PDCD11 ELAVL1 ATP2A2 | 2.73e-05 | 1006 | 266 | 30 | int:STIP1 |
| Interaction | CSNK2A1 interactions | SPTBN1 CHD4 ANKRD36C BCR BIRC6 DST BRCA1 PIP4K2A PIP4K2B MGA FKBP4 WDR44 SFN GPI CNKSR2 UPF1 IWS1 ANKRD36B PDIA6 IFRD1 LMNA ELAVL1 ANKRD36 CEP57 GRAMD1C ZHX1 MTDH ATP5F1A RPL13 | 2.75e-05 | 956 | 266 | 29 | int:CSNK2A1 |
| Interaction | CTDSPL interactions | 2.96e-05 | 92 | 266 | 8 | int:CTDSPL | |
| Interaction | ISG15 interactions | SPTAN1 PICALM FANCD2 SFN GPI WARS1 BMP2K MYH7B ANXA1 ANXA2 PPP1R10 LMNA LMO7 ELAVL1 LIMCH1 ATP2A2 MTDH ATP5F1A AHNAK2 | 3.36e-05 | 494 | 266 | 19 | int:ISG15 |
| Interaction | LAMTOR1 interactions | NUMBL MARK3 VPS13C SPTBN1 SPART TSC1 RABGAP1 GPRIN1 WASHC2A PICALM FANCD2 KIDINS220 DST CASKIN2 DIAPH3 FKBP4 WASHC2C BMP2K GPRIN3 VIPAS39 NUMB ELAVL1 KIRREL1 PLCH1 | 3.39e-05 | 722 | 266 | 24 | int:LAMTOR1 |
| Interaction | POU5F1 interactions | TPR ERC1 CHD4 FANCD2 CPSF1 AMOTL2 CPSF2 MGA PRRC2B WARS1 ANXA2 UPF1 PPP1R10 LIG3 NCOR2 RPRD1A SMC3 SMARCA2 ELAVL1 CABIN1 ATP5F1A | 3.48e-05 | 584 | 266 | 21 | int:POU5F1 |
| Interaction | CD79B interactions | RABGAP1 BIRC6 FANCD2 KIDINS220 SYK INTS4 ELAVL1 KIRREL1 ATP2B2 | 3.53e-05 | 122 | 266 | 9 | int:CD79B |
| Interaction | FANCF interactions | 3.53e-05 | 29 | 266 | 5 | int:FANCF | |
| Interaction | KCNA3 interactions | TPR NUMBL MYO9A MARK3 ERC1 SPTBN1 SPART GPRIN1 FABP4 KIDINS220 DST DIAPH3 PRRC2A MYH7B ANXA2 MED8 YTHDC2 UPF1 ATE1 PPM1G PDIA6 SMC3 NUMB PLCH1 ATP2A2 ATP5F1A RPL13 | 3.65e-05 | 871 | 266 | 27 | int:KCNA3 |
| Interaction | PRC1 interactions | TPR SPTAN1 SPTBN1 TSC1 NOL10 CHD4 MAP3K4 NCAPG BRCA1 UCHL1 GLYR1 ZNF638 ANXA2 ANXA2P2 SYNE1 UPF1 ESCO2 LIG3 AFAP1 ATP6V0D1 LMNA LMO7 P4HB PDCD11 ELAVL1 POTEJ UNC13A ATP5F1A RPL13 | 3.79e-05 | 973 | 266 | 29 | int:PRC1 |
| Interaction | NXF1 interactions | TPR CMPK1 CLUAP1 PHF20 MYO9A SPTBN1 TSC1 CEP350 FANCD2 PPP1R26 AUNIP RABGAP1L CPSF1 MFN2 OSBP2 DIAPH3 PRRC2B NOL8 TCF12 ANXA1 MED8 ACBD5 RAPGEF1 UPF1 HPS3 IWS1 ESCO2 LIG3 ZNF106 AFAP1 RPRD1A LMNA CLSPN ATP5F1A ZMYM4 RPL13 | 4.13e-05 | 1345 | 266 | 36 | int:NXF1 |
| Interaction | MCM2 interactions | TPR MYO9A MED14 CHD4 CMYA5 BCR PICALM FANCD2 DST BRCA1 CPSF1 FKBP4 CNOT3 SFN RAD52 ANXA1 ANXA2 ANXA2P2 SYNE1 ESCO2 PDIA6 LMNA RNH1 SBNO1 SMC3 MYH14 P4HB CLSPN CABIN1 ATP5F1A RPL13 | 4.18e-05 | 1081 | 266 | 31 | int:MCM2 |
| Interaction | HAPSTR1 interactions | TPR FSIP1 NASP BIRC6 PICALM FANCD2 NCAPG PELO PRRC2A VARS1 CNOT3 GPI CASP8AP2 ANKFY1 ANXA1 PPM1G CERS5 IFRD1 RNH1 PDCD11 ELAVL1 POTEJ POTEI ATP2A2 ATP5F1A ZMYM4 | 4.22e-05 | 829 | 266 | 26 | int:HAPSTR1 |
| Interaction | PTEN interactions | TPR SPTAN1 SPTBN1 CHD4 GPRIN1 BIRC6 PELO AP1M1 OSBP2 PRRC2A DCAF13 ANXA2 ANXA2P2 YTHDC2 UPF1 PPM1G PPP1R10 LIG3 NCOR2 PDIA6 LMNA SMC3 PDCD11 NUMB ELAVL1 ATP2A2 ATP5F1A RPL13 | 4.27e-05 | 929 | 266 | 28 | int:PTEN |
| Interaction | CDK2 interactions | SPTAN1 SPTBN1 NASP DST BRCA1 UCHL1 VARS1 FKBP4 GPI RAP1GDS1 BMP2K ANXA1 ANXA2 UPF1 NCOR2 PDIA6 AFAP1 LATS2 LMNA SMC3 LMO7 P4HB LIMCH1 ATP5F1A RPL13 | 4.47e-05 | 783 | 266 | 25 | int:CDK2 |
| Interaction | LCK interactions | NUMBL MARK3 SPTAN1 SPTBN1 GPRIN1 FANCD2 KIDINS220 DST BRCA1 CASKIN2 SYK VARS1 FKBP4 GPRIN3 NUMB PLCH1 ATP5F1A AHNAK2 | 4.72e-05 | 463 | 266 | 18 | int:LCK |
| Interaction | RNF8 interactions | SPTAN1 SPTBN1 NASP CHD4 CASKIN2 ALB AMOTL2 GPRASP2 SFN ANXA1 ANXA2 CASP12 LMNA P4HB MTDH ATP5F1A KCNH5 | 4.81e-05 | 421 | 266 | 17 | int:RNF8 |
| Interaction | LGR4 interactions | TPR CHD4 KIDINS220 ZNF638 CPSF1 PRRC2A POTEF RAPGEF1 MYH14 PDCD11 POTEJ ATP2A2 ATP2B2 | 4.86e-05 | 262 | 266 | 13 | int:LGR4 |
| Interaction | GSK3A interactions | MYO9A MARK3 ERC1 BCR WASHC2A PICALM CEP350 PTPN12 KIDINS220 DST MAST4 NHS SFN YTHDC2 AFAP1 SBNO1 CEP152 RPL13 | 4.86e-05 | 464 | 266 | 18 | int:GSK3A |
| Cytoband | 9q34.11 | 2.69e-04 | 53 | 269 | 4 | 9q34.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 3.01e-04 | 153 | 269 | 6 | chr2q11 | |
| Cytoband | 2q21.1 | 3.81e-04 | 58 | 269 | 4 | 2q21.1 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 8.64e-08 | 13 | 171 | 5 | 685 | |
| GeneFamily | Myosin heavy chains | 1.99e-07 | 15 | 171 | 5 | 1098 | |
| GeneFamily | UNC13 homologs | 3.30e-06 | 4 | 171 | 3 | 836 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD36C POTEE KIDINS220 CASKIN2 POTEH ANKFY1 POTEF ANKRD36B ANKRD36 POTEJ POTEI | 1.98e-05 | 242 | 171 | 11 | 403 |
| GeneFamily | Protein disulfide isomerases | 9.75e-04 | 21 | 171 | 3 | 692 | |
| GeneFamily | CERS class homeoboxes | 1.30e-03 | 6 | 171 | 2 | 530 | |
| GeneFamily | WASH complex | 1.30e-03 | 6 | 171 | 2 | 1331 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 1.30e-03 | 6 | 171 | 2 | 1328 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.81e-03 | 7 | 171 | 2 | 1113 | |
| GeneFamily | Classical BAR domain containing | 2.40e-03 | 8 | 171 | 2 | 1292 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 2.40e-03 | 8 | 171 | 2 | 831 | |
| GeneFamily | ATPases Ca2+ transporting | 3.06e-03 | 9 | 171 | 2 | 1209 | |
| GeneFamily | PDZ domain containing | 3.26e-03 | 152 | 171 | 6 | 1220 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.53e-03 | 66 | 171 | 4 | 722 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PHF20 PDE8A MARK3 ERC1 KDM3B SPART RABGAP1 PICALM MAP3K4 CEP350 ACSL4 PTPN12 KIDINS220 DST BRCA1 SACS RABGAP1L PIP4K2A ZNF638 DNMBP SLC23A2 DPYD TCF12 BMP2K CERS6 KIF20B NCOR2 IFRD1 AFAP1 SMC3 SMARCA2 NUMB PALS2 MICU2 ZMYM4 CUX1 | 6.92e-13 | 856 | 268 | 36 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PDE8A MARK3 RABGAP1 PICALM CEP350 PTPN12 DST BRCA1 PIP4K2A ZNF638 DNMBP DPYD TCF12 CERS6 KIF20B AFAP1 SMARCA2 NUMB LIMCH1 PALS2 ZMYM4 CUX1 | 3.31e-09 | 466 | 268 | 22 | M13522 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TPR MARK3 SPTAN1 SPTBN1 NASP SACS SCD RABGAP1L CPSF1 BAIAP2 SLC23A2 CASP8AP2 RAP1GDS1 TCF12 WARS1 DDX60 CERS6 GPR107 PPP1R10 ASPH NUMB ADGRE5 ATP2A2 MTDH CUX1 AHNAK2 SORD | 5.03e-08 | 790 | 268 | 27 | M12490 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | CMPK1 SPTBN1 KDM3B TSC1 HMGCR WASHC2A CEP350 ACSL4 SACS SCD RABGAP1L PIP4K2A SYK NOL8 ANKFY1 DCAF13 WASHC2C BMP2K ANXA2 CNTRL KRBOX4 GPR107 MMRN1 PPP1R10 ZNF106 PDIA6 IFRD1 ELAVL1 MICU2 CEP57 ATP2A2 MTDH ZMYM4 RPL13 | 1.10e-07 | 1215 | 268 | 34 | M41122 |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN | MARK3 INPP5D SPTBN1 EIF2B4 PRRC2B RAD52 ACBD5 CERS6 ATE1 HPS3 LIFR ADGRE5 GRAMD1C | 1.61e-07 | 200 | 268 | 13 | M9842 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | SPTAN1 SPTBN1 TSC1 RABGAP1 BCR DST CNTRL ALS2 SHROOM2 KIF20B SMC3 CEP57 | 1.08e-06 | 199 | 268 | 12 | M5893 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | PHF20 CEP350 FANCD2 NCAPG SACS PIK3CB RABGAP1L DIAPH3 DPYD DCAF13 TCF12 YTHDC2 KIF20B IWS1 ESCO2 LIG3 PDIA6 IFRD1 SBNO1 SMC3 ASPH CEP70 ELAVL1 POLD3 PALS2 CEP57 | 1.34e-06 | 877 | 268 | 26 | M2241 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | ERC1 VPS13C BIRC6 CEP350 BRCA1 IWS1 PPP1R10 ZNF106 SBNO1 DEPDC5 ATP2A2 | 2.67e-06 | 180 | 268 | 11 | M8239 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP | 9.87e-06 | 14 | 268 | 4 | M1353 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP | 9.87e-06 | 14 | 268 | 4 | MM565 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 9.87e-06 | 14 | 268 | 4 | M2576 | |
| Coexpression | LIM_MAMMARY_LUMINAL_PROGENITOR_DN | 9.87e-06 | 14 | 268 | 4 | MM961 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | TPR CMPK1 SPTBN1 CHD4 NCAPG PIK3CB SCD SYK GPI SMC3 ELAVL1 POLD3 | 1.13e-05 | 250 | 268 | 12 | M11318 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.22e-05 | 137 | 268 | 9 | M39241 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | PDE8A VPS13C SPART HMGCR ADRA1A DST SYK CPSF1 BAIAP2 SYNE1 AP1M2 RAPGEF1 YTHDC2 UPF1 ODF2 MYH14 LIMCH1 | 2.05e-05 | 506 | 268 | 17 | M253 |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | CFAP251 MYO9A ERC1 RABGAP1 FANCD2 PTPN12 SCD RABGAP1L OSBP2 DIAPH3 BAIAP2 PRRC2B SFN RAP1GDS1 ANKFY1 ARHGEF28 DNAJC18 RPRD1A ERCC6L2 KIRREL1 MTDH AHNAK2 | 2.06e-05 | 783 | 268 | 22 | M2488 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | NASP HMGCR RABGAP1 PICALM HMCES NCAPG BRCA1 SCD ALB FKBP4 WARS1 UPF1 PPM1G MMRN1 PPP1R10 PDIA6 ATP6V0D1 LMNA DEPDC5 POLD3 | 2.07e-05 | 669 | 268 | 20 | M18635 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | SPTBN1 DST IL1R2 SCD SYK SFN ANXA2 AP1M2 LAMA3 PPM1G PDIA6 LMNA LMO7 MYH14 P4HB MTDH | 2.24e-05 | 458 | 268 | 16 | M40010 |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | SPTAN1 SPTBN1 NASP PTPN12 MAST4 WARS1 ANXA1 ANXA2 MMRN1 LIFR LMNA LIMCH1 EMCN | 2.27e-05 | 313 | 268 | 13 | M39128 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | PHF20 FABP4 ACSL4 PTPN12 DST MAST4 SCD RABGAP1L HEATR5B ANXA1 ACBD5 GPRIN3 CERS6 SHROOM2 LIFR IFRD1 LATS2 ARVCF LMO7 KIRREL1 ADGRE5 ZHX1 EMCN | 2.58e-05 | 854 | 268 | 23 | M1533 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPR PHF20 MARK3 VPS13C INPP5D SPTAN1 BIRC6 PICALM CEP350 ACSL4 KIDINS220 PELO SACS RABGAP1L PIP4K2A ZNF638 AP1M1 PRRC2B TYW3 RAP1GDS1 ANXA1 SYNE1 CNTRL RAPGEF1 GPRIN3 YTHDC2 SBNO1 SMC3 SMARCA2 PCNX1 ADGRE5 MTDH RPL13 | 2.63e-05 | 1492 | 268 | 33 | M40023 |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_DC_UP | PPRC1 INPP5D NASP PPP1R26 SACS PIP4K2A PIP4K2B DPYD MED8 TNR | 4.15e-05 | 199 | 268 | 10 | M5143 |
| Coexpression | GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP | 4.33e-05 | 200 | 268 | 10 | M8522 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | CMPK1 PHF20 MARK3 GAS2 KDM3B HMGCR PICALM ACSL4 PTPN12 BRCA1 PIK3CB SCD CPSF1 VARS1 FKBP4 WDR44 CASP8AP2 RAP1GDS1 TCF12 ANXA1 UPF1 IFRD1 LMNA SMC3 KCTD3 CEP70 SMARCA2 ELAVL1 MICU2 ATP2A2 SORD | 4.54e-05 | 1399 | 268 | 31 | M535 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | PHF20 FABP4 ACSL4 PTPN12 DST MAST4 SCD RABGAP1L HEATR5B ANXA1 ACBD5 GPRIN3 CERS6 SHROOM2 LIFR IFRD1 LATS2 ARVCF LMO7 KIRREL1 ADGRE5 ZHX1 EMCN | 4.71e-05 | 888 | 268 | 23 | MM1018 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYO9A VPS13C CEP350 KIDINS220 BRCA1 SACS RABGAP1L ZNF638 DIAPH3 CASP8AP2 KIF20B IWS1 SMC3 CEP70 SMARCA2 MICU2 CEP57 ZHX1 MTDH | 5.10e-05 | 656 | 268 | 19 | M18979 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | NUMBL SPTBN1 CHD4 GPRIN1 NRXN3 PRRC2B GPRIN3 CEP70 SMARCA2 MTDH | 5.55e-05 | 206 | 268 | 10 | M2817 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | NUMBL SPTBN1 CHD4 GPRIN1 NRXN3 PRRC2B GPRIN3 CEP70 SMARCA2 MTDH | 6.02e-05 | 208 | 268 | 10 | MM581 |
| Coexpression | TIEN_INTESTINE_PROBIOTICS_24HR_DN | 7.93e-05 | 215 | 268 | 10 | M19666 | |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 9.17e-05 | 177 | 268 | 9 | M7632 | |
| Coexpression | YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN | 9.59e-05 | 72 | 268 | 6 | M1208 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 9.99e-05 | 179 | 268 | 9 | M39308 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | ANKRD36C HMCES FANCD2 NCAPG MAST4 BRCA1 DIAPH3 CCHCR1 CASP8AP2 POC1A CNTRL CERS6 ODF2 KIF20B ESCO2 ANKRD36B NCOR2 INTS4 CEP152 ANKRD36 POLD3 CLSPN CUX1 | 1.09e-04 | 939 | 268 | 23 | M45768 |
| Coexpression | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN | 1.14e-04 | 25 | 268 | 4 | M7910 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | PHF20 WASHC2A KIDINS220 GLYR1 PIP4K2B ANKFY1 WASHC2C ANXA2 DDX60 MED8 PDIA6 RPRD1A ASPH | 1.15e-04 | 367 | 268 | 13 | M41159 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | TPR NASP FANCD2 PTPN12 NCAPG BRCA1 SCD DIAPH3 CPSF2 RAP1GDS1 DCAF13 ANXA1 LZIC KIF20B HPS3 RPRD1A SMC3 KIRREL1 | 1.26e-04 | 644 | 268 | 18 | M10501 |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | PHF20 KDM3B PTPN12 KIDINS220 EIF2B4 CNOT3 RAP1GDS1 DCAF13 BMP2K PPP1R10 ZNF106 IFRD1 ASPH CEP57 MTDH | 1.31e-04 | 477 | 268 | 15 | M40930 |
| Coexpression | GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN | 1.34e-04 | 186 | 268 | 9 | M8175 | |
| Coexpression | OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP | 1.34e-04 | 146 | 268 | 8 | M41190 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | TPR ERC1 TSC1 BCR PICALM FANCD2 BRCA1 SYK RAP1GDS1 TCF12 CNTRL LIFR | 1.35e-04 | 323 | 268 | 12 | M9150 |
| Coexpression | LIAO_METASTASIS | NUMBL VPS13C SPTBN1 MAP3K4 UCHL1 CPSF1 PRRC2A PRRC2B ANXA2 RAPGEF1 ZNF783 HPS3 GPR107 IFRD1 SBNO1 ASPH | 1.55e-04 | 540 | 268 | 16 | M13809 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | SPTAN1 SPTBN1 HMGCR GPRIN1 AMER2 MAST4 SNX32 UCHL1 PIP4K2A CEP126 BAIAP2 RAP1GDS1 SMARCA2 LIMCH1 PALS2 | 1.67e-04 | 488 | 268 | 15 | M39104 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | SERPINA3 ASIC1 SPTBN1 NASP CHD4 RFTN2 KIDINS220 DST BRCA1 RABGAP1L AMOTL2 TCF12 SYNE1 ACBD5 RAPGEF1 CERS6 SHROOM2 VIPAS39 AFAP1 LATS2 SMARCA2 ELAVL1 PCNX1 CABIN1 TNR | 1.79e-04 | 1102 | 268 | 25 | M2369 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NOL4 MYT1 ADGRB1 CHRM5 ACSL4 AMER2 NRXN3 MAST4 UCHL1 RABGAP1L PIP4K2B CEP126 PRRC2B LAMA3 SHC4 GPRIN3 CERS6 SHROOM2 CCDC141 ANKRD36B ANKRD36 ATP2B2 PCDH8 UNC13A AHNAK2 | 1.90e-04 | 1106 | 268 | 25 | M39071 |
| Coexpression | GSE22033_WT_VS_PPARG_KO_MEF_UP | 1.91e-04 | 195 | 268 | 9 | M7694 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 2.03e-04 | 155 | 268 | 8 | M39041 | |
| Coexpression | GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN | 2.14e-04 | 198 | 268 | 9 | M3242 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8 | 2.17e-04 | 12 | 268 | 3 | M5304 | |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | SPTBN1 CEP350 CNOT3 GPI CASP8AP2 TCF12 ANKRD36B ZNF106 CABIN1 | 2.22e-04 | 199 | 268 | 9 | M3257 |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP | 2.22e-04 | 199 | 268 | 9 | M8396 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_UP | 2.22e-04 | 199 | 268 | 9 | M5508 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 2.22e-04 | 199 | 268 | 9 | M3186 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_UP | 2.30e-04 | 200 | 268 | 9 | M3396 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 2.30e-04 | 200 | 268 | 9 | M9327 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP | 2.30e-04 | 200 | 268 | 9 | M3413 | |
| Coexpression | GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN | 2.30e-04 | 200 | 268 | 9 | M4971 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP | 2.30e-04 | 200 | 268 | 9 | M7148 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN | 2.30e-04 | 200 | 268 | 9 | M8869 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP | 2.30e-04 | 200 | 268 | 9 | M3869 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 2.30e-04 | 200 | 268 | 9 | M7417 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN | 2.30e-04 | 200 | 268 | 9 | M5052 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN | 2.30e-04 | 200 | 268 | 9 | M7767 | |
| Coexpression | GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN | 2.30e-04 | 200 | 268 | 9 | M6938 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_ENS_NEURONS | 2.63e-04 | 161 | 268 | 8 | M40214 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | VPS13C GAS2 NASP CHD4 FABP4 CEP350 NCAPG CASKIN2 CPSF1 PRRC2B CCHCR1 SYNE1 UPF1 SMARCA2 DEPDC5 CABIN1 | 2.68e-04 | 567 | 268 | 16 | M16909 |
| Coexpression | LEE_LIVER_CANCER_MYC_E2F1_UP | 2.69e-04 | 56 | 268 | 5 | M4420 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 3.07e-04 | 208 | 268 | 9 | M39233 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP | CFAP251 ASIC1 ERC1 DNAH14 LIPH NHS AKAP5 COL28A1 MAGEE2 ESCO2 MFSD2A TLL2 ATP2B2 RCN3 EMCN | 3.10e-04 | 517 | 268 | 15 | M7140 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 3.28e-04 | 90 | 268 | 6 | M39250 | |
| Coexpression | LEIN_MEDULLA_MARKERS | 3.28e-04 | 90 | 268 | 6 | MM719 | |
| Coexpression | GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP | 3.74e-04 | 129 | 268 | 7 | M423 | |
| Coexpression | GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN | 3.79e-04 | 170 | 268 | 8 | M8926 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_31_5P_GENES | 3.89e-04 | 34 | 268 | 4 | MM17500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | VPS13C SPTAN1 NASP BIRC6 MAP3K4 ACSL4 PTPN12 NCAPG BRCA1 ABRAXAS1 SCD ZNF638 CEP126 WDR44 NOL8 CASP8AP2 ODF2 KIF20B IWS1 ZNF106 MFSD2A IFRD1 SMC3 PALS2 CLSPN CEP57 | 4.07e-09 | 532 | 267 | 26 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPR NOL4 PHF20 MARK3 MED14 NASP CHD4 HMGCR TGM5 CEP350 FANCD2 PTPN12 NCAPG AUNIP NRXN3 BRCA1 ABRAXAS1 SCD CEP126 CPSF2 NOL8 CASP8AP2 TCF12 TTC41P CNTRL ODF2 KIF20B IWS1 ZNF2 ESCO2 MFSD2A ARVCF SBNO1 SMC3 MYH14 CEP70 PALM3 CLSPN CEP57 MTDH CUX1 | 1.05e-06 | 1459 | 267 | 41 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPR PHF20 MARK3 MED14 NASP CHD4 HMGCR TGM5 CEP350 FANCD2 PTPN12 NCAPG AUNIP BRCA1 ABRAXAS1 SCD CEP126 CPSF2 NOL8 CASP8AP2 TCF12 TTC41P CNTRL ODF2 KIF20B IWS1 ZNF2 ESCO2 MFSD2A SBNO1 SMC3 MYH14 CEP70 CLSPN CEP57 MTDH CUX1 | 1.28e-06 | 1257 | 267 | 37 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | MED14 RABGAP1 BIRC6 FABP4 CEP350 DNMBP ANKFY1 ARHGEF28 CCDC141 LIFR LIG3 SBNO1 ERCC6L2 CUX1 | 6.08e-06 | 261 | 267 | 14 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | PHF20 MED14 NASP CHD4 BIRC6 FABP4 CEP350 DNMBP ARHGEF28 CNTRL KIF20B LIG3 ERCC6L2 LIMCH1 POLD3 CUX1 | 6.78e-06 | 339 | 267 | 16 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | TPR PDE8A MYT1 MED14 NASP PPP1R26 NRXN3 BRCA1 PIK3CB NHS CEP126 SFN UNC13B CASP8AP2 ANXA2 ACBD5 ABCC9 MAGEE2 ODF2 KIF20B IWS1 PPP1R10 MFSD2A ARVCF SMC3 PALM3 PLCH1 CLSPN ATP2B2 | 2.01e-05 | 986 | 267 | 29 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | TPR NASP NCAPG ZNF638 NHS CASP8AP2 ODF2 KIF20B CEP70 PALM3 CLSPN | 2.49e-05 | 186 | 267 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ZNF597 PHF20 MYO9A PPRC1 SPTAN1 TSC1 FANCD2 NCAPG BRCA1 PIK3CB LIPH ABRAXAS1 UCHL1 PIP4K2A MGA NOL8 DCAF13 ALS2 KIF20B ESCO2 SBNO1 CEP70 PDCD11 CLSPN CABIN1 | 3.56e-05 | 810 | 267 | 25 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PDE8A MYO9A FSIP1 FANCD2 NCAPG AUNIP BRCA1 LIPH ABRAXAS1 RABGAP1L DIAPH3 MGA WDR44 NOL8 UNC13B CASP8AP2 DCAF13 ALS2 YTHDC2 CNKSR2 ESCO2 KCTD3 ERCC6L2 POLD3 CLSPN | 4.34e-05 | 820 | 267 | 25 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | VPS13C MYT1 NASP CEP350 ACSL4 NRXN3 BRCA1 RABGAP1L NHS GPRASP2 NOL8 CASP8AP2 DPYD ANXA1 CERS6 ODF2 KIF20B IWS1 MFSD2A SMC3 CEP70 PALM3 POLD3 PLCH1 CLSPN CEP57 ATP2B2 CUX1 | 4.95e-05 | 983 | 267 | 28 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TPR NOL4 NUMBL SPTAN1 MED14 NASP TSC1 BRCA1 PIK3CB ABRAXAS1 NHS FLRT3 CEP126 AMOTL2 UNC13B CASP8AP2 TCF12 MED8 CNTRL ODF2 SHROOM2 KIF20B ESCO2 PPP1R10 MFSD2A ARVCF SMC3 MYH14 PALM3 POLD3 PLCH1 CLSPN MTDH CUX1 KCNH5 | 5.18e-05 | 1370 | 267 | 35 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MYO9A ERC1 NASP TSC1 RABGAP1 PICALM ACSL4 MAST4 BRCA1 HEATR5B ANKFY1 POC1A KIF20B GPR107 IWS1 CERS5 AFAP1 CGRRF1 CEP70 ERCC6L2 PALM3 CLSPN ZMYM4 CUX1 | 5.38e-05 | 780 | 267 | 24 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | FSIP1 FANCD2 NCAPG AUNIP BRCA1 ABRAXAS1 DIAPH3 CASP8AP2 DCAF13 ALS2 ESCO2 KCTD3 ERCC6L2 POLD3 CLSPN | 5.73e-05 | 361 | 267 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | NASP ACSL4 SCD NOL8 ODF2 KIF20B IWS1 ZNF106 MFSD2A IFRD1 SMC3 | 5.79e-05 | 204 | 267 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 |
| CoexpressionAtlas | Pluripotent Stem Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | MED14 NASP NOL10 HMGCR ACSL4 SACS SCD RABGAP1L PIP4K2A VARS1 GPI DCAF13 POC1A KIF20B HPS3 NKX1-2 ESCO2 MFSD2A PALM3 FHDC1 PALS2 PLCH1 UNC13A SORD | 7.37e-05 | 796 | 267 | 24 | PCBC_ratio_SC_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR PHF20 ERC1 NASP HMGCR FANCD2 AUNIP BRCA1 SCD CEP126 NOL8 UNC13B CCHCR1 CASP8AP2 TCF12 TTC41P CNTRL MAGEE2 ODF2 KIF20B HPS3 PPP1R10 MFSD2A ARVCF SMC3 MYH14 CEP70 PLCH1 CLSPN | 7.38e-05 | 1060 | 267 | 29 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPR PHF20 PDE8A NASP CHD4 TGM5 NCAPG AUNIP BRCA1 ABRAXAS1 SCD NHS FLRT3 CEP126 NOL8 CASP8AP2 TTC41P MYH7B CNTRL CNKSR2 ODF2 KIF20B MMRN1 MFSD2A SBNO1 SMC3 MYH14 CEP70 PALS2 CLSPN CEP57 ATP5F1A | 9.39e-05 | 1241 | 267 | 32 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | PHF20 NASP DST ZNF638 CEP126 HEATR5B NOL8 RAP1GDS1 KIF20B IWS1 SMC3 MYH14 PALM3 DEPDC5 PALS2 CLSPN CEP57 | 1.00e-04 | 469 | 267 | 17 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | SERPINA3 MYH7 MED14 FABP4 CEP350 ACSL4 DST LIPH UCHL1 RABGAP1L WDR44 AKAP5 ANXA1 ABCC9 CCDC141 CASP12 ZNF106 LATS2 LMO7 ERCC6L2 ATP2A2 CUX1 AHNAK2 | 1.25e-04 | 772 | 267 | 23 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.66e-04 | 192 | 267 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | NASP ACSL4 BRCA1 MAGEE2 KIF20B IWS1 MFSD2A CEP70 PALM3 CLSPN | 1.66e-04 | 192 | 267 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | MED14 NASP BRCA1 CASP8AP2 ODF2 KIF20B IWS1 AFAP1 SMC3 CEP70 PALM3 CLSPN CUX1 | 1.68e-04 | 311 | 267 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | VPS13C NASP CEP350 ACSL4 DST BRCA1 NHS GPRASP2 NOL8 CASP8AP2 DPYD ODF2 KIF20B IWS1 SMC3 POLD3 CLSPN CEP57 CUX1 SORD | 2.47e-04 | 654 | 267 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TPR PDE8A ERC1 INPP5D NASP TSC1 CHD4 TGM5 PTPN12 AUNIP ABRAXAS1 SCD ZNF638 NHS CEP126 CASP8AP2 TCF12 CNTRL CNKSR2 ODF2 KIF20B HPS3 ESCO2 MMRN1 PPP1R10 MFSD2A SMC3 MYH14 ASPH CEP70 CLSPN | 2.49e-04 | 1252 | 267 | 31 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | PPRC1 NOL10 FANCD2 NCAPG BRCA1 PIK3CB LIPH UCHL1 VARS1 NOL8 DCAF13 KIF20B ESCO2 CEP70 PDCD11 CLSPN | 2.74e-04 | 463 | 267 | 16 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | VPS13C NASP CEP350 ACSL4 BRCA1 NOL8 CASP8AP2 DPYD IWS1 SMC3 POLD3 CEP57 CUX1 | 2.82e-04 | 328 | 267 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | MYT1 MED14 NASP ACSL4 BRCA1 PIK3CB SCD UCHL1 PIP4K2A NOL8 UNC13B CASP8AP2 ODF2 KIF20B IWS1 MFSD2A IFRD1 AFAP1 ARVCF SMC3 CEP70 PALM3 PLCH1 CLSPN ATP2B2 CUX1 | 3.28e-04 | 989 | 267 | 26 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | MYO9A ERC1 MED14 NASP ACSL4 BRCA1 SCD NOL8 CASP8AP2 POC1A ODF2 KIF20B GPR107 IWS1 CERS5 IFRD1 AFAP1 SMC3 CGRRF1 ERCC6L2 PALM3 CLSPN CUX1 | 3.58e-04 | 831 | 267 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TPR MED14 NASP RABGAP1 BIRC6 CEP350 DNMBP LIFR LIG3 SBNO1 ERCC6L2 MTDH ZMYM4 CUX1 | 3.97e-04 | 385 | 267 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TPR NASP ABRAXAS1 HEATR5B MGA SYNE1 ABCC9 CERS6 ODF2 KIF20B SMC3 CEP70 PALM3 NUMB CLSPN | 4.03e-04 | 432 | 267 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | MED14 NASP BRCA1 NHS UNC13B CASP8AP2 ACBD5 ODF2 IWS1 MFSD2A SMC3 CLSPN | 4.17e-04 | 298 | 267 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | TPR PDE8A NASP ZNF638 CEP126 ABCC9 CERS6 KIF20B MYH14 CEP70 LIMCH1 CLSPN | 4.17e-04 | 298 | 267 | 12 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR NOL4 PHF20 ERC1 NASP HMGCR TGM5 FANCD2 AUNIP NRXN3 BRCA1 SCD CEP126 NOL8 UNC13B CCHCR1 CASP8AP2 TCF12 TTC41P CNTRL MAGEE2 ODF2 KIF20B HPS3 PPP1R10 MFSD2A ARVCF SMC3 MYH14 CEP70 PLCH1 CLSPN KCNH5 | 4.50e-04 | 1414 | 267 | 33 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000 | INPP5B RFTN2 PICALM NRXN3 PIP4K2A ABCC9 GPRIN3 YTHDC2 ATE1 HPS3 CASP12 AFAP1 LMO7 | 4.95e-04 | 348 | 267 | 13 | gudmap_kidney_adult_Mesangium_Meis_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | MYT1 NASP ACSL4 NRXN3 BRCA1 NOL8 CASP8AP2 ODF2 KIF20B IWS1 MFSD2A SMC3 CEP70 PLCH1 CLSPN ATP2B2 | 5.45e-04 | 493 | 267 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | PHF20 SPTBN1 NASP CHD4 BIRC6 PTPN12 NCAPG MAST4 BRCA1 LIPH SCD ZNF638 JAKMIP1 MGA CNOT3 NOL8 ANKFY1 ESCO2 SBNO1 ASPH DEPDC5 CEP57 | 5.79e-04 | 806 | 267 | 22 | gudmap_developingGonad_e12.5_epididymis_1000 |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | MYO9A ARHGEF38 HMGCR ACSL4 LIPH SCD FLRT3 UNC13B SYNE1 ABCC9 CCDC141 MFSD2A ASPH LIMCH1 FHDC1 | 1.53e-12 | 199 | 269 | 15 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGEF38 DNAH14 MAST4 LIPH UNC13B LAMA3 CCDC141 MFSD2A LMO7 MYH14 ASPH CEP70 LIMCH1 PLCH1 | 2.18e-11 | 199 | 269 | 14 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYO9A ARHGEF38 DNAH14 MAST4 LIPH UNC13B LAMA3 CCDC141 LMO7 MYH14 ASPH CEP70 LIMCH1 PLCH1 | 2.18e-11 | 199 | 269 | 14 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | MYO9A ARHGEF38 DNAH14 LIPH UNC13B LAMA3 CCDC141 MFSD2A LMO7 MYH14 ASPH CEP70 LIMCH1 PLCH1 | 2.18e-11 | 199 | 269 | 14 | 8587bd98de7767a575088afbea07a1feb4516b9b |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | ARHGEF38 ACSL4 MAST4 UNC13B SYNE1 ABCC9 CCDC141 MFSD2A ASPH CEP70 LIMCH1 FHDC1 PLCH1 | 8.25e-11 | 180 | 269 | 13 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | ARHGEF38 DNAH14 MAST4 SCD UNC13B CCDC141 MFSD2A LMO7 MYH14 CEP70 LIMCH1 FHDC1 PLCH1 | 1.73e-10 | 191 | 269 | 13 | 276455a64c2c3503d5048615762eb2ee37f0ac70 |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYO9A ARHGEF38 DNAH14 MAST4 UNC13B SYNE1 LAMA3 CCDC141 MFSD2A LMO7 MYH14 CEP70 LIMCH1 | 2.10e-10 | 194 | 269 | 13 | 53f3e49e91b1096f3226010e2de767efb490dfe4 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | NASP FANCD2 NCAPG AUNIP BRCA1 DIAPH3 CASP8AP2 POC1A KIF20B ESCO2 CEP152 POLD3 CLSPN | 2.23e-10 | 195 | 269 | 13 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | MYO9A ARHGEF38 DNAH14 MAST4 LIPH UNC13B SYNE1 LAMA3 LMO7 MYH14 CEP70 LIMCH1 PLCH1 | 2.23e-10 | 195 | 269 | 13 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ARHGEF38 DNAH14 MAST4 LIPH UNC13B LAMA3 CCDC141 MFSD2A LMO7 MYH14 CEP70 LIMCH1 PLCH1 | 2.87e-10 | 199 | 269 | 13 | 725610310e5c5fd7120c0be9acb55bf152026ddd |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | TPR VPS13C CEP350 DST WARS1 ABCC9 ZNF106 SBNO1 SMC3 LMO7 SMARCA2 ANKRD36 LIMCH1 | 2.87e-10 | 199 | 269 | 13 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | ARHGEF38 MAST4 LIPH UNC13B LAMA3 ABCC9 CCDC141 LIFR MFSD2A CEP70 LIMCH1 PLCH1 | 1.35e-09 | 183 | 269 | 12 | 6847c1252d6bb105524f812658112517fd351eab |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ACSL4 NRXN3 RAP1GDS1 ARHGEF28 LAMA3 GPRIN3 LMO7 MYH14 ASPH LIMCH1 PLCH1 GRAMD1C | 1.52e-09 | 185 | 269 | 12 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | ARHGEF38 MAST4 LIPH FLRT3 SFN ABCC9 CCDC141 MFSD2A LMO7 CEP70 LIMCH1 FHDC1 | 1.83e-09 | 188 | 269 | 12 | eb6d79d733b53f64ca615bb777c64ed456866549 |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | ARHGEF38 DNAH14 MAST4 UNC13B LAMA3 CCDC141 LMO7 MYH14 ASPH CEP70 LIMCH1 PLCH1 | 1.83e-09 | 188 | 269 | 12 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | ARHGEF38 LIPH SCD UNC13B CCDC141 MFSD2A LMO7 MYH14 CEP70 LIMCH1 FHDC1 PLCH1 | 2.06e-09 | 190 | 269 | 12 | 27a1a86620fe9b5ee930d388b32352206485e6d0 |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | ARHGEF38 DNAH14 MAST4 LIPH UNC13B LAMA3 CCDC141 MFSD2A LMO7 MYH14 LIMCH1 PLCH1 | 2.19e-09 | 191 | 269 | 12 | e432c6e1ae82dddf84314ce73d2b7a991630d905 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | MYH7 GAS2 CMYA5 DST MAST4 RABGAP1L MYH7B CERS6 CCDC141 LMO7 LIMCH1 ATP2A2 | 2.19e-09 | 191 | 269 | 12 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | ARHGEF38 DNAH14 MAST4 LIPH UNC13B LAMA3 MFSD2A LMO7 MYH14 CEP70 LIMCH1 PLCH1 | 2.32e-09 | 192 | 269 | 12 | 499e8893afea5e6d3371e0bd018f7e86a524d669 |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | ARHGEF38 DNAH14 NRXN3 MAST4 UNC13B ABCC9 CCDC141 MFSD2A CEP70 LIMCH1 FHDC1 PLCH1 | 2.32e-09 | 192 | 269 | 12 | 06013a07e3a873b1d1c0451643c528593ac32a9c |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | ARHGEF38 DNAH14 MAST4 LIPH UNC13B LAMA3 MFSD2A LMO7 MYH14 CEP70 LIMCH1 PLCH1 | 2.32e-09 | 192 | 269 | 12 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ARHGEF38 DNAH14 MAST4 PIK3C2G UNC13B LAMA3 CCDC141 MFSD2A LMO7 CEP70 LIMCH1 PLCH1 | 2.32e-09 | 192 | 269 | 12 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | NASP FANCD2 NCAPG BRCA1 DIAPH3 CASP8AP2 POC1A KIF20B ESCO2 CEP152 POLD3 CLSPN | 2.77e-09 | 195 | 269 | 12 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | NASP FANCD2 NCAPG BRCA1 DIAPH3 CASP8AP2 POC1A KIF20B ESCO2 CEP152 POLD3 CLSPN | 2.77e-09 | 195 | 269 | 12 | 56d8734d020b3da08a5aa9e67999706a9e023a99 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | NASP FANCD2 NCAPG BRCA1 DIAPH3 CASP8AP2 POC1A KIF20B ESCO2 CEP152 POLD3 CLSPN | 2.93e-09 | 196 | 269 | 12 | df366d76ea55f49e349d622effa57c1535df8400 |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | ACSL4 NRXN3 FLRT3 BAIAP2 FKBP4 ANXA1 ANXA2 AP1M2 LAMA3 LMO7 MYH14 P4HB | 3.48e-09 | 199 | 269 | 12 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | NASP FANCD2 NCAPG BRCA1 DIAPH3 POC1A KIF20B ESCO2 SMC3 CEP152 POLD3 CLSPN | 3.69e-09 | 200 | 269 | 12 | 43571c9284d4e41402a2d1eefc1efe2ce8476d4a |
| ToppCell | Control|World / group, cell type (main and fine annotations) | NRXN3 UNC13B ARHGEF28 SYNE1 LAMA3 CCDC141 LMNA LMO7 MYH14 LIMCH1 PLCH1 | 6.71e-09 | 168 | 269 | 11 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | SPTAN1 RABGAP1 BCR PPP1R26 AMER2 DST CASKIN2 SCD SYNE1 ACBD5 TNR | 1.16e-08 | 177 | 269 | 11 | e8ab340b20cd41554c3841fe980e078e878af35f |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | NASP FANCD2 NCAPG AUNIP BRCA1 DIAPH3 CASP8AP2 POC1A LAMA3 ESCO2 CLSPN | 1.30e-08 | 179 | 269 | 11 | 88d44b04eb5c079531db663ed98ddb20b60feb9a |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ACSL4 NRXN3 MAST4 BAIAP2 ARHGEF28 LAMA3 MFSD2A LMO7 MYH14 ASPH PLCH1 | 1.30e-08 | 179 | 269 | 11 | fd2cbee532e7b44113410dca82aec7db1a7fb69f |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | MAST4 FLRT3 SFN UNC13B ABCC9 CCDC141 MFSD2A LMO7 CEP70 LIMCH1 FHDC1 | 1.83e-08 | 185 | 269 | 11 | 563b4e6d92bb5d77a3829556116a8e99aebac615 |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FSIP1 FANCD2 NCAPG AUNIP BRCA1 DIAPH3 POC1A KIF20B ESCO2 PLCH1 CLSPN | 1.93e-08 | 186 | 269 | 11 | 9feef5936985e936b3d88f9d1bb012abb6468570 |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ACSL4 NRXN3 MAST4 BAIAP2 RAP1GDS1 ARHGEF28 LAMA3 MFSD2A LMO7 MYH14 PLCH1 | 1.93e-08 | 186 | 269 | 11 | e83718fabb057100835d3357df407f283d23fe16 |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FSIP1 FANCD2 NCAPG AUNIP BRCA1 DIAPH3 POC1A KIF20B ESCO2 PLCH1 CLSPN | 1.93e-08 | 186 | 269 | 11 | 89f5b06bc56674af304912d481ac697c7c870904 |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | LIPH RABGAP1L FLRT3 AKAP5 ARHGEF28 POC1A ANXA1 AP1M2 LAMA3 LMO7 MYH14 | 2.04e-08 | 187 | 269 | 11 | a4b41904ba05eb76212c949fc3ac197f906c8351 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | MYH7 GAS2 CMYA5 ADRA1A MAST4 MYH7B CERS6 CCDC141 LMO7 LIMCH1 ATP2A2 | 2.28e-08 | 189 | 269 | 11 | 5e80c47f63980904c4c1ff02c201b67b456a0974 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | MYH7 GAS2 CMYA5 DST MAST4 MYH7B CERS6 CCDC141 LMO7 LIMCH1 ATP2A2 | 2.41e-08 | 190 | 269 | 11 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ARHGEF38 MAST4 UNC13B SYNE1 ABCC9 CCDC141 MFSD2A CEP70 LIMCH1 FHDC1 PLCH1 | 2.83e-08 | 193 | 269 | 11 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ARHGEF38 MAST4 UNC13B SYNE1 ABCC9 CCDC141 MFSD2A CEP70 LIMCH1 FHDC1 PLCH1 | 2.83e-08 | 193 | 269 | 11 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ARHGEF38 DNAH14 MAST4 LIPH UNC13B LAMA3 LMO7 MYH14 CEP70 LIMCH1 PLCH1 | 2.83e-08 | 193 | 269 | 11 | a0ca3231992f14abcf1a6129573bace320e89d2a |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | FABP4 FFAR4 NCAPG BRCA1 DIAPH3 ARHGEF28 POC1A KIF20B ESCO2 POLD3 CLSPN | 2.98e-08 | 194 | 269 | 11 | a12b64945e10f00aa983678a02586c59badc1570 |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | AMER2 IL1R2 LIPH FLRT3 AKAP5 LAMA3 RPRD1A LMO7 MYH14 PITPNM3 | 3.35e-08 | 153 | 269 | 10 | 5501095bcf73080872ae01128f21399f9cfc5dd1 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | SERPINA3 ACSL4 NRXN3 RABGAP1L BAIAP2 UNC13B ARHGEF28 LAMA3 CCDC141 LMO7 ASPH | 3.49e-08 | 197 | 269 | 11 | 1485933986921ff45669d9b7501c8d17050b3e97 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ACSL4 NRXN3 FLRT3 BAIAP2 ANXA1 AP1M2 LAMA3 CCDC141 LMO7 MYH14 P4HB | 3.68e-08 | 198 | 269 | 11 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ACSL4 NRXN3 FLRT3 BAIAP2 ANXA1 ANXA2 AP1M2 LAMA3 LMO7 MYH14 P4HB | 3.68e-08 | 198 | 269 | 11 | f006d68e6c51923be7772eea118546a5762e8a5e |
| ToppCell | LPS_IL1RA-Epithelial_alveolar|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ACSL4 NRXN3 FLRT3 ANXA1 ANXA2 AP1M2 LAMA3 PDIA6 LMO7 MYH14 P4HB | 3.87e-08 | 199 | 269 | 11 | 5b140ac88ebc25ce397ae577e48f3e271faf46e7 |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | TPR VPS13C CEP350 CNTRL ABCC9 CERS6 IWS1 SBNO1 SMC3 LMO7 SMARCA2 | 3.87e-08 | 199 | 269 | 11 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | VPS13C CEP350 CEP126 ANXA2 CNTRL ABCC9 ANKRD36B SBNO1 SMC3 SMARCA2 ANKRD36 | 3.87e-08 | 199 | 269 | 11 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | FANCD2 NCAPG BRCA1 DIAPH3 POC1A CNTRL KIF20B ESCO2 CEP70 CEP152 CLSPN | 3.87e-08 | 199 | 269 | 11 | be2276c9a1994579ba1d2998b49bf549c1324d44 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | FANCD2 NCAPG AUNIP BRCA1 DIAPH3 POC1A CNTRL KIF20B ESCO2 CEP152 CLSPN | 4.07e-08 | 200 | 269 | 11 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | FANCD2 NCAPG AUNIP BRCA1 DIAPH3 POC1A CNTRL KIF20B ESCO2 CEP152 CLSPN | 4.07e-08 | 200 | 269 | 11 | 0675f580ccef705875854247bbfd4ee2bcf126a1 |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | GAS2 MED14 PPP1R26 NCAPG AUNIP SHROOM2 ESCO2 POLD3 PLCH1 CLSPN | 1.01e-07 | 172 | 269 | 10 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | PHF20 SYK CEP126 AKAP5 DNAJC18 VIPAS39 LATS2 ASPH ANKRD36 ZMYM4 | 1.47e-07 | 179 | 269 | 10 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FANCD2 NCAPG AUNIP BRCA1 SACS DIAPH3 POC1A KIF20B ESCO2 CLSPN | 1.71e-07 | 182 | 269 | 10 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TPR VPS13C SPTBN1 CHD4 BIRC6 CEP350 ZNF638 CNTRL PPP1R10 ZNF106 | 1.90e-07 | 184 | 269 | 10 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-07 | 184 | 269 | 10 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | ARHGEF38 MAST4 SCD UNC13B CCDC141 MFSD2A LMO7 CEP70 LIMCH1 PLCH1 | 1.90e-07 | 184 | 269 | 10 | 369b82f793deab672204558ae4e112cfa5aa9ccc |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ACSL4 NRXN3 BAIAP2 RAP1GDS1 ARHGEF28 LAMA3 MFSD2A LMO7 MYH14 ASPH | 1.90e-07 | 184 | 269 | 10 | ab2f06906fc7a9931dfa0864ef506832b07fb93e |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | ARHGEF38 MAST4 LIPH UNC13B LIFR LMO7 CEP70 UNC13C LIMCH1 PALS2 | 1.99e-07 | 185 | 269 | 10 | 673f0c688ae6984bc8027df2da335787924f4137 |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | ARHGEF38 NRXN3 MAST4 LIPH UNC13B LMO7 MYH14 CEP70 LIMCH1 PLCH1 | 1.99e-07 | 185 | 269 | 10 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | MYH7 GAS2 CMYA5 MAST4 RABGAP1L MYH7B CERS6 CCDC141 LMO7 LIMCH1 | 1.99e-07 | 185 | 269 | 10 | 6baccb26f999145e51b91d94315bf8d4655bef31 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FANCD2 NCAPG BRCA1 DIAPH3 POC1A LAMA3 KIF20B ESCO2 CEP152 CLSPN | 1.99e-07 | 185 | 269 | 10 | 30e041d6f6e310d64809e9d6d93cd30052972f3b |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.10e-07 | 186 | 269 | 10 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | MAST4 SFN UNC13B ABCC9 CCDC141 MFSD2A LMO7 CEP70 LIMCH1 FHDC1 | 2.10e-07 | 186 | 269 | 10 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-07 | 187 | 269 | 10 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | FANCD2 NCAPG BRCA1 DIAPH3 POC1A LAMA3 KIF20B ESCO2 CEP152 CLSPN | 2.20e-07 | 187 | 269 | 10 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CMYA5 RFX8 FANCD2 OSBP2 SFN WARS1 SHROOM2 LATS2 ATP2A2 AHNAK2 | 2.20e-07 | 187 | 269 | 10 | a6a112689d1c9049f57935ad9d2f4955538427de |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | NCAPG BRCA1 PIK3C2G DIAPH3 POC1A KIF20B ESCO2 UNC13C CEP152 CLSPN | 2.20e-07 | 187 | 269 | 10 | 057569c9437219ecc396aa6e673b1178a2273837 |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-07 | 187 | 269 | 10 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | MYH7 GAS2 CMYA5 ADRA1A MAST4 MYH7B CERS6 CCDC141 LMO7 LIMCH1 | 2.31e-07 | 188 | 269 | 10 | 0758b474457efa36488e0195f7357100f4b6a090 |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | ARHGEF38 MAST4 LIPH UNC13B LAMA3 LMO7 MYH14 CEP70 LIMCH1 PLCH1 | 2.31e-07 | 188 | 269 | 10 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | SPTBN1 BCR PTPN12 NRXN3 ANO2 RAPGEF1 SHROOM2 MMRN1 NUMB EMCN | 2.43e-07 | 189 | 269 | 10 | c81787a8c662db5d7814c583dd64562857629e81 |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 2.55e-07 | 190 | 269 | 10 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | FANCD2 NCAPG BRCA1 DIAPH3 POC1A KIF20B ESCO2 CEP152 POLD3 CLSPN | 2.55e-07 | 190 | 269 | 10 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | FANCD2 NCAPG BRCA1 NHS DIAPH3 POC1A ESCO2 CEP152 FHDC1 CLSPN | 2.55e-07 | 190 | 269 | 10 | e83fa8b711aa79a1767818474f1c193b674b1c31 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | ARHGEF38 MAST4 UNC13B CCDC141 LIFR MFSD2A CEP70 LIMCH1 FHDC1 PLCH1 | 2.68e-07 | 191 | 269 | 10 | a0332a4ef629510fb313ec119195c44a3f704a80 |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | MYH7 GAS2 CMYA5 MAST4 MYH7B CERS6 CCDC141 LMO7 LIMCH1 ATP2A2 | 2.81e-07 | 192 | 269 | 10 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | PDE8A ERC1 BIRC6 PICALM RABGAP1L DPYD TCF12 RAPGEF1 PCNX1 CUX1 | 2.95e-07 | 193 | 269 | 10 | 779276e775cb2492e8dd36436295a536084a6415 |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | FABP4 BRCA1 SCD DIAPH3 CPSF2 RAP1GDS1 TCF12 CERS6 ESCO2 CLSPN | 2.95e-07 | 193 | 269 | 10 | c2673d86f7d7b849788036032a93a6d136a70040 |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | SPTBN1 BCR PTPN12 NRXN3 ANO2 RAPGEF1 SHROOM2 MMRN1 LIFR EMCN | 2.95e-07 | 193 | 269 | 10 | 2531266bc57339d4e2b22a88817008e32b8c1598 |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.95e-07 | 193 | 269 | 10 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.09e-07 | 194 | 269 | 10 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.09e-07 | 194 | 269 | 10 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO9A ARHGEF38 DIAPH3 ARHGEF28 SYNE1 LAMA3 LMO7 MYH14 KIRREL1 PLCH1 | 3.09e-07 | 194 | 269 | 10 | e577d9e88390b36b5a09b97fe1026089892275a3 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | ARHGEF38 MAST4 UNC13B SYNE1 LAMA3 CCDC141 MFSD2A LIMCH1 FHDC1 PLCH1 | 3.09e-07 | 194 | 269 | 10 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.09e-07 | 194 | 269 | 10 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.09e-07 | 194 | 269 | 10 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.09e-07 | 194 | 269 | 10 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.09e-07 | 194 | 269 | 10 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | CFAP251 SPTBN1 SNTN MAST4 LIPH CEP126 SYNE1 LMO7 LIMCH1 PLCH1 | 3.24e-07 | 195 | 269 | 10 | fce0c29574bb7aab181b9c00feb42681e285d1f2 |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | CFAP251 SPTBN1 SNTN MAST4 LIPH CEP126 SYNE1 LMO7 LIMCH1 PLCH1 | 3.24e-07 | 195 | 269 | 10 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | CLUAP1 ERC1 SPTBN1 ANKRD36C ZNF638 NHS ANKRD36B LMO7 ERCC6L2 ANKRD36 | 3.24e-07 | 195 | 269 | 10 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 3.24e-07 | 195 | 269 | 10 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ARHGEF38 HMGCR ACSL4 UNC13B SYNE1 CCDC141 MFSD2A ASPH LIMCH1 FHDC1 | 3.40e-07 | 196 | 269 | 10 | 7e5addaa844e66f8160e05858c341866a80aed23 |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 3.40e-07 | 196 | 269 | 10 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | SPTBN1 FLRT3 AKAP5 ARHGEF28 ANXA1 LAMA3 LMO7 MYH14 LIMCH1 CUX1 | 3.40e-07 | 196 | 269 | 10 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | SPTBN1 FLRT3 AKAP5 ARHGEF28 ANXA1 LAMA3 LMO7 MYH14 LIMCH1 CUX1 | 3.40e-07 | 196 | 269 | 10 | b9ceceeacbcf81976ce92adf044f0d0aa132632b |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ARHGEF38 HMGCR ACSL4 UNC13B SYNE1 CCDC141 MFSD2A ASPH LIMCH1 FHDC1 | 3.56e-07 | 197 | 269 | 10 | bf10727fbe90b71d2ac60a11711e5f0701b3799d |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | ANKRD36C CEP350 ZNF638 PRRC2A NOL8 DDX55 LMNA CEP152 ANKRD36 CLSPN | 3.56e-07 | 197 | 269 | 10 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Down 200; 8uM; PC3; HT_HG-U133A | PHF20 SPTAN1 MED14 NOL10 PTPN12 IL1R2 PIK3CB ANKFY1 AP1M2 LIFR NCOR2 AFAP1 PCNX1 GRAMD1C | 1.02e-07 | 197 | 269 | 14 | 4189_DN |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | BCR CEP350 KIDINS220 PIK3CB RABGAP1L ANKFY1 AFAP1 LMNA LMO7 PCNX1 PLCH1 CABIN1 GRAMD1C | 6.46e-07 | 196 | 269 | 13 | 6605_DN |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | SPTBN1 NASP PICALM NRXN3 MFN2 ANKFY1 NCOR2 ASPH SMARCA2 PCNX1 LIMCH1 PLCH1 RCN3 | 6.85e-07 | 197 | 269 | 13 | 6758_DN |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A | TPR ASIC1 SPTBN1 PICALM PTPN12 OSBP2 BAIAP2 DCAF13 MED8 CNKSR2 ASPH RCN3 | 3.25e-06 | 192 | 269 | 12 | 5959_DN |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; HL60; HG-U133A | ERC1 ACSL4 GLYR1 SYK PRRC2B SFN CERS6 LMNA MYH14 KCTD3 SMARCA2 PDCD11 | 3.82e-06 | 195 | 269 | 12 | 1726_DN |
| Drug | Cefaclor [70356-03-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A | PHF20 ASIC1 SPTBN1 BCR CASKIN2 RABGAP1L BAIAP2 RAD52 UPF1 GPR107 ARVCF ATP2A2 | 4.02e-06 | 196 | 269 | 12 | 2843_UP |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A | MYO9A ERC1 INPP5B KIDINS220 RABGAP1L BAIAP2 PRRC2A BMP2K ZNF783 GPR107 ASPH PLCH1 | 4.02e-06 | 196 | 269 | 12 | 7222_DN |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A | ASIC1 SPTAN1 ADGRB1 RABGAP1 UCHL1 PIP4K2B FLRT3 LIG3 AFAP1 MYH14 ADGRE5 AHNAK2 | 4.24e-06 | 197 | 269 | 12 | 7486_DN |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | INPP5B BCR CEP350 BRCA1 PIP4K2A SLC23A2 ANKFY1 NUCB1 KRBOX4 ARVCF CEP152 CEP57 | 4.24e-06 | 197 | 269 | 12 | 6792_DN |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | PHF20 MED14 PIP4K2B CNOT3 BMP2K YTHDC2 AFAP1 SMARCA2 NUMB PCNX1 LIMCH1 GRAMD1C | 4.70e-06 | 199 | 269 | 12 | 4390_DN |
| Drug | Bleomycin A6 | 6.47e-06 | 4 | 269 | 3 | CID005483658 | |
| Drug | 4-amino-2,6-dinitrotoluene | SPTAN1 HMGCR SACS MFN2 AP1M1 NOL8 GPI AKAP5 WARS1 MYH7B LAMA3 ATE1 PPM1G CERS5 NCOR2 LMNA SBNO1 SMARCA2 PDCD11 ATP2A2 | 7.62e-06 | 541 | 269 | 20 | ctd:C035207 |
| Drug | p-Chloromercuribenzoic Acid | NOL4 CLUAP1 ASIC1 VPS13C INPP5D NRXN3 PELO UCHL1 RABGAP1L NHS SFN ARHGEF28 ZSCAN31 ANXA1 ANXA2 ANXA2P2 SYNE1 CNKSR2 HPS3 ANKRD36B LIFR IFRD1 LMO7 SMARCA2 GRAMD1C ZHX1 PCDH8 | 1.11e-05 | 908 | 269 | 27 | ctd:D020245 |
| Drug | Podophyllotoxin [518-28-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | ACSL4 NRXN3 MFN2 ALB BAIAP2 ODF2 ZNF783 GPR107 LMNA SMARCA2 UNC13A | 1.48e-05 | 187 | 269 | 11 | 5841_UP |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | TPR SPTBN1 CEP350 PTPN12 KIDINS220 FLRT3 SLC23A2 BMP2K SMC3 ASPH KIRREL1 | 1.64e-05 | 189 | 269 | 11 | 4271_DN |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | INPP5B SPTAN1 SPTBN1 MED14 MAST4 GLYR1 BAIAP2 SLC23A2 RAD52 ANKFY1 ODF2 | 1.72e-05 | 190 | 269 | 11 | 3833_DN |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; PC3; HT_HG-U133A | INPP5B SPTAN1 SPTBN1 FABP4 MFN2 ANKFY1 CNTRL ASPH PCNX1 PLCH1 ATP2A2 | 1.90e-05 | 192 | 269 | 11 | 6713_DN |
| Drug | Chrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | ERC1 SPART NCAPG PIK3CB RABGAP1L PIP4K2B BAIAP2 BMP2K KIF20B GPR107 IFRD1 | 1.99e-05 | 193 | 269 | 11 | 6485_DN |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | TPR INPP5B ARHGEF38 CHD4 PIK3CB SLC23A2 BMP2K SMC3 ASPH KIRREL1 RPL13 | 2.09e-05 | 194 | 269 | 11 | 4320_DN |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | SPTAN1 SPTBN1 ACSL4 GLYR1 CNTRL LMNA ARVCF LIMCH1 PLCH1 CABIN1 AHNAK2 | 2.09e-05 | 194 | 269 | 11 | 4387_DN |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A | INPP5B SPTAN1 PICALM FABP4 MAP3K4 KIDINS220 GLYR1 PIP4K2B AMOTL2 SLC23A2 CEP57 | 2.19e-05 | 195 | 269 | 11 | 1831_UP |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | MED14 FABP4 CASKIN2 MFN2 PIP4K2B BAIAP2 SLC23A2 ZNF783 LMO7 SMARCA2 CABIN1 | 2.19e-05 | 195 | 269 | 11 | 6614_DN |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | MED14 NOL10 DNMBP CNOT3 PRRC2B RAD52 BMP2K SYNE1 NUMB MYH15 PCNX1 | 2.19e-05 | 195 | 269 | 11 | 2901_DN |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | INPP5B MAST4 BRCA1 CPSF1 PIP4K2B FLRT3 PRRC2A ANKFY1 LAMA3 CEP152 CUX1 | 2.30e-05 | 196 | 269 | 11 | 5293_DN |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A | PHF20 ASIC1 INPP5B BRCA1 CASKIN2 PIP4K2B CNOT3 DDX60 NUCB1 NCOR2 PCNX1 | 2.30e-05 | 196 | 269 | 11 | 3673_DN |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; PC3; HT_HG-U133A | PHF20 SPTAN1 BCR CEP350 PIK3CB OSBP2 AKAP5 SYNE1 ZNF783 LMO7 CABIN1 | 2.52e-05 | 198 | 269 | 11 | 7317_UP |
| Drug | Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | SERPINA3 PHF20 ASIC1 INPP5B RABGAP1 BRCA1 PRRC2B ANKFY1 PLCH1 CABIN1 RPL13 | 2.52e-05 | 198 | 269 | 11 | 7334_DN |
| Drug | Pentylenetetrazole [54-95-5]; Up 200; 29uM; PC3; HT_HG-U133A | PHF20 ERC1 INPP5B MED14 RAD52 AKAP5 YTHDC2 ODF2 ZNF783 LIG3 RCN3 | 2.64e-05 | 199 | 269 | 11 | 2092_UP |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; PC3; HT_HG-U133A | SPTAN1 SPTBN1 MED14 KIDINS220 CASKIN2 BAIAP2 ARHGEF28 YTHDC2 GPR107 LIG3 RCN3 | 2.77e-05 | 200 | 269 | 11 | 5043_DN |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | SPTBN1 BCR MAST4 SLC23A2 BMP2K CNTRL ASPH PCNX1 ADGRE5 LIMCH1 CABIN1 | 2.77e-05 | 200 | 269 | 11 | 3577_DN |
| Drug | 45-P | 3.18e-05 | 6 | 269 | 3 | CID000448407 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | NOL4 HECW1 FABP4 NRXN3 FLRT3 BAIAP2 MYH14 PLCH1 GRAMD1C AHNAK2 | 5.89e-05 | 180 | 269 | 10 | 4344_UP |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A | INPP5B SPTBN1 MED14 HMGCR TGM5 KIDINS220 SACS SYK PIP4K2B DPYD | 7.40e-05 | 185 | 269 | 10 | 2927_DN |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | SPTAN1 BRCA1 BAIAP2 WDR44 NOL8 IFRD1 PDCD11 POLD3 ATP2A2 MTDH | 7.40e-05 | 185 | 269 | 10 | 7209_DN |
| Drug | AC1LBXVB | 8.74e-05 | 8 | 269 | 3 | CID000544370 | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; PC3; HT_HG-U133A | 9.24e-05 | 190 | 269 | 10 | 5855_DN | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; PC3; HT_HG-U133A | INPP5B SPTAN1 HMGCR BCR PIK3CB GLYR1 ANKFY1 ASPH SMARCA2 RCN3 | 1.01e-04 | 192 | 269 | 10 | 7364_UP |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A | CMPK1 VPS13C SPTAN1 SLC23A2 SFN SHROOM2 GPR107 LMNA SBNO1 SMARCA2 | 1.05e-04 | 193 | 269 | 10 | 1988_UP |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A | PTPN12 BRCA1 RAP1GDS1 ANKFY1 BMP2K DDX60 NCOR2 KIRREL1 PLCH1 ATP2B2 | 1.05e-04 | 193 | 269 | 10 | 4623_DN |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | PICALM CASKIN2 DCAF13 TCF12 BMP2K YTHDC2 ZNF783 LIG3 ASPH SMARCA2 | 1.05e-04 | 193 | 269 | 10 | 7097_UP |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | SPTAN1 CHD4 RABGAP1 MAP3K4 BRCA1 CASKIN2 MFN2 SLC23A2 SMARCA2 ZMYM4 | 1.10e-04 | 194 | 269 | 10 | 1670_DN |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | INPP5B MED14 YTHDC2 LIG3 AFAP1 ASPH SMARCA2 NUMB ADGRE5 CABIN1 | 1.10e-04 | 194 | 269 | 10 | 3316_DN |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.10e-04 | 194 | 269 | 10 | 4308_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | TPR NOL10 RABGAP1 PIK3CB SLC23A2 SBNO1 SMC3 ASPH KIRREL1 PCNX1 | 1.10e-04 | 194 | 269 | 10 | 4309_DN |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | TPR CHD4 RABGAP1 PIK3CB ZNF783 SMC3 ASPH KIRREL1 PCNX1 CEP152 | 1.10e-04 | 194 | 269 | 10 | 4312_DN |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | INPP5D MED14 BCR PIP4K2B NUCB1 KRBOX4 SMC3 CEP70 SMARCA2 CEP152 | 1.10e-04 | 194 | 269 | 10 | 1264_DN |
| Drug | radicicol; Up 200; 0.1uM; PC3; HT_HG-U133A | GAS2 ACSL4 GLYR1 PIP4K2B BAIAP2 SLC23A2 FKBP4 ARHGEF28 LIG3 SMARCA2 | 1.15e-04 | 195 | 269 | 10 | 5952_UP |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; PC3; HT_HG-U133A | INPP5B PIK3CB SLC23A2 PRRC2B DCAF13 BMP2K LIG3 PCNX1 LIMCH1 PLCH1 | 1.15e-04 | 195 | 269 | 10 | 5109_DN |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A | RABGAP1 PIP4K2B BAIAP2 DCAF13 YTHDC2 GPR107 LIG3 MYH14 PCNX1 ADGRE5 | 1.15e-04 | 195 | 269 | 10 | 2808_DN |
| Drug | Etomidate [33125-97-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A | SPTAN1 PTPN12 MAST4 CASKIN2 PIP4K2B FLRT3 BAIAP2 SLC23A2 PCNX1 PALS2 | 1.15e-04 | 195 | 269 | 10 | 3519_DN |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | ERC1 NASP KIDINS220 CASKIN2 MFN2 BMP2K UPF1 IFRD1 LMNA PCNX1 | 1.19e-04 | 196 | 269 | 10 | 987_DN |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | PDE8A ASIC1 INPP5B FABP4 AMOTL2 WARS1 SHROOM2 ZNF783 PCNX1 LIMCH1 | 1.19e-04 | 196 | 269 | 10 | 6585_DN |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; MCF7; HT_HG-U133A | CASKIN2 BAIAP2 SLC23A2 CNTRL LAMA3 YTHDC2 LIG3 ASPH SMARCA2 PCNX1 | 1.19e-04 | 196 | 269 | 10 | 5005_DN |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 269 | 10 | 7269_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | PHF20 INPP5B RABGAP1 MAST4 CASKIN2 MFN2 PIP4K2B BAIAP2 LIG3 SMARCA2 | 1.19e-04 | 196 | 269 | 10 | 7128_UP |
| Drug | Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | TPR SPTBN1 SPART BAIAP2 PRRC2A UNC13B ARHGEF28 NUMB DEPDC5 AHNAK2 | 1.19e-04 | 196 | 269 | 10 | 1536_UP |
| Drug | staurosporine; Down 200; 0.01uM; MCF7; HG-U133A | BCR PICALM TGM5 CASKIN2 PIP4K2B AMOTL2 ARHGEF28 GPR107 LIG3 ARVCF | 1.19e-04 | 196 | 269 | 10 | 425_DN |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | INPP5B SPTBN1 MAST4 BAIAP2 SLC23A2 BMP2K GPR107 AFAP1 MYH14 PCNX1 | 1.25e-04 | 197 | 269 | 10 | 4532_DN |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | PHF20 INPP5B SPTBN1 SLC23A2 RAD52 YTHDC2 PPM1G LIG3 ADGRE5 LIMCH1 | 1.25e-04 | 197 | 269 | 10 | 2814_DN |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | INPP5B SPTBN1 MAST4 CASKIN2 RABGAP1L SYK CPSF1 LAMA3 ZNF783 NCOR2 | 1.25e-04 | 197 | 269 | 10 | 5211_DN |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | PHF20 SPTAN1 PIP4K2B BAIAP2 LIG3 LMNA ARVCF MYH14 PCNX1 UNC13A | 1.25e-04 | 197 | 269 | 10 | 6250_UP |
| Drug | S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | BCR BRCA1 PIP4K2B BAIAP2 ANKFY1 BMP2K NUCB1 ODF2 ZNF783 LMNA | 1.25e-04 | 197 | 269 | 10 | 5694_DN |
| Drug | Carisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | HECW1 RAD52 NUCB1 ZNF783 LIG3 ARVCF ASPH PCNX1 DEPDC5 CABIN1 | 1.25e-04 | 197 | 269 | 10 | 4955_UP |
| Drug | Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | NOL10 MAST4 CASKIN2 RAD52 ZSCAN31 UPF1 LMNA NUMB ELAVL1 LIMCH1 | 1.25e-04 | 197 | 269 | 10 | 5527_DN |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | INPP5B BCR PTPN12 CASKIN2 GLYR1 OSBP2 MYH14 PCNX1 CEP152 CABIN1 | 1.25e-04 | 197 | 269 | 10 | 4553_DN |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | SPART MAST4 GLYR1 ZNF282 PRRC2A ZSCAN31 YTHDC2 UPF1 ADGRE5 CEP152 | 1.25e-04 | 197 | 269 | 10 | 3478_DN |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | PPRC1 NASP BRCA1 SYK PRRC2A PRRC2B UPF1 SHROOM2 AFAP1 PDCD11 | 1.25e-04 | 197 | 269 | 10 | 1215_DN |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.30e-04 | 198 | 269 | 10 | 4825_DN | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; MCF7; HT_HG-U133A | ACSL4 PTPN12 BRCA1 SYK SLC23A2 ZNF783 LMNA ARVCF DEPDC5 CABIN1 | 1.30e-04 | 198 | 269 | 10 | 4783_UP |
| Drug | Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; MCF7; HT_HG-U133A | ASIC1 INPP5B SPART RABGAP1L PIP4K2B SLC23A2 CNTRL NUMB PLCH1 CABIN1 | 1.30e-04 | 198 | 269 | 10 | 5992_DN |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | ADRA1A BRCA1 CASKIN2 PIP4K2B ZNF783 ARVCF SMARCA2 PCNX1 CABIN1 UNC13A | 1.30e-04 | 198 | 269 | 10 | 4977_UP |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; PC3; HT_HG-U133A | SPTBN1 NASP RABGAP1 BCR BAIAP2 CNTRL GPR107 LMNA CABIN1 GRAMD1C | 1.30e-04 | 198 | 269 | 10 | 5727_DN |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | SPTAN1 MED14 RABGAP1 PIK3CB FLRT3 SYNE1 YTHDC2 ZNF783 LIG3 SMC3 | 1.30e-04 | 198 | 269 | 10 | 2124_UP |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | PHF20 INPP5B ACSL4 PIK3CB GLYR1 RABGAP1L SLC23A2 YTHDC2 LIG3 LIMCH1 | 1.30e-04 | 198 | 269 | 10 | 4733_DN |
| Drug | Tiabendazole [148-79-8]; Down 200; 19.8uM; PC3; HT_HG-U133A | INPP5B SLC23A2 GPR107 NCOR2 LMO7 MYH14 ASPH PLCH1 GRAMD1C RCN3 | 1.30e-04 | 198 | 269 | 10 | 4579_DN |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | ERC1 INPP5B SPTAN1 CEP350 BRCA1 CASKIN2 PRRC2A GPR107 PCNX1 CABIN1 | 1.30e-04 | 198 | 269 | 10 | 5335_DN |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | BCR PICALM KIDINS220 BRCA1 SLC23A2 ZNF282 ANKFY1 BMP2K PPM1G ZMYM4 | 1.30e-04 | 198 | 269 | 10 | 7135_DN |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A | MED14 AUNIP BRCA1 DNMBP CNTRL AP1M2 NCOR2 SMARCA2 CABIN1 ATP2A2 | 1.35e-04 | 199 | 269 | 10 | 7311_DN |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | INPP5B BCR NRXN3 CASKIN2 OSBP2 SLC23A2 LIG3 AFAP1 MYH15 RCN3 | 1.35e-04 | 199 | 269 | 10 | 4534_DN |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HT_HG-U133A | INPP5B NASP PICALM PIK3CB GLYR1 DDX60 UPF1 SHROOM2 SMARCA2 LIMCH1 | 1.35e-04 | 199 | 269 | 10 | 6740_DN |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | TPR MED14 PRRC2B ANXA1 UPF1 ZNF783 GPR107 ARVCF SMARCA2 NUMB | 1.35e-04 | 199 | 269 | 10 | 2618_DN |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; HL60; HT_HG-U133A | GAS2 ADGRB1 ARHGEF38 NOL10 KIDINS220 IL1R2 PIP4K2B SFN ANKFY1 SYNE1 | 1.35e-04 | 199 | 269 | 10 | 2198_UP |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | SPTBN1 MED14 PTPN12 CASKIN2 GLYR1 MFN2 ANKFY1 DCAF13 LAMA3 RPL13 | 1.35e-04 | 199 | 269 | 10 | 5695_DN |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | ERC1 SPTAN1 BCR BAIAP2 SLC23A2 CNOT3 YTHDC2 PPM1G NCOR2 SMARCA2 | 1.35e-04 | 199 | 269 | 10 | 4649_DN |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | HECW1 ASIC1 MAST4 SLC23A2 RAD52 CNTRL NUCB1 NCOR2 AFAP1 ATP2B2 | 1.35e-04 | 199 | 269 | 10 | 5485_UP |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; MCF7; HT_HG-U133A | MED14 NOL10 RABGAP1 KIDINS220 RAD52 ANKFY1 NCOR2 ARVCF DEPDC5 ATP2B2 | 1.35e-04 | 199 | 269 | 10 | 7202_UP |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; HL60; HG-U133A | MARK3 MED14 IL1R2 RABGAP1L WDR44 DPYD DDX60 GPR107 ASPH PALS2 | 1.35e-04 | 199 | 269 | 10 | 1973_UP |
| Drug | trifluoperazine | MYH7 MYO9A SPTAN1 SPTBN1 ADRA1A MYH7B ANXA1 ANXA2 PPM1G MYH14 CABIN1 ATP2A2 ATP2B2 | 1.38e-04 | 324 | 269 | 13 | CID000005566 |
| Drug | aa 288 | 1.39e-04 | 2 | 269 | 2 | CID002724650 | |
| Drug | zinc fluoride | 1.39e-04 | 2 | 269 | 2 | CID000024551 | |
| Drug | Picotamide monohydrate [80530-63-8]; Up 200; 10.2uM; HL60; HG-U133A | VPS13C MED14 PRRC2A CNOT3 PRRC2B NUCB1 PPM1G LIG3 SMARCA2 PDCD11 | 1.41e-04 | 200 | 269 | 10 | 1387_UP |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; PC3; HT_HG-U133A | PICALM CEP350 SYK AP1M2 ODF2 SHROOM2 LIG3 SMARCA2 PCNX1 CABIN1 | 1.41e-04 | 200 | 269 | 10 | 6321_UP |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | PHF20 INPP5B SPTAN1 SPTBN1 SPART MAST4 RAD52 ANKFY1 ARVCF RCN3 | 1.41e-04 | 200 | 269 | 10 | 6970_UP |
| Drug | Netilmicin sulfate [56931-57-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A | SPART ACSL4 GLYR1 RABGAP1L BAIAP2 CNTRL LAMA3 LMNA ARVCF ASPH | 1.41e-04 | 200 | 269 | 10 | 6005_DN |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.90e-06 | 13 | 259 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.28e-05 | 7 | 259 | 3 | C0751337 | |
| Disease | urate measurement, bone density | ERC1 DNAH14 KIDINS220 MAST4 RABGAP1L CPSF2 SLC23A2 PRRC2B RAD52 CASP8AP2 SYNE1 GPR107 LATS2 CEP70 CABIN1 ATP2B2 KCNH5 | 3.82e-05 | 619 | 259 | 17 | EFO_0003923, EFO_0004531 |
| Disease | Colorectal Carcinoma | ACSL4 AMER2 NCAPG SACS JAKMIP1 UNC13B DPYD SYNE1 CNKSR2 HPS3 LIFR LIG3 LMO7 OLFM2 POLD3 MTDH ZMYM4 CUX1 | 5.49e-05 | 702 | 259 | 18 | C0009402 |
| Disease | myopathy (implicated_via_orthology) | 6.31e-05 | 48 | 259 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 7.53e-05 | 80 | 259 | 6 | DOID:1459 (biomarker_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 7.66e-05 | 10 | 259 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 7.66e-05 | 10 | 259 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 7.66e-05 | 10 | 259 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 7.66e-05 | 10 | 259 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 7.66e-05 | 10 | 259 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 7.66e-05 | 10 | 259 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 7.66e-05 | 10 | 259 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 7.66e-05 | 10 | 259 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Charlevoix-Saguenay spastic ataxia (implicated_via_orthology) | 7.68e-05 | 2 | 259 | 2 | DOID:0050946 (implicated_via_orthology) | |
| Disease | paranasal sinus benign neoplasm (is_marker_for) | 7.68e-05 | 2 | 259 | 2 | DOID:1350 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | SPTAN1 ARHGEF38 MED14 FABP4 ADRA1A BRCA1 SNX32 PIK3CB ABRAXAS1 NHS AP1M1 PRRC2A GPI DPYD WARS1 SYNE1 SHROOM2 RPRD1A SBNO1 CLSPN PCDH8 MTDH CUX1 | 8.30e-05 | 1074 | 259 | 23 | C0006142 |
| Disease | intellectual disability (is_implicated_in) | 1.33e-04 | 30 | 259 | 4 | DOID:1059 (is_implicated_in) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.39e-04 | 12 | 259 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.39e-04 | 12 | 259 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | Liver carcinoma | TSC1 HMGCR FANCD2 ACSL4 ADRA1A NCAPG SCD UCHL1 SFN DPYD LIFR MFSD2A PITPNM3 DEPDC5 | 1.75e-04 | 507 | 259 | 14 | C2239176 |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 2.27e-04 | 14 | 259 | 3 | DOID:4450 (biomarker_via_orthology) | |
| Disease | Left ventricular noncompaction | 2.27e-04 | 14 | 259 | 3 | C1960469 | |
| Disease | interleukin 2 receptor antagonist measurement | 2.45e-04 | 35 | 259 | 4 | EFO_0008332 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.81e-04 | 15 | 259 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 4.55e-04 | 4 | 259 | 2 | cv:CN293514 | |
| Disease | cancer (implicated_via_orthology) | 6.45e-04 | 268 | 259 | 9 | DOID:162 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 7.54e-04 | 5 | 259 | 2 | C1450051 | |
| Disease | ribitol measurement | 7.54e-04 | 5 | 259 | 2 | EFO_0800143 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 7.54e-04 | 5 | 259 | 2 | C0410190 | |
| Disease | prostate-associated microseminoprotein measurement | 7.54e-04 | 5 | 259 | 2 | EFO_0802920 | |
| Disease | age at menarche | NOL4 KDM3B DST BRCA1 SNX32 OSBP2 DPYD ANXA1 ATE1 LRRC53 SMARCA2 UNC13C LINC00523 OLFM2 | 8.41e-04 | 594 | 259 | 14 | EFO_0004703 |
| Disease | cleft lip | DST BRCA1 PIP4K2A ARHGEF28 SYNE1 RAPGEF1 NCOR2 ERCC6L2 LINC00523 | 9.71e-04 | 284 | 259 | 9 | EFO_0003959 |
| Disease | Emery-Dreifuss muscular dystrophy | 1.12e-03 | 6 | 259 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.12e-03 | 6 | 259 | 2 | C0410189 | |
| Disease | Prostatic Neoplasms | SERPINA3 ACSL4 BRCA1 PIK3CB MGA CNOT3 NOL8 CCHCR1 ANXA1 LIFR MYH14 P4HB INTS4 PCDH8 | 1.19e-03 | 616 | 259 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | SERPINA3 ACSL4 BRCA1 PIK3CB MGA CNOT3 NOL8 CCHCR1 ANXA1 LIFR MYH14 P4HB INTS4 PCDH8 | 1.19e-03 | 616 | 259 | 14 | C0376358 |
| Disease | Mouth Neoplasms | 1.30e-03 | 54 | 259 | 4 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 1.30e-03 | 54 | 259 | 4 | C0153381 | |
| Disease | Vertigo | 1.47e-03 | 139 | 259 | 6 | HP_0002321 | |
| Disease | alcohol consumption measurement | CMPK1 MARK3 SPTBN1 ADGRB1 BIRC6 C4orf17 NRXN3 MAST4 RABGAP1L MYH16 MGA ANXA1 DDX55 PPM1G ESCO2 MMRN1 NCOR2 TTLL6 ANKRD36 PLCH1 CUX1 EMCN | 1.51e-03 | 1242 | 259 | 22 | EFO_0007878 |
| Disease | caudate volume change measurement, age at assessment | 1.67e-03 | 27 | 259 | 3 | EFO_0008007, EFO_0021491 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.75e-03 | 195 | 259 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | interleukin 5 measurement | 1.86e-03 | 28 | 259 | 3 | EFO_0008185 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 1.86e-03 | 28 | 259 | 3 | DOID:7998 (biomarker_via_orthology) | |
| Disease | response to corticosteroid | 2.06e-03 | 29 | 259 | 3 | GO_0031960 | |
| Disease | Schizophrenia | NUMBL CHD4 CMYA5 CHRM5 ADRA1A NRXN3 BRCA1 PIK3CB PIP4K2A DPYD ZSCAN31 LIFR ARVCF SBNO1 SMARCA2 ATP2A2 PCDH8 | 2.20e-03 | 883 | 259 | 17 | C0036341 |
| Disease | Primary familial dilated cardiomyopathy | 2.28e-03 | 30 | 259 | 3 | cv:C0340427 | |
| Disease | reticulocyte count | INPP5D BIRC6 PICALM FFAR4 PELO AMOTL2 SLC23A2 RAD52 CCHCR1 ARHGEF28 BMP2K POTEF LAMA3 RNH1 PALM3 DEPDC5 LINC00523 FHDC1 CUX1 | 2.35e-03 | 1045 | 259 | 19 | EFO_0007986 |
| Disease | Adenocarcinoma of lung (disorder) | 2.38e-03 | 206 | 259 | 7 | C0152013 | |
| Disease | cholangiocarcinoma (is_marker_for) | 2.44e-03 | 64 | 259 | 4 | DOID:4947 (is_marker_for) | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 2.65e-03 | 9 | 259 | 2 | EFO_0800314 | |
| Disease | colorectal cancer (is_marker_for) | 2.71e-03 | 157 | 259 | 6 | DOID:9256 (is_marker_for) | |
| Disease | microcephaly (implicated_via_orthology) | 2.75e-03 | 32 | 259 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Primary dilated cardiomyopathy | 3.27e-03 | 34 | 259 | 3 | cv:C0007193 | |
| Disease | heart disease (is_marker_for) | 3.30e-03 | 10 | 259 | 2 | DOID:114 (is_marker_for) | |
| Disease | cerebrospinal fluid biomarker measurement, alpha synuclein measurement | 3.30e-03 | 10 | 259 | 2 | EFO_0006794, EFO_0009323 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 3.30e-03 | 10 | 259 | 2 | cv:C5675009 | |
| Disease | Fanconi anemia (is_implicated_in) | 3.30e-03 | 10 | 259 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | stroke outcome severity measurement | 3.38e-03 | 114 | 259 | 5 | EFO_0009603 | |
| Disease | Endometrial Carcinoma | 3.74e-03 | 72 | 259 | 4 | C0476089 | |
| Disease | Tachycardia, Ventricular | 4.01e-03 | 11 | 259 | 2 | C0042514 | |
| Disease | schizophrenia, gastroesophageal reflux disease | 4.01e-03 | 11 | 259 | 2 | EFO_0003948, MONDO_0005090 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 4.13e-03 | 74 | 259 | 4 | EFO_0007869, EFO_0007878 | |
| Disease | forced expiratory volume | CLUAP1 ARHGEF38 NRXN3 DST CROCC2 FKBP4 PRRC2B ZSCAN31 BMP2K SYNE1 ATE1 NCOR2 ERCC6L2 SMARCA2 PITPNM3 | 4.42e-03 | 789 | 259 | 15 | EFO_0004314 |
| Disease | testosterone measurement | PDE8A RFTN2 BIRC6 IL1R2 FAM186A EIF2B4 MYH16 DNMBP VARS1 FKBP4 TCF12 WARS1 ANXA2 NCOR2 ATP6V0D1 CEP70 SMARCA2 PALM3 LINC00523 ATP2B2 SORD | 4.46e-03 | 1275 | 259 | 21 | EFO_0004908 |
| Disease | heart disease (implicated_via_orthology) | 4.49e-03 | 38 | 259 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | migraine disorder | PHF20 INPP5B ANKRD36C RABGAP1L SPATA19 CNKSR2 NCOR2 ZNF106 LIMCH1 | 4.52e-03 | 357 | 259 | 9 | MONDO_0005277 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 4.78e-03 | 12 | 259 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia | 4.78e-03 | 12 | 259 | 2 | EFO_1001304 | |
| Disease | Squamous cell carcinoma | 4.84e-03 | 124 | 259 | 5 | C0007137 | |
| Disease | gut microbiome measurement, bone density | 4.98e-03 | 78 | 259 | 4 | EFO_0003923, EFO_0007874 | |
| Disease | opioid dependence | 5.13e-03 | 237 | 259 | 7 | EFO_0005611 | |
| Disease | invasive ductal carcinoma (is_marker_for) | 5.20e-03 | 40 | 259 | 3 | DOID:3008 (is_marker_for) | |
| Disease | X-11444 measurement | 5.62e-03 | 13 | 259 | 2 | EFO_0021237 | |
| Disease | middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement | 5.62e-03 | 13 | 259 | 2 | EFO_0006514, EFO_0010316 | |
| Disease | X-24588 measurement | 5.62e-03 | 13 | 259 | 2 | EFO_0800898 | |
| Disease | Cardiomegaly | 5.94e-03 | 82 | 259 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 5.94e-03 | 82 | 259 | 4 | C1383860 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 6.37e-03 | 43 | 259 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | age at assessment, pelvic organ prolapse | 6.37e-03 | 43 | 259 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | severe acute respiratory syndrome, COVID-19 | INPP5D GAS2 NOL10 PIK3C2G SLC23A2 ARHGEF28 POTEF UNC13C CEP57 TNR | 6.46e-03 | 447 | 259 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 6.51e-03 | 14 | 259 | 2 | C1858991 | |
| Disease | telomere length | 6.70e-03 | 313 | 259 | 8 | EFO_0004505 | |
| Disease | Myocardial Reperfusion Injury | 6.74e-03 | 85 | 259 | 4 | C0027055 | |
| Disease | Malignant Head and Neck Neoplasm | 6.79e-03 | 44 | 259 | 3 | C0278996 | |
| Disease | amino acid measurement | MYT1 TGM5 MAP3K4 ADRA1A RABGAP1L SYK ANO2 TCF12 ARHGEF28 SYNE1 DNAJC18 MMRN1 UNC13C | 7.29e-03 | 678 | 259 | 13 | EFO_0005134 |
| Disease | amyotrophic lateral sclerosis, age at onset | 7.47e-03 | 15 | 259 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | delta-6 desaturase measurement | 7.47e-03 | 15 | 259 | 2 | EFO_0007765 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 7.47e-03 | 15 | 259 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | Tinnitus, response to cisplatin | 7.47e-03 | 15 | 259 | 2 | GO_0072718, HP_0000360 | |
| Disease | Autosomal recessive primary microcephaly | 7.47e-03 | 15 | 259 | 2 | cv:C3711387 | |
| Disease | N-acetylmethionine measurement | 7.47e-03 | 15 | 259 | 2 | EFO_0021427 | |
| Disease | B-cell acute lymphoblastic leukemia | 7.47e-03 | 15 | 259 | 2 | EFO_0000094 | |
| Disease | health study participation | 7.70e-03 | 195 | 259 | 6 | EFO_0010130 | |
| Disease | QT interval | RFTN2 PIP4K2A PRRC2B ARHGEF28 UPF1 CCDC141 LIG3 IFRD1 ERCC6L2 ATP2A2 CUX1 | 7.95e-03 | 534 | 259 | 11 | EFO_0004682 |
| Disease | body weight | VPS13C INPP5B ARHGEF38 RABGAP1 HMCES DNAH14 NRXN3 MAST4 RABGAP1L PIP4K2A ZNF638 BAIAP2 CPSF2 MGA UNC13B RAD52 DPYD CNKSR2 LINC00523 POLD3 | 8.15e-03 | 1261 | 259 | 20 | EFO_0004338 |
| Disease | Cardiomyopathy | 8.15e-03 | 47 | 259 | 3 | cv:C0878544 | |
| Disease | Unipolar Depression | 8.19e-03 | 259 | 259 | 7 | C0041696 | |
| Disease | bipolar I disorder | 8.25e-03 | 141 | 259 | 5 | EFO_0009963 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLKSDTRSAEEGGAA | 1686 | Q9UPW8 | |
| RLLDTQDKRSKADTG | 361 | Q6UWZ7 | |
| GKKDSLGTREILSEE | 91 | O60488 | |
| ESSAEKAGRIEKLES | 336 | Q9Y2J4 | |
| GGKDNEETSSLSRLK | 571 | Q8N7J2 | |
| LDDSGERDEKLSKSI | 226 | Q8IYS0 | |
| IKDEKDGLTLSLRES | 276 | O94986 | |
| EKSGELLALQKEADS | 2036 | Q7Z7A1 | |
| LDELRDEGKASSAKQ | 206 | P02768 | |
| ELTGRSKNKSVELED | 221 | Q9Y6Q5 | |
| VDKSLEGEKTGSRDV | 876 | O00192 | |
| KNGFEREKTSDISTL | 886 | Q9NR09 | |
| DLEKSGISRKNDIDL | 41 | Q6Y288 | |
| SNEREGRDSLSEKLK | 56 | Q86TU6 | |
| QATEEEKSKLESGLT | 491 | Q9P2I0 | |
| TGDDKKRIIDSARSA | 136 | P31947 | |
| NGTRGKITDLIKDLD | 186 | P01011 | |
| GKKSSSLVDIREEET | 461 | Q96Q42 | |
| GDGDIFKKLDSELSR | 1321 | O14514 | |
| ALESTKASELDLEKG | 481 | P11274 | |
| GSDEAIKSILEQAKR | 666 | P39880 | |
| EIVEDKKSGRSSDIT | 146 | Q5T8D3 | |
| ELEKKLSSERPSSDG | 271 | Q8N556 | |
| GLKTDKSDSEQVTLR | 221 | P35348 | |
| LQRSTGEESDLAKKE | 451 | Q9NXL2 | |
| AEAGTKKDNSILEIR | 576 | Q9NZU0 | |
| KVQDLGRDSKTSSAE | 281 | P48960 | |
| DNTGRGKSKSVELED | 221 | Q9BXS5 | |
| KKTLDEERNSSSRSG | 441 | Q86XR8 | |
| TDSGKVLSKLQARLD | 331 | Q6Q788 | |
| TELAKKSEDSGADAL | 651 | Q12882 | |
| DFNSEKDIVRGSSKL | 581 | Q6XZF7 | |
| KDGSVLREGTLKDIQ | 886 | O60706 | |
| EKDIISDTSGDFRKL | 156 | P07355 | |
| SSAEKDSVLNIARGK | 896 | A6QL64 | |
| SFSNITREKKDGEIS | 936 | A6QL64 | |
| DSFSNITREKKDGEI | 441 | Q8N2N9 | |
| DDAKVLLGLKERSTS | 101 | Q12797 | |
| LFRKLKDETEAGETD | 706 | Q9NQ90 | |
| SATRLSKAKEIGADL | 206 | Q00796 | |
| ESNRKKETELLGSFS | 1161 | Q9NSV4 | |
| SKENISVALTDGKDR | 1041 | Q9NSY1 | |
| EKDIISDTSGDFRKL | 156 | A6NMY6 | |
| KKQLSSDISSDGERE | 81 | Q6UXS9 | |
| SFGRDSDEGKLEKTS | 1156 | Q9UKL3 | |
| RGKVSKDDRSDVESS | 341 | Q8N5B7 | |
| ASEKLGVLTSREKAA | 356 | Q9NV06 | |
| LTGESDQVRKSVDKD | 241 | Q01814 | |
| IRADGKISEQSDAKL | 526 | P25705 | |
| GSKSKLSLQLEDAET | 131 | Q8TBY9 | |
| NSEDDKKRGRSTDSE | 281 | O75175 | |
| SADGLRVVDDKTKDL | 121 | Q9Y6R0 | |
| TDKDGRLSKAEILGN | 291 | Q96D15 | |
| GDLSEKEASLLDLKE | 666 | Q8IUD2 | |
| DGSLSAKSFQELKDR | 111 | O95897 | |
| ALSLEKARKEAVTDG | 136 | P43351 | |
| EDKNKATSRSIGLDT | 421 | Q52LD8 | |
| DKDVTIGFSLDRTKN | 81 | Q5VW38 | |
| EKSVTKDAEGLAARD | 181 | Q96HW7 | |
| KREKTIASDSEEEAG | 431 | Q96ST2 | |
| KILGDIGERVKSASD | 836 | O75747 | |
| IDSRKGAEKLLSSLD | 736 | P12883 | |
| KLELESRGSAEKLGT | 431 | A6NDB9 | |
| GRTSESDEDKRKAEA | 1196 | Q8N1W1 | |
| KRDLAKDITSDTSGD | 161 | P04083 | |
| GLKATSDEKDSVLNI | 926 | Q5JPF3 | |
| KSAEAILKRESGAAE | 851 | Q9P2R3 | |
| TRSERGDGSDVKEKT | 71 | O60829 | |
| RVKGISSTKEVLDED | 981 | Q9Y3P9 | |
| SATGDEKFADRLLKD | 1561 | O75140 | |
| GRSSSENDVELLTKK | 496 | Q9C0D6 | |
| EGLKATTTDVRKNDS | 86 | Q9ULC0 | |
| GSEDLTKDRSLTGKL | 131 | Q9Y618 | |
| DLKLTSEEESQRLKG | 496 | A5A3E0 | |
| DGRLIVSASDDKTVK | 156 | Q8NBT0 | |
| ALLDKKDSSDSGVRS | 1576 | Q9ULH0 | |
| GDARKTLDSVAKERA | 86 | P02545 | |
| TALRKLGEKLTADDE | 136 | Q8WZA0 | |
| GDKTKERSLTAGLEF | 291 | Q8TD90 | |
| ELSDKVRELSRSAGK | 2121 | Q16787 | |
| GKSGITEDARVLKTE | 2226 | Q8IWI9 | |
| SLDAKVLGSKDATRQ | 46 | Q9NRM7 | |
| GKVSEDKSREFQSLL | 361 | Q13201 | |
| DRKLLTLEDKELGSG | 366 | P43405 | |
| RTGRSLKEKTSLADD | 6766 | Q03001 | |
| LKDSSEKDGLSEVDT | 591 | Q76N89 | |
| TSKVSLGLDENVSKR | 286 | P04035 | |
| SEDNIDLSGLSTKTK | 616 | A6NM62 | |
| SGITKSDLRLDKAGE | 866 | Q8NCM2 | |
| EEEFEKGLLTTGKRT | 571 | Q8NHQ9 | |
| RSEEGKTTKDLSIAV | 656 | Q8IY21 | |
| DAEALTKNDRSTEGK | 46 | Q10570 | |
| EKGAILTDTSVKRND | 341 | Q5NUL3 | |
| GALNEAESKTIRLSK | 1311 | Q7Z406 | |
| DSRKATEKLLGSLDL | 786 | A7E2Y1 | |
| LTTSKSDLEAKEGEV | 716 | Q96RV3 | |
| DSDSDISGDALKKDL | 926 | O95206 | |
| LESELRDGSGKKVAV | 51 | O60658 | |
| DDESSQKDIKVSSRG | 541 | Q99081 | |
| NSGDEKRKLSLSEGK | 121 | Q49A26 | |
| ETEKLKEELSASSAR | 1256 | Q96Q89 | |
| KSLKLTVDDDVAEGT | 786 | Q9Y4C0 | |
| DKLLERVSAIASEGK | 71 | Q8WX92 | |
| ETKEAGSLRSVLNKE | 1236 | Q7LBC6 | |
| KALEDSSFLKRSGRD | 206 | Q8WWI1 | |
| STEEARKELQAAGKS | 441 | P06744 | |
| RDGAADKVKTALLTE | 121 | Q96N16 | |
| DITIKLRDKAGNTTE | 346 | Q8WWY8 | |
| SSIGEVESAKLIRDK | 41 | Q15717 | |
| KAEGSEIRLAKVDAT | 71 | P07237 | |
| RLKIEAKNGTLSVSD | 621 | Q9BSC4 | |
| SGLETAKKRNSISDD | 286 | Q76FK4 | |
| RATTKKIEDLTELEG | 151 | P49916 | |
| NAEDIKSGKLSRELD | 76 | Q02818 | |
| SVGSSKREEEAKSEL | 286 | Q9UI10 | |
| ITEAKEDSRKAEGST | 466 | Q969R2 | |
| AAALRAAEKSIGTKE | 1156 | Q8WXE0 | |
| LTETKDGSGLEEKVR | 401 | P49321 | |
| LLTEGSEEKRSAKTV | 146 | O95140 | |
| SKEGALKLAATGRED | 151 | B7ZAP0 | |
| KGITEETQKALDRSL | 691 | O60244 | |
| KKALQALRDEASSSG | 516 | Q8NA29 | |
| DLKLTSEEESQRLKG | 496 | Q6S8J3 | |
| LTDSDLKKTVDESAR | 481 | Q9NZW5 | |
| LKDETGELSSADEKR | 591 | Q92900 | |
| GTRDEISLDSAKKAA | 211 | P38398 | |
| DTELKGLSKIERANA | 456 | P16615 | |
| LKIKDARLSDSGEFS | 386 | Q8N9C0 | |
| LLKSLKSAESQGRSE | 141 | Q9P2D3 | |
| KISEESGETAKRRSA | 381 | Q9Y6J0 | |
| DVGSTRSESEKILNK | 486 | Q6ZP82 | |
| VITDGQTDSRDKEKL | 901 | Q2UY09 | |
| SVKSKIGELEDESLS | 121 | Q8NHQ1 | |
| KSAAEREALKGEIQS | 911 | H7BZ55 | |
| AAAIRDSIELTKEKG | 606 | Q9P2H0 | |
| ESKGSLIDFSEDRLK | 2416 | Q8N3K9 | |
| FTAKSKVLTRDTEGD | 261 | Q53FE4 | |
| DKEDDITELKTGSDL | 281 | P52306 | |
| SSRIESEAKKLAGAS | 836 | Q5VT06 | |
| AKSTQDLSEGISRKD | 176 | P24588 | |
| SRGKVSKDDRSDIES | 331 | Q6ZMG9 | |
| KAEGLEKSLSSLETR | 196 | Q8TD31 | |
| DVQTTSGDLKLDKID | 196 | Q9BSJ5 | |
| SEISDIEGDLTLRKK | 921 | Q0VDD8 | |
| TLDKSAKTRQAALEG | 91 | O00458 | |
| GRTQKSKSEVIEDSD | 231 | Q56NI9 | |
| ADSDLKEDGISSRKS | 441 | P27448 | |
| GEGTEKSSQAKELLR | 1661 | O15021 | |
| KRDKVLTDSGSLDST | 206 | Q86UE4 | |
| KTLSDDIKESLESEG | 141 | O95260 | |
| ILGVSRDASDEELKK | 86 | Q9H819 | |
| ELLKDLDEKDSGLSS | 281 | Q8NA03 | |
| TATKLNSGEDKIEDI | 746 | P32019 | |
| KSSGRSDDNRESLEK | 136 | P30085 | |
| AVASTELLKDGKRET | 166 | Q96J84 | |
| GKETLKDESGQESRT | 111 | Q5JUW0 | |
| ADDRKVKSTITLDGG | 76 | P15090 | |
| ILKRKGTSDISDESD | 981 | Q5T890 | |
| TESLDKEGKGEIRSL | 571 | A6NE01 | |
| LLDGTKFDSSLDRKD | 61 | Q02790 | |
| TSAEKVDLVLSGKRD | 276 | Q7Z2K8 | |
| AKTSLIAASGKEDDL | 11 | Q6ZVF9 | |
| FGSKRKRSSSEDDDL | 301 | Q14839 | |
| EKNTDRSLLEKVGLS | 246 | Q99675 | |
| KTEVAEALTKAEAGR | 6 | Q86T23 | |
| RGISSKLDSLADELK | 401 | Q9NZJ4 | |
| ILDLGSGDEKVRKSD | 1146 | A3KN83 | |
| IAEGFSESKKRSSED | 731 | Q9Y597 | |
| KEGLSLNSEEKLDSA | 411 | Q5VV67 | |
| DLVVKKELRASGSSQ | 271 | Q96FZ2 | |
| KGDSSAEELKLATQL | 136 | P26373 | |
| SSCLLDRKEEKGDSA | 181 | Q9H7T9 | |
| DLKGSTVAREASDKE | 211 | P48426 | |
| RLSKSEDKESLTEDA | 6 | Q9BXW9 | |
| LESGRSDIKVKNITD | 776 | P42702 | |
| KTRESDRLEEKGSLT | 886 | Q9UPQ0 | |
| QGRSDSSSKKDVIEL | 151 | Q15084 | |
| LEKISKEERESESGG | 151 | Q96G25 | |
| GALLKRLAEADSEKA | 291 | Q5BJF6 | |
| STKESEEGQLKSALE | 361 | Q9BVI0 | |
| SADGLRVVDEKTKDL | 91 | P49757 | |
| SKKLERLESEDDSLG | 491 | Q9Y6R4 | |
| KSTGNLLDDAVKRIS | 196 | O43903 | |
| ELVRSLKAGNASKDE | 21 | P23381 | |
| SDIEVDKKELTGRTL | 486 | P26640 | |
| RAKLDELSAKRETSG | 236 | Q9UQE7 | |
| KAKSGQELTVDLDDL | 1081 | Q7Z5M5 | |
| LDGTTKSEDRAALLK | 1096 | P51531 | |
| ESSDRTGDSKVLEAK | 2431 | Q8NF91 | |
| ESTLGSKDTLEKRLS | 2651 | Q8NF91 | |
| SKIKELIDSREIGAS | 2881 | Q8NF91 | |
| GSSAEKASKAELLTL | 5236 | Q8NF91 | |
| SVTLESTGLADEKRK | 271 | Q969F9 | |
| SSLRKSDGNADISEK | 856 | Q6T4R5 | |
| ARKSLAEVEAGKDAS | 46 | Q9UD57 | |
| TADGESLSIKEDKIQ | 81 | Q9Y2K3 | |
| EEKSSLGAVAREEAK | 426 | Q96D09 | |
| DLKGSTVAREASDKE | 216 | P78356 | |
| ESGKRKLEEVLSTEG | 516 | O15355 | |
| IFRNSSDSDGKLEKA | 66 | A6NMZ2 | |
| KNVREKLSAGESISL | 301 | Q8IYU8 | |
| ERSEQKKSEGLITSE | 706 | Q05209 | |
| DKDSDLRLVVGDSLK | 1766 | P48634 | |
| DLKLTSEEESQRFKG | 341 | P0CG39 | |
| KLTSEEESQRLKGSE | 461 | P0CG39 | |
| TRSKAEELLSRTGKD | 11 | Q92835 | |
| SEELAREIVGKDKSL | 1316 | Q13796 | |
| GSGRTSVKALDEDKE | 721 | Q6ZUB1 | |
| LSDTKAAGEVKALDD | 266 | Q9BRX2 | |
| GKTDEARRLDEKESS | 666 | Q5T8A7 | |
| DLKLTSEEESQRLKG | 496 | P0CG38 | |
| GKRVALSDDETKETE | 301 | Q15054 | |
| DSLALGKSEEEALKQ | 1026 | P42338 | |
| SVIQGDSSKRADKDE | 151 | P0DJH9 | |
| LDKDNEKFLSVRGTT | 176 | P27930 | |
| KTTDGVGVDEKLSLR | 86 | O94818 | |
| LSQEGKSTDEVDSKR | 1446 | Q01082 | |
| EKRTKDLADLQGSDS | 221 | P08912 | |
| KSSSTGNLLDKDDLA | 451 | Q9UQB8 | |
| KTLEGDGDQERLISK | 231 | Q8IVF2 | |
| EGDLSLADKEVTAKD | 816 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 981 | Q8IVF2 | |
| EGELSLADKDVTAKD | 1146 | Q8IVF2 | |
| EGDLSLADKAVTAKD | 1641 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 1806 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 2961 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 3126 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 3291 | Q8IVF2 | |
| EGDLSLAEKDVTAKD | 3456 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 3621 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 3786 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 4116 | Q8IVF2 | |
| EGDLSLADKDVTAKD | 4446 | Q8IVF2 | |
| KRSSADKGVALSLDD | 476 | P78348 | |
| SLDTSEEGGRKKLLA | 411 | Q9BPX3 | |
| FEEGSELSKGTTRKE | 261 | Q9HAW4 | |
| EEKRLLKSGSNDDSD | 301 | Q96AJ1 | |
| EKSESREEKLGDSLQ | 896 | Q8WXI2 | |
| STGLSLTKVDEREKQ | 311 | Q13492 | |
| LSRKAAESLLVKDGD | 531 | Q6S5L8 | |
| TEEEASRGIKEKLSI | 46 | Q7Z5L4 | |
| NLFDISTEEGSTKRK | 31 | Q14690 | |
| GKRAKDTSSEEVNLS | 386 | Q8N0X7 | |
| SSLSESLKTELGKDL | 1111 | Q92574 | |
| DASDKKSEGSLRECL | 101 | Q9BSG1 | |
| LGDSKLQRDVSLDSK | 201 | Q96LW9 | |
| EKARIVSGNDLDASK | 1001 | Q8NB66 | |
| KLSKSDEQLSSLDRD | 356 | Q13905 | |
| KGLRKSDNSRSSDED | 631 | Q9UGH3 | |
| EVSLLDKITDKESGE | 196 | Q96P16 | |
| SATKRKGAILSEEEL | 361 | P12270 | |
| SKKALASDRSGADEL | 331 | Q6ZV50 | |
| EDKGDSLDSVEALIK | 1471 | Q13813 | |
| KSTDGSRKELIVDAE | 1076 | Q92752 | |
| DKLAKESGLARTDIV | 691 | Q9UKY1 | |
| QLEDDSLDSKGKELS | 76 | Q5JSH3 | |
| SLDSKGKELSDQATA | 81 | Q5JSH3 | |
| TKEAGKDGRENTTLL | 116 | Q9Y6L7 | |
| LDDEKKGERLPSSSS | 191 | Q6P2S7 | |
| LGEESTRLAKEKEQS | 966 | Q5JSZ5 | |
| RAKESLKELSLAGNE | 281 | P13489 | |
| ESLKFGRTDVAESEK | 751 | Q9Y4E1 | |
| SRIEEALQKAAEKGT | 116 | Q709C8 | |
| KGSTLDLSDLEAEKL | 196 | O00767 | |
| EFVKLKSESRSTEEG | 1576 | O14795 | |
| DKGSAEEEKIDALLS | 471 | Q9H9C1 | |
| DKLIRISALGEEKSS | 591 | O43548 | |
| SFSTDSRLDKEVKDG | 366 | Q8N841 | |
| KRLSKSNIDISSGLE | 316 | Q9BZ71 | |
| SETAKDIEGKENSLA | 986 | Q4KWH8 | |
| ASLSAAKRKLEGELS | 126 | Q9H6N6 | |
| ESLKFGRTDVAESEK | 751 | Q641Q2 | |
| KRGTEDRSDQSSLKS | 1241 | Q9H6S0 | |
| DGLTKRLESASKNTL | 331 | Q6ZSB9 | |
| RSLSKDGTKESLEDA | 36 | Q96LX8 | |
| ASREKLQKLGEGDSS | 96 | Q86XE0 | |
| KLEGRVASDEDLKLS | 276 | Q86XE0 | |
| SKSSEDEELRKLASV | 121 | Q96QC0 | |
| LKLTSEEESQRLKGS | 416 | Q6S545 | |
| RTLEDGKKEAAASGL | 41 | O95881 | |
| SRNVEESEKGSLKIE | 566 | Q9H2Y7 | |
| ASTLKRDADASKAVE | 771 | Q14966 | |
| SLVRENSKETFSGKE | 156 | Q5VZL5 | |
| NLEGRTGTAEKKLAD | 121 | Q9UDV7 | |
| GASSEDTLLKDAAKV | 186 | P09936 | |
| SKADLSRKGSVDEDV | 16 | Q6IPR3 | |
| TLEGRTGTAEKKLAD | 66 | Q6ZMS7 | |
| NSFGTELSKEDRAKL | 226 | P61421 | |
| KSKLESVISDEGDLQ | 1341 | B2RTY4 | |
| EDAASEESSKQKGIL | 241 | Q01538 |